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The objective of studies described in this thesis was to investigate mechanisms through 
which lithocholic acid (LCA) and caloric restriction (CR) delay chronological aging of the budding 
yeast Saccharomyces cerevisiae. My overall hypothesis was that each of these aging-delaying 
interventions slows down yeast chronological aging by targeting different cell biological 
processes. Findings presented here support this hypothesis. Indeed, I found that LCA delays the 
chronological mode of S. cerevisiae aging by altering the lipid composition of mitochondrial 
membranes. I demonstrated that these LCA-driven alterations in mitochondrial membrane 
lipidome elicit distinct changes in the abundance of many mitochondrial proteins, thereby enabling 
the establishment of a geroprotective pattern of mitochondrial functionality. These findings 
provided the first comprehensive evidence that mitochondrial lipidome plays an essential role in 
defining longevity of chronologically aging yeast. I found that CR slows yeast chronological aging 
through a different mechanism. This previously unknown mechanism links the chronological 
mode of S. cerevisiae aging to cell cycle regulation and controlled cell differentiation. The key 
aspects of my hypothesis-driven investigation of these two different mechanisms of aging delay 
are outlined below.    
The Titorenko laboratory has previously found that exogenously added LCA delays yeast 
chronological aging. The laboratory has demonstrated that LCA enters the yeast cell, is sorted to 
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mitochondria, resides in both mitochondrial membranes, changes the relative concentrations of 
different membrane phospholipids, triggers changes in the concentrations of many mitochondrial 
proteins, and alters some key aspects of mitochondrial functionality. Based on these observations, 
I hypothesized that the LCA-driven changes in mitochondrial lipidome may have a causal role in 
the remodeling of mitochondrial proteome, which may in turn alter the functional state of 
mitochondria to create a mitochondrial pattern that delays yeast chronological aging. To test this 
hypothesis, I investigated how the ups1Δ, ups2Δ and psd1Δ mutations that eliminate enzymes 
involved in mitochondrial phospholipid metabolism influence the mitochondrial lipidome. I also 
assessed how these mutations affect the mitochondrial proteome, influence mitochondrial 
functionality and impinge on the efficiency of aging delay by LCA. My findings provide evidence 
that 1) LCA initially creates a distinct pro-longevity pattern of mitochondrial lipidome by 
proportionally decreasing phosphatidylethanolamine and cardiolipin concentrations to maintain 
equimolar concentrations of these phospholipids, and by increasing phosphatidic acid 
concentration; 2) this pattern of mitochondrial lipidome allows to establish a specific, aging-
delaying pattern of mitochondrial proteome; and 3) this pattern of mitochondrial proteome plays 
an essential role in creating a distinctive, geroprotective pattern of mitochondrial functionality.  
A yeast culture grown in a nutrient-rich medium initially containing 2% glucose is not 
limited in calorie supply. When yeast cells cultured in this medium consume glucose, they undergo 
cell cycle arrest at a checkpoint in late G1 and differentiate into quiescent and non-quiescent cell 
populations. Studies of such differentiation have provided insights into mechanisms of yeast 
chronological aging under conditions of excessive calorie intake. CR is an aging-delaying dietary 
intervention. I hypothesized that CR may slow down yeast chronological aging by eliciting specific 
changes in cell cycle regulation and controlled cell differentiation. To test this hypothesis, I 
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investigated how CR influences the differentiation of chronologically aging yeast cultures into 
quiescent and non-quiescent cells, and how it affects their properties. I found that CR extends yeast 
chronological lifespan via a mechanism linking cellular aging to cell cycle regulation, maintenance 
of quiescence, entry into a non-quiescent state and survival in this state. My findings suggest that 
CR delays yeast chronological aging by causing specific changes in the following: 1) a checkpoint 
in G1 for cell cycle arrest and entry into a quiescent state; 2) a growth phase in which high-density 
quiescent cells are committed to become low-density quiescent cells; 3) the differentiation of low-
density quiescent cells into low-density non-quiescent cells; and 4) the conversion of high-density 
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1.1     Introduction 
          Studies of the budding yeast Saccharomyces cerevisiae, a unicellular eukaryote amenable 
to comprehensive molecular analyses, have provided deep insights into mechanisms of cellular 
aging in multicellular eukaryotes [1-5]. These studies have been instrumental in identifying 
genes, uncovering signaling pathways and discovering chemical compounds shown to 
orchestrate a distinct set of cellular processes that define organismal longevity in eukaryotes 
across phyla [5-21]. These studies have revealed that the key features of the aging process and 
the mechanisms of its deceleration by certain longevity-extending genetic, dietary and 
pharmacological interventions are evolutionarily conserved [1-3, 6, 8-10, 15-19].  
          Two different methods have been established to investigate aging of budding yeast; each of 
them is designed to monitor a distinct aspect of the aging process. One method measures yeast 
replicative lifespan (RLS) by assessing the number of asymmetric mitotic divisions a mother cell 
can undergo prior to cell cycle arrest [2, 3, 5]. Another method measures yeast chronological 
lifespan (CLS) by assessing the length of time a cell remains viable following cell cycle arrest; a 
cell is considered to be viable if it can re-enter the cell cycle in response to addition of essential 
nutrients [2-4, 12, 13]. The use of these two methods has significantly advanced our understanding 
of mechanisms that underlie the replicative and chronological paradigms of cellular aging in yeast 
[2-5, 12, 13]. 
 
1.1.1   Some traits of mitochondrial functionality are essential for aging of S. cerevisiae 
          An age-related deterioration of mitochondrial functionality is the universal hallmark of 
aging in eukaryotes across phyla [22]. This age-related deterioration is manifested as a progressive 
decline of the efficiencies with which mitochondria create the bulk of cellular ATP and generate 
biosynthetic intermediates for amino acids, nucleotides and lipids [22-31].  
          The functional state of mitochondria defines the pace of the replicative and chronological 
modes of aging in the yeast S. cerevisiae [32-36]. Some traits of mitochondrial functionality are 
well known for their essential roles in yeast replicative and chronological aging. These 
mitochondrial traits include the following: 1) electron transport chain, oxidative phosphorylation 
and membrane potential [32-43]; 2) reactive oxygen species (ROS) homeostasis [32-34, 38, 44-
55]; 3) protein synthesis and proteostasis [32, 48, 56-68]; 4) synthesis and assembly of iron-sulfur 
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clusters [40, 48, 69-71]; 5) amino acid synthesis [33, 45, 48, 55, 72-77]; and 6) NADPH synthesis 
[33, 48, 55, 78, 79].  
          However, prior to studies described in my thesis, it was unknown if such an important trait 
of mitochondrial functionality as the composition of mitochondrial membrane lipids can play a 
role in yeast aging. Our high-throughput screen of almost 19,000 chemical compounds from 
several commercial libraries has previously identified lithocholic bile acid (LCA) as a molecule 
that delays the onset and decreases the rate of yeast chronological aging [7, 80]. Although LCA 
delays the chronological mode of aging in S. cerevisiae, this yeast is unable to synthesize LCA or 
any other bile acid [7]. Bile acids are known to be synthesized from cholesterol in mammalian 
hepatocytes of the liver [7]. In mammals, these amphipathic by their chemical structure molecules 
operate as 1) trophic factors for the enteric epithelium; 2) detergents for the emulsification and 
absorption of dietary lipids and fat-soluble vitamins; and 3) signaling molecules that control lipid, 
glucose and energy homeostasis and stimulate detoxification of xenobiotics [7].  
We showed that in S. cerevisiae, the aging-delaying efficiency of LCA under caloric 
restriction (CR) on 0.2% glucose greatly exceeds its aging-delaying efficiency under non-CR 
conditions on 2% glucose [7]. We demonstrated that exogenously added LCA enters the yeast cell, 
accumulates in mitochondria, resides mainly in the inner mitochondrial membrane (IMM), and 
associates with the outer mitochondrial membrane (OMM) [81]. We provided evidence that 
mitochondria-associated LCA alters the abundance and relative concentrations of different classes 
of membrane phospholipids [81], elicits age-related changes in the concentrations of many 
mitochondrial proteins [82], and modifies the age-related chronology of some key aspects of 
mitochondrial functionality [81]. Based on these findings, we proposed the following hypotheses: 
1) LCA delays yeast chronological aging because it initially causes specific changes in the 
composition of mitochondrial membrane lipids; 2) as outlined in Figure 1.1, these changes in 
mitochondrial membrane lipidome include an increase in the concentrations of phosphatidic acid 
(PA), phosphatidylglycerol (PG), phosphatidylcholine (PC) and phosphatidylserine (PS), as well 
as a decrease in the concentrations of cardiolipin (CL),  monolysocardiolipin (MLCL) and 
phosphatidylethanolamine (PE); 3) the LCA-driven changes in mitochondrial lipidome then alter 
mitochondrial proteome; and 4) these changes in protein composition of mitochondria lead to 
specific alterations in mitochondrial functionality, thus creating a mitochondrial pattern that delays 
the onset and slows down the progression of yeast chronological aging (Figure 1.1) [82, 83]. 
 3 
Figure 1.1. Our hypothesis on how LCA 
delays yeast chronological aging by altering 
the composition of mitochondrial membrane 
phospholipids. See text for more details. 
Abbreviations: Abbreviations: CDP-DAG, 
cytidine diphosphate-diacylglycerol; CL, 
cardiolipin; DAG, diacylglycerol; ER, the 
endoplasmic reticulum; IMM, the inner 
mitochondrial membrane; IMS, the 
intermembrane space; MAM, the 
mitochondria-associated membrane domain of 
the ER; OMM, the outer mitochondrial 




phosphatidylinositol; PS, phosphatidylserine. 
 
 
The relative concentrations of different classes of membrane phospholipids in yeast 
mitochondria depend on several processes known to be accelerated by enzymes confined to both 
mitochondria and the endoplasmic reticulum (ER) [192-199]. Among these processes are the 
following steps of phospholipid synthesis and transfer: 1) the synthesis of PA, cytidine 
diphosphate-diacylglycerol (CDP-DAG), diacylglycerol (DAG), PS, PC and phosphatidylinositol 
(PI) in the ER; 2) the movement of PA from the ER to the outer mitochondrial membrane (OMM) 
through mitochondria-ER contact sites at zones of a juxtaposition between the OMM and the 
mitochondria-associated membrane (MAM) domain of the ER; 3) the transfer of PA from the 
OMM across the intermembrane space (IMS) to the inner mitochondrial membrane (IMM; 4) the 
conversion of ER-derived PA into CDP-DAG, phosphatidylglycerol-phosphate (PGP), PG, CL 
and MLCL in a series of reactions that occur in the IMM; 5) the transfer of PS from the ER to the 
OMM via mitochondria-ER contact sites; 6) the transport of PS from the OMM via the IMS to the 
IMM, where PS is converted into PE; 7) the synthesis of PE from PS in the OMM, which requires 
a close apposition between the two mitochondrial membranes; 8) the transfer of PC and PI from 
the ER to the OMM via mitochondria-ER contact sites, which is followed by the movement of PC 
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and PI from the OMM to the IMM; and 9) the movement of DAG and CDP-DAG from the ER to 
the OMM across mitochondria-ER contact sites, and the subsequent transfer of these two 
phospholipids to the IMM (Figure 1.1) [192-199]. 
We have previously demonstrated that mitochondrial membranes of yeast treated with 
LCA have decreased concentrations of non-bilayer forming phospholipids and increased 
concentrations of bilayer forming phospholipids [81]. The shape of a phospholipid molecule is 
known to be defined by the relative sizes of the cross-sectional areas of its hydrophilic head group 
and hydrophobic acyl chains, as follows: 1) if the cross-sectional areas of the hydrophilic head 
group and hydrophobic acyl chains of a phospholipid are equally sized, it has a cylindrical shape; 
2) if the cross-sectional area of the hydrophilic head group of a phospholipid is smaller than the 
cross-sectional area of its hydrophobic acyl chains, it has a cone shape; and 3) if the cross-sectional 
area of the hydrophilic head group of a phospholipid is larger than the cross-sectional area of its 
hydrophobic acyl chains, it has an inverted cone shape [81]. Moreover, the relative concentrations 
of cylinder-, cone- and inverted cone-shaped phospholipids in a membrane have been shown to 
define membrane curvature; therefore, changes in the relative concentration of these differently 
shaped lipids can elicit changes in membrane curvature [81]. For the IMM, an increase in the 
relative concentrations of phospholipids having the bilayer forming shape of a cylinder decreases 
the extent of membrane curving [81]. This, in turn, causes the following three kinds of 
simultaneous changes in mitochondrial morphology: 1) an increase in the abundance of the IMM 
domains exhibiting so-called “flat” bilayer conformation; 2) a decrease in the abundance of the 
IMM domains displaying negative curvature (i.e., membrane curving away from the mitochondrial 
matrix) characteristic of mitochondrial contact sites between the IMM and OMM; and 3) a 
decrease in the abundance of the IMM domains having positive curvature (i.e., membrane curving 
towards the mitochondrial matrix) characteristic of mitochondrial cristae formed by the IMM [81]. 
Furthermore, the simultaneous increase in the relative concentrations of cone- and inverted cone-
shaped phospholipids, both being non-bilayer forming species, increases the extent of membrane 
curving thus increasing the abundance of mitochondrial contact sites and mitochondrial cristae 
[18, 73, 74]. We have previously found that LCA 1) decreases the relative concentrations of non-
bilayer forming phospholipids; 2) increases the relative concentrations of bilayer forming 
phospholipids; 3) decreases the abundance of the IMM domains having negative curvature 
characteristic of mitochondrial contact sites between the IMM and OMM; 4) decreases the 
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abundance of the IMM domains that have positive curvature typical of mitochondrial cristae 
formed by the IMM; and 5) increases the abundance of the IMM domains having flat bilayer 
conformation [81]. 
 
1.1.2 Chronologically aging yeast cultures contain populations of quiescent and non-
quiescent cells 
          A body of knowledge about mechanisms underlying chronological aging of the yeast 
Saccharomyces cerevisiae has been provided by studies in which yeast cells were cultured in a 
nutrient-rich liquid medium initially containing 2% glucose [84, 85]. Under these so-called non-
caloric restriction (non-CR) conditions yeast cells are not limited in the supply of calories [84, 86, 
87]. When glucose is exhausted at the diauxic shift, cells in a non-CR yeast culture undergo arrest 
at the checkpoint START A in the late G1 phase of the cell cycle [97]. The non-CR yeast culture 
then differentiates into several cell populations [88-91].  
          One of these cell populations is a population of quiescent (Q) cells (Figure 1.2); these cells 
exist in a distinct non-proliferative state called G0 [88-94]. Q cells are mainly daughter cells [88-
90]. They are unbudded and uniformly sized, are refractive by phase-contrast microscopy and 
enclosed by a rigid cell wall, have high buoyant density, store glycogen and trehalose in bulk 
quantities, are highly metabolically active, exhibit high rates of mitochondrial respiration and low 
concentrations of reactive oxygen species (ROS), are able to form colonies when plated on fresh 
solid medium, can re-enter mitosis when nutrients become available following transfer to fresh 
liquid medium, are resistant to long-term thermal and oxidative stresses, exhibit low rates of 
mutations that impair mitochondrial functionality, and display a delayed onset of the apoptotic and 
necrotic modes of programmed cell death (PCD) [88-91, 93, 94]. 
          The differentiation of a non-CR yeast culture following glucose exhaustion at the diauxic 
shift also yields at least three subpopulations of non-quiescent (NQ) cells (Figure 1.2), most or all 
of which are first- and higher-generation mother cells [88-96, 93, 94]. One subpopulation of NQ 
cells consists of metabolically active cells that exhibit high reproductive (colony-forming) 
capacities, high ROS concentrations, impaired mitochondrial respiration and elevated frequencies 
of mutations impairing mitochondrial functionality (Figure 1.2) [88-91, 93, 94]. Another 
subpopulation of NQ cells includes metabolically active cells that are impaired in reproductive 
(clonogenic) ability and are likely to be descended from NQ cells of the first subpopulation (Figure 
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1.2) [88-91, 93, 94]. The third subpopulation of NQ cells is composed of cells that exhibit 
hallmarks of the apoptotic and/or necrotic modes of PCD and may derive from NQ cells of the 
second subpopulation (Figure 1.2) [88-91, 91, 94].  
          
Figure 1.2. When glucose is exhausted at the 
diauxic shift in a yeast culture grown on 2% 
glucose, cells in this culture undergo arrest at the G1 
phase of the cell cycle; this culture then 
differentiates into four cell populations. One of 
these cell populations is a population of quiescent 
(Q) cells. In addition, there are at least three 
subpopulations of non-quiescent (NQ) cells. From: 
Reference [90]. 
 
           
          In response to a depletion of glucose (as well as nitrogen, phosphate or sulfur), a signaling 
network of certain proteins and protein complexes orchestrates cell cycle arrest at the G1 phase of 
the cell cycle, the differentiation of a chronologically aging non-CR yeast culture into populations 
of Q and NQ cells, and quiescence maintenance. Proteins and protein complexes integrated into 
this signaling network operate as network nodes, many of which are connected by physical links 
known to be predominantly phosphorylations and dephosphorylations that activate or inhibit 
specific target proteins [92, 95-100]. The core hubs of this signaling network of a quiescence 
program are four nutrient-sensing protein complexes, each of which exhibits a protein kinase 
activity and modulates many downstream effector proteins integrated into the network (Figure 
1.3). These core hubs of the network are: 1) TORC1 (target of rapamycin complex 1), a key 
regulator of cell metabolism, growth, division and stress resistance in response to changes in the 
availabilities of nitrogen and carbon sources; 2) PKA (protein kinase A), an essential controller of 
cell metabolism, proliferation and stress resistance in response to changes in carbon source 
availability; 3) Snf1 (sucrose non-fermenting, protein 1), a heterotrimeric protein complex required 
for cell growth support and energy homeostasis maintenance after glucose exhaustion; and 4) 
Pho85 (phosphate metabolism, protein 85), a protein kinase associated with various cyclins to 
promote phosphate metabolism, glycogen and trehalose synthesis, oxidative stress response and 
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cellular proteostasis in response to changes in the accessibility of a phosphate source or following 
glucose exhaustion (Figure 1.3) [92, 95, 97, 101, 102]. 
 
 
Figure 1.3. In response to a 
depletion of glucose, a signaling 
network of certain proteins and 
protein complexes orchestrates cell 
cycle arrest at the G1 phase of the 
cell cycle, the differentiation of a 
chronologically aging non-CR 
yeast culture into populations of 
quiescent and non-quiescent cells, 
and quiescence maintenance. See 
text for more details. 
 
           
The four core hubs of the signaling network of the quiescence program modulate many 
downstream effector proteins, including the following: 1) Rim15, a serine-threonine protein kinase 
which, following glucose exhaustion at the diauxic shift, is essential for cell cycle arrest at G1, cell 
survival during stationary growth phase, transcription of many stress response genes, trehalose and 
glycogen accumulation, autophagy, and post-transcriptional protection of a subset of mRNAs 
needed for entry into quiescence; Rim15 is controlled by the TORC1, PKA and Pho85 core hubs 
of the network (Figure 1.3) [101, 103-114]; 2) Sch9, a serine-threonine protein kinase which, prior 
to glucose exhaustion at the diauxic shift, prevents entry into quiescence by stimulating 
transcription of genes essential for ribosome biogenesis, promoting translation initiation and 
suppressing transcription of many stress response genes; Sch9 is modulated by TORC1 (Figure 
1.3) [99, 101, 106, 111, 115-119]; 3) Yak1, a serine-threonine protein kinase which in yeast cells 
entering SP phase is required for cell cycle arrest at G1, suppresses transcription of genes encoding 
ribosomal proteins and activates transcription of many stress response genes; Yak1 is under the 
control of PKA (Figure 1.3) [120-123]; 4) Mck1, a dual-specificity serine-threonine and tyrosine 
protein kinase which, after glucose exhaustion at the diauxic shift, is essential for the accumulation 
of trehalose and glycogen, ROS detoxification and transcription of many stress response genes; 
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Mck1 is likely to be controlled by TORC1 and PKA (Figure 1.3) [125-127]; 5) Msn2/4 and Gis1, 
transcription factors that activate expression of stress-responsive element- and post-diauxic shift-
controlled (respectively) genes involved in protection against thermal, oxidative and osmotic 
stresses, as well as in carbohydrate metabolism; these transcription factors are modulated by 
TORC1, PKA and Snf1 (Figure 1.3) [108, 109, 112, 128-138]; 6) Hsf1, a transcription factor which 
activates expression of many heat shock element-controlled genes involved in protein folding, 
protein synthesis and modification, ROS detoxification, energy generation, carbohydrate 
metabolism, intracellular vesicular trafficking, and cell wall maintenance; Hsf1 is controlled by 
Snf1 (Figure 1.3) [139-142]; 7) Gln3, a transcriptional activator of nitrogen catabolite-repressible 
genes involved in the metabolism and transport of alternative nitrogen sources; Gln3 is under the 
control of TORC1 and Snf1 (Figure 1.3) [130, 143-147]; 8) Gsy2, glycogen synthase which is 
induced upon glucose exhaustion or nitrogen starvation; Gsy2 is modulated by TORC1, PKA, Snf1 
and Pho85 (Figure 1.3) [146, 148-155]; 9) the Atg1-Atg13 complex, which initiates autophagy by 
enabling phagophore assembly site formation; this complex is controlled by TORC1, PKA, Snf1 
and Pho85 (Figure 1.3) [156-163]; 10) Sfp1, a transcription activator of genes encoding ribosomal 
proteins and protein components of ribosome biogenesis machinery; Sfp1 is under the control of 
TORC1 and PKA (Figure 1.3) [116, 118, 159, 164-170]; 11) eIF2α, a subunit of a protein complex 
involved in the initiation of protein synthesis on the ribosome; eIF2α is modulated by TORC1 and 
Snf1 (Figure 1.3) [171, 172]; ]; 12) Crz1, a transcription factor activating expression of stress 
response genes; Crz1 is modulated by PKA and Pho85 (Figure 1.3) [173-177]; 13) Igo1 and Igo2, 
two paralogues proteins whose Rim15-diven phosphorylation upon glucose exhaustion protects 
from degradation a specific set of mRNAs required for entry into quiescence; phosphorylated Igo1 
and Igo2 also inhibit the Cdc55 protein phosphatase 2A (PP2ACdc55) to prevent 
dephosphorylation of the transcription factor Gis1, thereby enabling phosphorylated Gis1 to 
activate transcription of many stress response and carbohydrate metabolism genes, as well as 
transcription of the XBP1 gene encoding a global transcriptional repressor of genes involved in 
cell cycle progression, transition to the Q state and recovery from it; additionally, the Igo1/2-
dependent inhibition of PP2ACdc55 prevents dephosphorylation of the cyclin-dependent kinase 
(CDK) inhibitor Sic1 to protect it from proteolysis - so that phosphorylated Sic1 can elicit cell 
cycle arrest at late G1 (Figure 1.3) [91, 113, 114, 178-184]; and 14) Mpk1, a mitogen-activated 
protein kinase which phosphorylates the CDK inhibitor Sic1 to prevent its proteolytic degradation 
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and to allow phosphorylated Sic1 to assist in arresting cell cycle at a checkpoint in late G1; Mpk1 
is controlled by TORC1 (Figure 1.3) [183, 184]. 
          CR is a dietary intervention that delays aging in yeast and other evolutionarily distant 
eukaryotic organisms [84, 85, 185-189]. Mechanisms linking yeast chronological aging to the 
quiescence program under non-CR conditions are well established [88-92, 94, 126, 127, 180, 190]. 
However, prior to studies described in my thesis, it was unknown if the aging-delaying effect of 
CR in chronologically aging yeast is due in part to the ability of this low-calorie diet to control the 
above quiescence program.    
  
1.2     Thesis outline and contributions of colleagues 
The objective of studies described in Chapter 2 was to test my hypothesis that LCA may 
delay the chronological mode of S. cerevisiae aging by altering the lipid composition of 
mitochondrial membranes. To attain this objective, I investigated how the ups1Δ, ups2Δ and psd1Δ 
mutations eliminating different enzymes involved in mitochondrial phospholipid metabolism 
influence the following: 1) mitochondrial lipidome and proteome; 2) mitochondrial functionality; 
and 3) the geroprotective (aging-delaying) efficiency of LCA in chronologically aging yeast. These 
analyses revealed a distinct LCA-dependent pro-longevity pattern of mitochondrial lipidome, 
which consists in a proportional decrease of phosphatidylethanolamine and cardiolipin 
concentrations to maintain equimolar concentrations of these phospholipids, and in an increase of 
phosphatidic acid concentration. I found that this pattern of mitochondrial lipidome enables a 
sustained specific aging-delaying pattern of mitochondrial proteome. Studies described in Chapter 
2 provide evidence that the mitochondrial lipidome defines not only the rate of yeast chronological 
aging but also the geroprotective efficiency of LCA in chronologically aging yeast. I conducted 
experiments shown in figures 2.1-2.5 and 2.9-2.18, and prepared these figures. The experiments 
shown in figures 2.6, 2.7 and 2.8 were carried out by Anthony Arlia-Ciommo, Simon Bourque, 
Olivia Koupaki and Karamat Mohammad. Pavlo Kyryakov, Paméla Dakik, Mélissa McAuley, 
Younes Medkour and Tamara Di Maulo conducted experiments shown in figures 2.19 and 2.20. 
All findings described in Chapter 2 have been published in Oncotarget (2017) 8:30672-30691. Dr. 
Titorenko provided intellectual leadership of this project; he also edited the first draft of Chapter 
2 and the entire manuscript of the above article. 
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The objective of studies described in Chapter 3 was to test my hypothesis that CR may 
slow down yeast chronological aging by eliciting specific changes in cell cycle regulation and 
controlled cell differentiation. To attain this objective, I investigated how CR influences the 
differentiation of chronologically aging yeast cultures into quiescent and non-quiescent cells, and 
how it affects their properties. Findings presented in Chapter 3 demonstrated that CR extends yeast 
chronological lifespan via a mechanism that links cellular aging to cell cycle regulation, 
maintenance of the Q state, entry into the NQ state and survival in the NQ state. My comparative 
analyses of physical, morphological, reproductive, biochemical and physiological properties of Q 
and NQ cells from differently aged CR or non-CR yeast cultures suggested a hypothetical model 
for this mechanism. This model is critically discussed in Chapter 3. I conducted experiments 
shown in figures 3.1-3.6 and prepared these figures. I designed a model shown in figure 3.11 and 
prepared this figure. Rachel Feldman, Amanda Piano, Anthony Arlia-Ciommo, Vicky Lutchman, 
Masoumeh Ahmadi, Sarah Elsaser, Hana Fakim, Mahdi Heshmati-Moghaddam, Asimah Hussain, 
Sandra Orfali, Harshvardhan Rajen, Negar Roofigari-Esfahani and Leana Rosanelli conducted 
experiments shown in figures 3.7-3.10. All findings described in Chapter 3 have been published 
in Oncotarget (2017) 8:69328-69350. Dr. Titorenko provided intellectual leadership of this 
project; he also edited the first draft of Chapter 3 and the entire manuscript of the above article.          
          In Chapter 4 of my thesis I critically analyzed recent progress in understanding how various 
intercompartmental (i.e., organelle-organelle and organelle-cytosol) communications regulate 
cellular aging in evolutionarily distant eukaryotes. My analysis suggested several models for an 
intricate network of intercompartmental communications that underlie cellular aging in eukaryotic 
organisms across phyla. My models posit that the numerous directed, coordinated and regulated 
organelle-organelle and organelle-cytosol communications integrated into this network define the 
long-term viability of a eukaryotic cell and, thus, are critical for regulating cellular aging. I 
designed models shown in figures 4.1-4.4 and prepared these figures. Chapter 4 has been published 
as a review article in International Union of Biochemistry and Molecular Biology Life (2013) 
65:665-674]. Dr. V. Titorenko provided intellectual leadership of this project; he also edited the 
first draft of Chapter 4 and the entire manuscript of the above review article. 
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2 Specific changes in mitochondrial lipidome alter mitochondrial proteome and 
increase the geroprotective efficiency of lithocholic acid in chronologically aging yeast 
 
2.1       Introduction 
            As described in the Introduction section, we hypothesized that 1) the observed LCA-
dependent specific changes in the composition of mitochondrial membrane lipids [81] may have a 
causal role in the age-related remodeling of mitochondrial proteome; 2) certain mitochondrial 
proteins whose abundance is altered in response to LCA-driven changes in mitochondrial lipidome 
may play essential roles in creating a distinct, aging-delaying pattern of mitochondrial 
functionality; and 3) these changes in mitochondrial functionality may alter the geroprotective 
(aging-delaying) efficiency of LCA in chronologically aging yeast. This chapter summarizes my 
studies aimed at testing these hypotheses. 
 
2.2     Materials and methods 
2.2.1  Yeast strains and growth conditions 
The WT strain BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) and single-gene-deletion mutant 
strains in the BY4742 genetic background (all from Thermo Scientific/Open Biosystems) were 
grown in YP medium (1% yeast extract, 2% peptone) initially containing 0.2% glucose with 50 
µM LCA or without it. Cells were cultured at 30oC with rotational shaking at 200 rpm in 
Erlenmeyer flasks at a ʺflask volume/medium volumeʺ ratio of 5:1. 
 
2.2.2  Isolation of crude mitochondrial fractions 
          Yeast cells were harvested at 3,000 × g for 5 min at room temperature, washed with water 
and resuspended in DTT buffer (100 mM Tris-H2SO4, pH 9.4, 10 mM dithiothreitol [DTT]). Cells 
were incubated in DTT buffer incubated for 20 min at 30°C to weaken the cell wall. The cells then 
were washed with Zymolyase buffer (1.2 M sorbitol, 20 mM potassium phosphate, pH 7.4) and 
centrifuged at 3,000 × g for 5 min at room temperature. Cells were then incubated with 3 mg/g 
(wet weight) of Zymolyase-100T in 7 ml/g (wet weight) Zymolyase buffer for 45 min at 30°C. 
Following an 8-min centrifugation at 2,200 × g at 4°C, the isolated spheroplasts were washed in 
ice-cold homogenization buffer (5 ml/g) (0.6 M sorbitol, 10 mM Tris-HCl, pH7.4, 1 mM EDTA, 
0.2% (w/v) BSA) and centrifuged at 2,200 × g for 8 min at 4°C. Spheroplasts were homogenized 
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in ice-cold homogenization buffer using 15 strokes. Cell debris was removed by centrifuging the 
resulting homogenates at 3,000 × g for 10 min at 4°C. The resulting supernatant was then 
centrifuged at 12,000 × g for 15 min at 4°C to pellet mitochondria. The remnant cell debris was 
removed by centrifuging the mitochondrial fraction at 3,000 × g for 5 min at 4°C. The resulting 
supernatant was then centrifuged at 12,000 × g for 15 min at 4°C to obtain the crude mitochondrial 
pellet, which was then resuspended in 3 ml of SEM Buffer (250 mM sucrose, 1 mM EDTA, 10 
mM MOPS, pH 7.2) and used for the purification of mitochondria as described below. 
 
2.2.3  Purification of mitochondria devoid of microsomal and cytosolic contaminations 
          A sucrose gradient was made by overlaying 1.5 ml of 60% sucrose with 4 ml of 32% sucrose, 
1.5 ml of 23% sucrose, and then 1.5 ml of 15% sucrose (all in EM buffer; 1 mM EDTA, 10 mM 
MOPS, pH 7.2). Finally, a 3-ml aliquot of the crude mitochondrial fraction in SEM buffer was 
applied to the gradient and centrifuged at 134,000 × g (33,000 rpm) for three hours at 4°C in 
vacuum (Rotor SW40Ti, Beckman). The purified mitochondria found at the 60%/32% sucrose 
interface were carefully removed and stored at - 80°C until lipids were extracted for mass 
spectrometry. 
 
2.2.4  Lipid extraction from yeast cells [191] 
          Yeast cells were harvested by centrifugation in a Centra CL2 clinical centrifuge at 3,000 × 
g for 5 min at room temperature. The cell pellet was resuspended in ice-cold 155 mM ammonium 
bicarbonate (pH 8.0), and the cells were subjected to centrifugation at 16,000 × g for 1 min at 4oC. 
The cell pellet was stored at -80ᴼC until lipid extraction. For lipid extraction, the pelleted cells kept 
at -80ᴼC were thawed on ice before being resuspended in 1 ml of ice-cold nanopure water. The 
volume that contained 5 × 107 cells was transferred to a 15-ml high-strength glass screw top 
centrifuge tube with a Teflon lined cap (#0556912; Fisher Scientific). The volume of each sample 
was topped off to 1 ml with ice-cold nanopure water. To each tube the following was added: 20 µl 
of the internal standard mix prepared in Chromasolv HPLC (>99.9%) chloroform (Sigma-Aldrich) 
(Table 2.1), 800 µl of 425-600 µM acid-washed glass beads to break open the cells (#G8772; 
Sigma-Aldrich) and 3 ml of a Chromasolv HPLC (>99.9%) chloroform-methanol mixture (both 
from Sigma-Aldrich) at a 17:1 ratio. The samples were then vortexed vigorously for 2 h at 4ᴼC 
and subjected to centrifugation in a Centra CL2 clinical centrifuge at 3,000 × g for 5 min at room 
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temperature; this centrifugation allowed to separate the upper aqueous phase from the lower 
organic phase, which contained nonpolar lipids TAG, PC, PE and PG. The lower organic phase 
was then transferred to another 15-ml high-strength glass screw top centrifuge tube using a glass 
Pasteur pipette with careful attention not to disrupt the glass beads or upper aqueous phase. 1.5 ml 
of chloroform-methanol (2:1) solution was added to the remaining upper aqueous phase to allow 
the separation of polar lipids PA, PS, PI and CL. The samples were again vortexed vigorously at 
4oC for 1 h. The initial separated organic band was kept at 4oC for the duration of the second 
vortexing. At the end of 1 h, the samples were again centrifuged for 5 min at 3,000 × rpm at room 
temperature; the lower organic phase was then separated and added to the corresponding initial 
organic phase with a glass Pasteur pipette. With both lower organic phases combined, the solvent 
was evaporated off by nitrogen gas flow. Once all solvent was evaporated, the remaining lipid film 
was dissolved in 100 µl of chloroform-methanol (1:2) and immediately transferred into 2-ml glass 
vials with Teflon screw tops to avoid evaporation until samples were analyzed by mass 
spectrometry. Samples were then stored at -80oC and ran on the LTQ Orbitrap Mass Spectrometer 
within one week of the extraction. 
  
Table 2.1. Internal standard mix composition (modified from [191]) 
 
 
Internal standards CL, PA, PE, PG, PS and PC were all from Avanti Polar Lipid, Alabaster, AL, 







Lipid chain composition 
(number carbons: number 
double bonds on fatty acid 
chain) 








mix                    
(mg/µL) 
Negative 
CL 14:0 / 14:0 / 14:0 /14:0 1274.9000 619.4157 0.10 
FFA 19:0 298.2872 297.2711 0.02 
PA 14:0 / 14:0 614.3920 591.4026 0.10 
PE 14:0 / 14:0 635.4526 634.4448 0.10 
PG 14:0 / 14:0 688.4290 665.4394 0.10 
PS 14:0 / 14:0 701.4240 678.4271 0.02 
Positive 
TAG 13:0 / 13:0 / 13:0 680.5955 698.6299 0.10 
PC 13:0 / 13:0 649.4683 650.4761 0.10 
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2.2.5  Lipid identification and quantitation using mass spectrometry 
          Samples were diluted (1:1) with 1:2 chloroform-methanol supplemented with 0.1% 
ammonium hydroxide for improved ionization efficiency. Samples were injected one at a time 
using a Thermo Orbitrap Velos Mass Spectrometer equipped with HESI-II ion source (Thermo 
Scientific) at a flow rate of 5 µl/ min. The instrument settings for the Orbitrap used the optimized 
settings, as described in reference 191 (Table 2.2).   
 
Table 2.2. Thermo Orbitrap Velos mass spectrometer’s tune file instrument settings (from [191]) 
Instrument polarity  Positive Negative 
Source voltage (kV) 3.9 4 
Capillary temperature (ᴼC) 275 275 
Sheath gas flow 5 5 
Aux gas flow 1 1 
FT-MS injection time (ms) 100 500 
FT-MS microscans 3 1 
 
Data were acquired according to the Instrument Method for data-dependent acquisition for 5 min 
in both positive and negative modes by the FT-MS analyzer at a resolution of 100,000 for both 
MS and MS/MS data (Table 2.3). 
 
Table 2.3. Instrument method for data-dependent acquisition (from [191]) 
Acquisition time                                  5 min (with a 0.25-min delay) 
Instrument polarity Positive Negative 





















































Between each sample, the line was flushed with chloroform-methanol (1:2) mixture until the ion 
detection steadied and returned back into the baseline level. Diluted internal standard mix was 
injected multiple times throughout the acquisition to ensure no sensitivity loss throughout the run. 
          Once all data was acquired, raw files were converted to open format mzXML using 
ProteoWizard MSConvert software (http://proteowizard.sourceforge.net/), the file format used by 
the Lipid Identification Software LipidXplorer (https://wiki.mpi-cbg.de/lipidx/Main_Page). Data 
files were then imported into this software using settings described in Table 2.4; all lipids in the 
PA, PC, PE, PI, PS, CL and TAG lipid classes were identified with the help of Molecular 
Fragmentation Query Language (MFQL) files. MFQL files were obtained from the LipidXplorer 
page listed above and aided in the identification of lipids by their m/z ratio as well as their 
fragmentation patterns.  
LipidXplorer’s output data was then opened under a Microsoft Excel file and all detected 
lipids were quantified by comparison with the intensity of the corresponding lipid class’ internal 
standard’s known concentration in the sample. Each quantified lipid had a corresponding internal 
standard from the same lipid class, allowing the calculation of molar percentage of each identified 
lipid species and, therefore, of each lipid class.  
 
Table 2.4. Lipid identification by LipidXplorer import settings for data acquired under positive and negative 
mode (from [191])  
 Positive mode  Negative mode 
Selection Window (Da) 
Time range (sec.) 
Calibration masses 
             MS 
             MS/MS 
m/z range (m/z-m/z) 
             MS 
             MS/MS 
Resolution (FMHW) 
             MS 
             MS/MS 
Tolerance (ppm) 
             MS 
             MS/MS 
Resolution Gradient (res/(m/z)) 
            MS 
            MS/MS 
Minimum Occupation (0<1) 
             MS 
             MS/MS 













































2.2.6  A plating assay for the analysis of chronological lifespan 
          Cells were grown in YEPD (0.2% glucose) medium at 30oC with rotational shaking at 200 
rpm in Erlenmeyer flasks at a flask volume/medium volume ratio of 5:1. A sample of cells was 
removed from each culture at various time points. A fraction of the cell sample was diluted to 
determine the total number of cells per ml of culture using a hemacytometer. 10 l of serial 
dilutions (1:10 to 1:103) of cells were applied to the hemacytometer, where each large square is 
calibrated to hold 0.1 l. The number of cells in 4 large squares was then counted and an average 
was taken to ensure greater accuracy. The concentration of cells was calculated as follows: number 
of cells per large square x dilution factor x 10 x 1,000 = total number of cells per ml of culture. A 
second fraction of the cell sample was diluted and serial dilutions (1:102 to 1:105) of cells were 
plated onto YEPD (2% glucose) plates in triplicate to count the number of viable cells per ml of 
each culture. 100 l of diluted culture was plated onto each plate. After a 48-h incubation at 30oC, 
the number of colonies per plate was counted. The number of colony forming units (CFU) equals 
to the number of viable cells in a sample. Therefore, the number of viable cells was calculated as 
follows: number of colonies x dilution factor x 10 = number of viable cells per ml. For each culture 
assayed, % viability of the cells was calculated as follows: number of viable cells per ml / total 
number of cells per ml x 100%. The % viability of cells in mid-logarithmic phase was set at 100% 
viability for that culture. The life span curves for wild-type and some of the mutant strains were 
also validated using a LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's 
instructions for stationary-phase cultures.   
 
2.2.7  Total cell lysates preparation 
          Total cell lysates were made by vortexing the cells in TCL buffer (25 mM Tris/HCl pH 8.5, 
150 mM NaCl, 1 mM EDTA, 0.1 mM DTT, 4% CHAPS, 1 mM PMSF, protease inhibitor cocktail 







2.2.8  Identification and quantification of proteins by mass spectrometry (MS) 
          Protein bands stained with QC Colloidal Coomassie Blue was cut out from an SDS-PAGE 
gel with a razor blade. The gel pieces were placed in individual 0.5-ml siliconized Eppendorf tubes. 
The bands were destained by washing twice with distilled water for 1 h. The bands were then 
incubated in 50 l of acetonitrile (ACN) for 5 min at 37°C, after which ACN was removed and the 
bands were dried at 37°C. Next, the destained bands were incubated in 50 l of 10 mM 
dithiothreitol for 30 min at 37°C to reduce thiol groups in peptides. DTT was discarded and the 
bands were incubated in 50 l of 55 mM iodoacetamide (IAA) for 20 min at 37°C in the dark to 
remove the residual DTT. IAA was removed and the bands were incubated in 50 l of a 1:1 mixture 
of 100 mM ABC and 50% acetonitrile for 10 min at 37°C. The mixture was discarded and the 
bands were incubated twice in 50 l of ACN under the same conditions and dried at 37°C. The 
trypsin and trypsin buffer were prepared as follows: (1) 1.6 ml of a 1:1 mixture of 100 mM ABC 
and 10mM CaCl2 were used to resuspend 20 g of trypsin; and (2) for protein digest, 50 l of 
trypsin solution (1 mg/ml) was added to the bands, which were then incubated overnight at 37°C.  
          The following day, the samples were spun down and the supernatants containing peptides 
were transferred to new 0.5-ml siliconized Eppendorf tubes. To extract more peptides, the gel 
pieces were subjected to several washes and treatments at room temperature; the supernatants were 
conserved and combined with the first set to extracted peptides. For the first extraction, the bands 
were initially incubated in 50 l of 25 mM ABC for 10 min and then in 50 l of ACN for 10 min. 
The samples were spun down and the supernatant were added to the first set of extracted peptides.  
For the second extraction, the bands were incubated in 50 l of 5% formic acid for 10 min and 
then in 50 l of ACN for 10 min. The samples were spun down and the supernatant were combined 
with the first set of extracted peptides. The gel pieces were no longer used and discarded. To 
prevent possible oxidation during storage, 12.5 l of 100 mM DTT was added to each set of 
peptides. The peptides were completely dried in a Speed-Vac at medium temperature settings 
(37°C) for 2 h and stored at -20°C until MS analysis. 
          Dried peptides were resuspended in 20 l of 5% ACN. For each recovered protein band, an 
aliquot of 10 l of dried peptides in 5% ACN was diluted 2-fold in Nano pure water for MS 
analysis. Samples can be stored at -20°C until being subjected to MS analysis. Individual proteins 
composing each band were then identified by reverse phase high performance liquid 
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chromatography coupled to mass spectrometry (RP-HPLC/MS) using an LTQ Orbitrap. 3-l 
aliquots of peptides were separated in ACN gradient using a 100-M capillary column packed 
with C18 mobile phase. 
          Once acquiring time was completed using the LTQ Orbitrap, the raw mass spectrometry 
data file obtained by Xcalibur were analyzed using the Thermo Scientific Xcalibur Proteome 
Discoverer application (version 1.3) hereafter referred to as the Proteome Discoverer. The 
Proteome Discoverer was used to identify individual proteins by comparing the raw data of mass 
spectra of digested fragments to the mass spectra of peptides within the Uniprot FASTA database. 
The analysis by the Proteome Discoverer coupled to the FASTA database was enabled by using 
the peak-finding search engine SEQUEST. The SEQUEST engine processes MS data using a 
peak-finding algorithm to search the raw data for generating a peak probability list with relative 
protein abundances. 
          The following settings of the SEQUEST search wizard within the Proteome Discoverer 
application were used: 
Raw file and Scan Range Selection Parameters: The raw file was selected and the Base peak ion 
chromatogram appeared to reveal: 1) the “Intensity (counts)” corresponding to the intensity of the 
largest peak in the spectrum; and 2) the “Time (min)” showing the retention time (RT). The 
following algorithm and settings were used: 
Lower RT Limit (min): The beginning of the RT of the scan range of interest: 10 min. 
Upper RT Limit (min): The end of the retention time of the scan range of interest: 18 min. 
Scan Extraction Parameters 
First mass: The mass of the first precursor ion in the range of ion fragments to search for in the 
database: 350 Daltons (Da). 
Last mass: The mass of the last precursor ion in the range of ion fragments to search for in the 
database: 5000 Daltons (Da). 
Activation type: The fragmentation method to use for activating the scan: Collision Induced 
Dissociation (CID). 
Unrecognized charge replacement: Specifies the charge number of the precursor ions: Automatic 
(Default), assigns a charge number of +2 and +3 to the spectrum. 
Intensity threshold: Specifies the intensity threshold below which ions are filtered out. The default 
value of 0.0 was used. 
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Minimum ion count: The minimum ion count corresponds to the minimum number of ions that 
must be present in an MS/MS spectrum for it to be included in a search. The default value of 1 
was used. 
S/N threshold: The signal-to-noise threshold is the intensity of the signal to the intensity of the 
background noise. The use of this threshold filters out low-intensity ions that function as a noise. 
The value of 1.5 was used. 
Database: Uniprot_sprot FASTA 
Enzyme: Trypsin 
Missed Cleavages: The maximum number of internal cleavage sites per peptide fragment that is 
acceptable for an enzyme to miss during proteolytic digest. The default value of 2 was used. 
Precursor mass tolerance: The precursor mass tolerance value used for finding peptide 
candidates. The possible range of values is 0.01 to 5000 ppm. The default value of 10 ppm was 
used. 
Fragment mass tolerance: The default mass tolerance value of 0.8 Da was used for matching 
fragment peaks. The possible range of values was 0.0001 to 2.0 Da. 
Ions series calculated: Specifies the ion factors for a, b, c, x, y, and z ions for the experiment type. 
The possible range is 0 through 1.0 for all ion factors. The ion factors used are b ions: 1 and y ions 
:1. 
Search against decoy database: Specifies if the application uses a decoy database in the search; 
the “yes” was used. 
Target FDR (strict): Specifies a strict target false discovery rate (FDR) for peptide matches with 
high confidence. The possible value range of 0.0 to 1.0 was used. The default value of 0.01 (1% 
FDR) was used. 
Target FDR (relaxed): Specifies a relaxed target false discovery rate (FDR) for peptide matches 
with moderate confidence. The possible value ranges from 0.0 to 1.0 was used. The default value 
of 0.05 (5% FDR) was used. 
          The Thermo Proteome Search Results Report for the identification of proteins was created. 
The protein page displays all the proteins and their corresponding peptides found in the sample 
during the database search. For each protein, the report shows the following results: 
Accession: The unique identifier was assigned to the protein by the Uniprot FASTA database. 
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Description: The name and description of the protein of the identifier appeared in the 
corresponding Accession column.  
Score: The SEQUEST protein score is the sum of all peptide XCorr values above the specified 
score threshold. The score threshold was calculated as 0.8 + peptide charge * peptide relevance 
factor, where peptide relevance factor has a default value of 0.4. For each spectrum, only the 
highest-scoring match was used. For each spectrum and sequence, the Proteome Discoverer 
application uses only the highest scored peptide.  
Coverage: Represents the percentage of the protein sequence covered by the identified peptides. 
# Proteins: Represents the number of identified proteins in the protein group of a master protein. 
When the Protein Grouping setting is disabled, the #Proteins is always equal to 1.  
# Unique Peptides: Represents the number of peptide sequences unique to a protein. 
# Peptides: Represents the number of different peptide sequences identified in the protein.   
# PSMs: The peptide spectrum matches (PSMs) value corresponds to the total number of identified 
peptide sequences for the protein, including those that have been identified redundantly. 
# AAs: Represents the number of amino acid in the sequence length of the protein. 
MW kDa: Represents the calculated molecular weight of the protein. 
Calc. pI: Represents the theoretically calculated isoelectric point, i.e. the pH value at which a 
molecule carries no net electrical charge. 
Peptides Results Parameters: For each identified peptide, the report shows the following results: 
Protein Descriptions: Identifies a protein associated with the peptides. This description is taken 
from the Uniprot FASTA file. 
# Proteins: Represents the total number of proteins in which this peptide can be found. 
Probability: Represents the probability score for the peptide. 
SpScore (search-dependent): Represents the raw value of the preliminary score of the SEQUEST 
algorithm. 
XCorr (search-dependent): Scores the number of fragment ions that are common to two different 
peptides with the same precursor mass; calculates the cross-correlation score for all candidate 
peptides queried from the database. 
Δ Score: A measure of the difference between the top two scores for the peptides identified by that 
spectrum; the Proteome Discoverer application calculates this score as follows: ΔScore = Score 
(Rank N Peptide) – Score (Rank 1 Peptide)/Score (Rank 1 Peptide). 
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ΔCn: Represents the normalized score difference between the currently selected PSM and the 
highest-scoring PSM for that spectrum. 
# Missed Cleavages: Represents the number of cleavage sites in a peptide sequence that trypsin 
did not cleave, excluding the cases where the presence of proline prevents trypsin from cleaving 
the peptide bond. 
Peptides Matched: Represents the number of peptides included in the precursor mass tolerance 
window set for the search. 
Charge: Represents the charge state of the peptide. 
Intensity: Represents the intensity of the precursor ion. 
MH+ Da: Represents the protonated monoisotopic mass of the peptide, in Daltons. 
ΔM ppm: Represents the difference between the theoretical mass of the peptide and the experimental 
mass of the precursor ion. 
RT min: Represents the retention time when the peptide was observed, in minutes. 
          Xcalibur is a registered trademark of Thermo Fisher Scientific Inc. in the United States. 
SEQUEST is a registered trademark of the University of Washington in the United States. 
          The ″Proteome Discoverer″ software was used to calculate the exponentially modified 
protein abundance index (emPAI), a measure of the relative abundance of mitochondrial proteins 
in a pair of analyzed datasets.   
 
2.2.9  Oxygen consumption assay (cellular respiration measurement) 
          A sample of cells was taken from a culture at a certain time-point. Cells were pelleted by 
centrifugation and resuspended in 1 ml of fresh YP medium containing 0.05% glucose. Oxygen 
uptake by cells was measured continuously in a 2-ml stirred chamber using a custom-designed 
biological oxygen monitor (Science Technical Center of Concordia University) equipped with a 
Clark-type oxygen electrode. 
 
2.2.10  Mitochondrial membrane potential measurement  
            The mitochondrial membrane potential () was measured in live yeast by fluorescence 
microscopy of Rhodamine 123 (R123) staining. For R123 staining, 5 × 106 cells were harvested 
by centrifugation for 1 min at 21,000 × g at room temperature and then resuspended in 100 μl of 
50 mM sodium citrate buffer (pH 5.0) containing 2% glucose. R123 (Invitrogen) was added to a 
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final concentration of 10 μM. Following incubation in the dark for 30 min at room temperature, 
the cells were washed twice in 50 mM sodium citrate buffer (pH 5.0) containing 2% glucose and 
then analyzed by fluorescence microscopy. Images were collected with a Zeiss Axioplan 
fluorescence microscope (Zeiss) mounted with a SPOT Insight 2-megapixel color mosaic digital 
camera (Spot Diagnostic Instruments). For evaluating the percentage R123-positive cells, the 
UTHSCSA Image Tool (Version 3.0) software was used to calculate both the total number of cells 
and the number of stained cells. Fluorescence of individual R123-positive cells in arbitrary units 
was determined by using the UTHSCSA Image Tool software (Version 3.0). In each of 3 
independent experiments, the value of median fluorescence was calculated by analyzing at least 
800-1000 cells that were collected at each time-point. The median fluorescence values were plotted 
as a function of the number of days cells were cultured. 
 
2.2.11  Monitoring the formation of ROS  
            ROS production in wild-type and mutant cells grown in YEPD (0.2% glucose) with LCA 
was tested microscopically by incubation with Dihydrorhodamine 123 (DHR). In the cell, this non-
fluorescent compound can be oxidized to the fluorescent chromophore rhodamine 123 by ROS. 
Cells were also probed with a fluorescent counterstain Calcofluor White M2R (CW), which stains 
the yeast cell walls fluorescent blue. CW was added to each sample to label all cells for their proper 
visualization. DHR was stored in the dark at –20oC as 50 l aliquots of a 1 mg/ml solution in 
ethanol. CW was stored in the dark at –20oC as the 5-mM stock solution in anhydrous DMSO 
(dimethyl sulfoxide). The concurrent staining of cells with DHR and CW was carried out as 
follows. The required amounts of the 50 l DHR aliquots (1 mg/ml) and of the 5-mM stock 
solution of CW were taken out of the freezer and warmed to room temperature. The solutions of 
DHR and CW were then centrifuged at 21,000 × g for 5 min to clear them of any aggregates of 
fluorophores. For cell cultures with a titer of ~ 107 cells/ml, 100 l was taken out of the culture to 
be treated. If the cell titer was lower, proportionally larger volumes were used. 6 l of the 1 mg/ml 
DHR and 1 l of the 5-mM CW solutions were added to each 100 l aliquot of culture. After a 2-
h incubation in the dark at room temperature, the samples were centrifuged at 21,000 × g for 5 
min. Pellets were resuspended in 10 l of PBS buffer (20 mM KH2PO4/KOH, pH 7.5, and 150 
mM NaCl). Each sample was then supplemented with 5 l of mounting medium, added to a 
microscope slide, covered with a coverslip, and sealed using nail polish. Once the slides were 
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prepared, they were visualized under the Zeiss Axioplan fluorescence microscope mounted with a 
SPOT Insight 2-megapixel color mosaic digital camera. Several pictures of the cells on each slide 
were taken, with two pictures taken of each frame. One of the two pictures was of the cells seen 
through a rhodamine filter to detect cells dyed with DHR. The second picture was of the cells seen 
through a DAPI filter to visualize CW, and therefore all the cells present in the frame. For 
evaluating the percentage of DHR-positive cells, the UTHSCSA Image Tool (Version 3.0) 
software was used to calculate both the total number of cells and the number of stained cells. 
Fluorescence of individual DHR-positive cells in arbitrary units was determined by using the 
UTHSCSA Image Tool software (Version 3.0). In each of 3-5 independent experiments, the value 
of median fluorescence was calculated by analyzing at least 800-1000 cells that were collected at 
each time point. The median fluorescence values were plotted as a function of the number of days 
cells were cultured.  
 
2.2.12  ATP measurement 
            2 × 109 cells were harvested by centrifugation for 1 min at 16,000 × g at 4oC. The cell pellet 
was washed three times in ice-cold PBS (20 mM KH2PO4/KOH (pH 7.5) and 150 mM NaCl) and 
then resuspended in 200 μl of ice-cold SHE solution (50 mM NaOH and 1 mM EDTA). 800 μl of 
ice-cold SHE solution were added to the cell suspension. The resulting alkali extract was incubated 
at 60oC for 30 min to destroy endogenous enzyme activities and pyridine nucleotides. The extract 
was neutralized by adding 500 μl of THA solution (100 mM Tris/HCl (pH 8.1) and 50 mM HCl). 
The extract was then divided into 150 μl aliquots, quickly frozen in liquid nitrogen and stored at - 
80oC prior to use. For ATP measurement, 1 µl of alkali extract was added to 1 µl ATP reagent (50 
mM Tris-HCl (pH 8.1), 3 mM MgCl2, 0.2 mM glucose, 0.04% BSA, 0.05 mM NADP+, 10 µg/ml 
hexokinase, 2 µg/ml glucose-6-phosphate dehydrogenase). Following a 30-min incubation at 
25oC, the reaction was stopped by adding 1 µl of 0.15 M NaOH and heating at 80o C for 20 min. 
A 1 µl aliquot was transferred 100 µl of reagent containing 100 µg/ml hexokinase and 20 µg/ml 
glucose-6-phosphate dehydrogenase. The reaction mixture was incubated for 1 h at 38oC. The 
NADPH generated from NADP+ was measured fluorimetrically (excitation at 365 nm, emission 




2.2.13  Statistical analysis 
            Statistical analysis was performed using Microsoft Excel's (2010) Analysis ToolPak - 
VBA. All data on cell survival are presented as mean ± SEM. The p values for comparing the 
means of two groups using an unpaired two-tailed t test were calculated with the help of the 
GraphPad Prism 7 statistics software. The logrank test for comparing each pair of survival curves 
was performed with GraphPad Prism 7. Two survival curves were considered statistically different 
if the p value was less than 0.05. 
 
2.3      Results  
 
2.3.1  The relative concentrations of different classes of membrane phospholipids in yeast 
mitochondria depend on several processes of phospholipid synthesis and transfer 
          My first objective was to test a hypothesis that the composition of mitochondrial membrane 
lipids may define the efficiency with which LCA delays yeast chronological aging. To attain this 
objective, I examined how single-gene-deletion mutations eliminating proteins involved in 
different aspects of phospholipid metabolism and transfer in mitochondrial membranes influence 
mitochondrial lipidome. I also assessed how these mutations affect the efficiency of yeast 
chronological aging delay by LCA.    
          A spatiotemporal dynamic of processes that define the relative concentrations of different 
classes of membrane phospholipids in yeast mitochondria is well-understood [192-199]. These 
processes are catalyzed by enzymes that reside in both mitochondria and the endoplasmic 
reticulum (ER). These processes include the following steps of phospholipid synthesis and 
transfer: 1) the synthesis of phosphatidic acid (PA), cytidine diphosphate-diacylglycerol (CDP-
DAG), diacylglycerol (DAG), phosphatidylserine (PS), phosphatidylcholine (PC) and 
phosphatidylinositol (PI) in the ER; 2) the movement of PA from the ER to the OMM through 
mitochondria-ER contact sites at zones of a juxtaposition between the OMM and the mitochondria-
associated membrane (MAM) domain of the ER; 3) the transfer of PA from the OMM across the 
intermembrane space (IMS) to the IMM, which is catalyzed by the Ups1/Mdm35 protein complex 
and inhibited by CL; 4) the conversion of ER-derived PA into CDP-DAG, phosphatidylglycerol-
phosphate (PGP), phosphatidylglycerol (PG), cardiolipin (CL) and monolysocardiolipin (MLCL) 
in a series of reactions that are catalyzed by Tam41, Pgs1, Gep4, Crd1, Cld1 and Taz1 
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(respectively) in the IMM; 5) the transfer of PS from the ER to the OMM via mitochondria-ER 
contact sites by an unidentified mechanism; 6) the Ups2/Mdm35-dependent transport of PS from 
the OMM via the IMS to the IMM, where PS is converted into phosphatidylethanolamine (PE) in 
a reaction catalyzed by Psd1; 7) the synthesis of PE from PS in the OMM, which is catalyzed by 
Psd1, requires a close apposition between the two mitochondrial membranes and is assisted by the 
mitochondrial contact site (MICOS) protein complex; 8) the transfer of PC and PI from the ER to 
the OMM via mitochondria-ER contact sites, which is followed by the movement of PC and PI 
from the OMM to the IMM; mechanisms of both these processes remain obscure; and 9) the 
movement of DAG and CDP-DAG from the ER to the OMM across mitochondria-ER contact 
sites, and the subsequent transfer of these two phospholipids to the IMM by currently unknown 
mechanisms (Figure 2.1) [192-199]. 
 
 
Figure 2.1. The relative concentrations of different classes of membrane phospholipids in yeast mitochondria 
depend on several processes of phospholipid synthesis and transfer. These processes are catalyzed by enzymes 
that reside in the inner mitochondrial membrane (IMM), intermembrane space (IMS), outer mitochondrial membrane 
(OMM) and endoplasmic reticulum (ER). Only enzymes catalyzing these processes in the IMM, IMS and OMM are 
shown. A T bar denotes a cardiolipin (CL)-dependent inhibition of phosphatidic acid (PA) transfer from the OMM 
across the IMS to the IMM. In this study, I investigated various effects of single-gene-deletion mutations that eliminate 
enzymes displayed in red color. See text for more details. Abbreviations: CDP-DAG, cytidine diphosphate-
diacylglycerol; DAG, diacylglycerol; MAM, the mitochondria-associated membrane domain of the ER; MICOS, the 
mitochondrial contact site protein complex; MLCL, monolysocardiolipin; PC, phosphatidylcholine; PG, 




2.3.2 The ups1Δ mutation alters mitochondrial membrane lipidome and lowers the 
geroprotective efficiency of LCA 
          I used quantitative mass spectrometry to compare lipidomes of mitochondria purified from 
wild-type (WT) yeast cells cultured with or without LCA to those from ups1Δ cells. Both WT and 
ups1Δ cells were recovered on day 2, 4 or 7 of cell culturing, i.e. at different stages of chronological 
aging. The ups1Δ mutation eliminates a component of the Ups1/Mdm35 protein complex, which 
catalyzes the transfer of PA from the OMM across the IMS to the IMM [192, 200, 201]. I found 
that 1) akin to the effect of LCA on mitochondrial membrane lipidome in WT, LCA increases the 
concentrations of PS, PI, PC and PA in mitochondria of ups1Δ in an age-related manner; 2) similar 
to its effect in WT, LCA decreases the concentration of PE in mitochondrial membranes of ups1Δ 
at different stages of chronological aging; and 3) unlike an age-related decrease in the 
concentration of CL elicited by LCA in WT, this bile acid does not cause significant changes in 
CL concentration in ups1Δ (compare Figures 2.2 and 2.3). 
           
Figure 2.2. LCA exhibits age-related differential effects on the concentrations of different classes of 
mitochondrial membrane phospholipids in chronologically aging wild-type (WT) yeast. WT cells were cultured 
in the nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it. Mitochondria were 
purified from cells recovered on day 2, 4 or 7 of cell culturing. Extraction of mitochondrial membrane lipids, and mass 
spectrometric identification and quantitation of the extracted phospholipid classes were carried out as described in 
Materials and methods. The concentrations of phospholipids were calculated as nmoles phospholipid/mg protein. (A) 
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PS, PI and PC are phospholipid classes that exhibit the bilayer forming shape of a cylinder; they decrease the extent 
of membrane curving for the IMM. (B) PA, PE and CL are phospholipid classes that have the non-bilayer forming 
shape of a cone; they increase the extent of membrane curving for the IMM. Data are presented as means ± SEM (n = 
3; *p < 0.05; ns, not significant). Abbreviations: CL, cardiolipin; PA, phosphatidic acid; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PA, phosphatidic acid; PI, phosphatidylinositol; PS, phosphatidylserine. 
 
Figure 2.3. LCA exhibits age-related differential effects on the concentrations of different classes of 
mitochondrial membrane phospholipids in chronologically aging ups1Δ yeast. Cells of the ups1Δ mutant strain 
were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it. 
Mitochondria were purified from cells recovered on day 2, 4 or 7 of cell culturing. Extraction of mitochondrial 
membrane lipids, and mass spectrometric identification and quantitation of the extracted phospholipid classes were 
carried out as described in Materials and methods. The concentrations of phospholipids were calculated as nmoles 
phospholipid/mg protein. (A) PS, PI and PC are phospholipid classes that exhibit the bilayer forming shape of a 
cylinder; they decrease the extent of membrane curving for the IMM. (B) PA, PE and CL are phospholipid classes 
that have the non-bilayer forming shape of a cone; they increase the extent of membrane curving for the IMM. Data 
are presented as means ± SEM (n = 3; *p < 0.05; ns, not significant). Abbreviations: CL, cardiolipin; PA, phosphatidic 
acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PA, phosphatidic acid; PI, phosphatidylinositol; PS, 
phosphatidylserine. 
 
          I then used these data to compare the ratios between concentrations of all possible pairwise 
combinations of phospholipid classes in mitochondrial membranes of WT and ups1Δ cells cultured 
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with or without LCA. Of note, PA, PE and CL are phospholipid classes that have the non-bilayer 
forming shape of a cone; they increase the extent of membrane curving for the IMM, thereby 
raising the abundance of mitochondrial cristae (formed by the IMM) and mitochondrial contact 
cites (formed between the IMM and OMM) [81, 198, 199, 202-207]. In contrast, PS, PC and PI 
are phospholipid classes that exhibit the bilayer forming shape of a cylinder; they decrease the 
extent of membrane curving for the IMM, thus 1) increasing the abundance of the IMM domains 
having ″flat″ bilayer conformation; 2) decreasing the abundance of the IMM domains exhibiting 
negative curvature typical of mitochondrial contact sites; and 3) decreasing the abundance of the 
IMM domains displaying positive curvature characteristic of mitochondrial cristae [81, 198, 199, 
202-207]. I found that, in cells cultured with or without LCA, the ups1Δ mutation 1) increases the 
PA/PS, PA/PC and PA/PI ratios for non-bilayer forming PA vs. bilayer forming PS, PC and PI; 2) 
does not alter the PE/PS, PE/PC and PE/PI ratios for non-bilayer forming PE vs. PS, PC and PI; 
3) decreases the CL/PS, CL/PC and CL/PI ratios for non-bilayer forming CL vs. PS, PC and PI; 
4) does not change the PS/PI, PS/PC and PI/PC ratios for all these bilayer forming phospholipid 
classes; and 5) increases the PA/PE, PA/CL and PE/CL ratios for all these non-bilayer forming 
phospholipid classes (Figure 2.4). Thus, while this mutation alters the relative to each other 
concentrations for all non-bilayer forming phospholipids, it has no effect on the relative to each 
other concentrations for phospholipids that exhibit the bilayer forming shape. 
           
Figure 2.4. The ups1Δ mutation differently affects the ratios between concentrations of pairwise combinations 
of different phospholipid classes in mitochondrial membranes of chronologically aging yeast. ups1Δ cells were 
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cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it. 
Mitochondria were purified from cells recovered on day 2 (A), 4 (B) or 7 (C) of cell culturing. Extraction of 
mitochondrial membrane lipids, and mass spectrometric identification and quantitation of the extracted phospholipid 
classes were carried out as described in Materials and methods. Based on these data, the ratios between concentrations 
of all possible pairwise combinations of phospholipid classes were calculated. Data are presented as means ± SEM (n 
= 3; *p < 0.05; ns, not significant). 
 
          I then assessed the effect of the ups1Δ mutation on the chronological lifespan (CLS) of yeast 
cultured with or without LCA. I found that ups1Δ 1) significantly shortens yeast CLS in the 
absence of LCA (Figures 2.5A and 2.5B); and 2) substantially lowers the geroprotective efficiency 
of LCA by almost eliminating the ability of LCA to increase both the mean and the maximum CLS 
(Figures 2.5A-2.5D). 
           
Figure 2.5. The ups1Δ mutation shortens yeast CLS in the absence of LCA and lowers the aging-delaying 
efficiency of LCA. WT and ups1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% 
glucose with 50 µM LCA or without it. (A) Survival curves of chronologically aging WT and ups1Δ strains are shown. 
Data are presented as means ± SEM (n = 3). (B) p Values for different pairs of survival curves of WT and ups1Δ 
strains cultured with or without LCA. Survival curves shown in (A) were compared. Two survival curves were 
considered statistically different if the p value was less than 0.05. The p values for comparing pairs of survival curves 
using the logrank test were calculated as described in Materials and methods. (C and D) Survival curves shown in (A) 
were used to calculate the percentage of increase of the mean and maximum CLS by LCA for WT and ups1Δ strains. 
 30 
Data are presented as means ± SEM (n = 3; *p < 0.05). (E) The pattern of mitochondrial lipidome characteristic of the 
ups1Δ mutation is shown. Arrows next to the ratios between concentrations of different pairwise combinations of 
phospholipid classes indicate ratios that are increased (red arrows) or decreased (blue arrows) in ups1Δ cells (as 
compared to WT cells) cultured with or without LCA. Each colored line connects the names of two phospholipid 
classes whose concentration ratio is increased (red lines) or decreased (blue lines) by the ups1Δ mutation and cannot 
be restored by LCA. 
 
          In sum, these findings suggest that the ups1Δ mutation may accelerate yeast chronological 
aging and decrease the geroprotective efficiency of LCA because it creates a distinct pro-aging 
pattern of mitochondrial lipidome. This characteristic of ups1Δ pattern may include the following 
specific changes in the relative concentrations of different classes of membrane phospholipids: 1) 
an increase of the PA/PS, PA/PC and PA/PI ratios for non-bilayer forming PA vs. bilayer forming 
PS, PC and PI; 2) a decrease of the CL/PS, CL/PC and CL/PI ratios for non-bilayer forming CL 
vs. bilayer forming PS, PC and PI; and 3) an increase of the PA/PE, PA/CL and PE/CL ratios for 
all these non-bilayer forming phospholipid classes (Figure 2.5E). 
 
2.3.3  The ups2Δ mutation changes the composition of mitochondrial membrane lipids and 
amplifies the aging-delaying effect of LCA 
          Using quantitative mass spectrometry, I compared lipidomes of mitochondria purified from 
WT and ups2Δ cells. Both WT and mutant strains were cultured with or without LCA and 
recovered on day 2, 4 or 7 of cell culturing. The ups2Δ mutation eliminates a component of the 
Ups2/Mdm35 protein complex; Ups2/Mdm35 catalyzes the transfer of PS from the OMM across 
the IMS to the IMM, where PS is converted into PE in a Psd1-dependent reaction [195, 196, 199]. 
I found that, similar to the effect of LCA on mitochondrial membrane lipidome in WT, LCA causes 
an age-related increase in the concentrations of PS, PI, PC and PA in mitochondria of ups2Δ; 
however, the concentration of PA in mitochondria of ups2Δ exceeds that in WT mitochondria of 
cells cultured with or without LCA (compare Figures 2.2 and 2.6). I also observed that, akin to the 
effect of LCA on mitochondrial membrane lipidome in WT, LCA elicits an age-related decline in 
the concentrations of PE and CL in mitochondria of ups2Δ; yet, the concentrations of both these 
phospholipids in mitochondria of ups2Δ are lower than in WT mitochondria of cells cultured with 




Figure 2.6. LCA exhibits age-related differential effects on the concentrations of different classes of 
mitochondrial membrane phospholipids in chronologically aging ups2Δ yeast. Cells of the ups2Δ mutant strain 
were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it. 
Mitochondria were purified from cells recovered on day 2, 4 or 7 of cell culturing. Extraction of mitochondrial 
membrane lipids, and mass spectrometric identification and quantitation of the extracted phospholipid classes were 
carried out as described in Materials and methods. The concentrations of phospholipids were calculated as nmoles 
phospholipid/mg protein. (A) PS, PI and PC are phospholipid classes that exhibit the bilayer forming shape of a 
cylinder; they decrease the extent of membrane curving for the IMM. (B) PA, PE and CL are phospholipid classes 
that have the non-bilayer forming shape of a cone; they increase the extent of membrane curving for the IMM. Data 
are presented as means ± SEM (n = 3; *p < 0.05; ns, not significant). Abbreviations: CL, cardiolipin; PA, phosphatidic 
acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PA, phosphatidic acid; PI, phosphatidylinositol; PS, 
phosphatidylserine. These experiments were conducted by Anthony Arlia-Ciommo, Simon Bourque, Olivia Koupaki 
and Karamat Mohammad. 
          Using the above data, I then compared the ratios between concentrations of all conceivable 
pairwise combinations of different phospholipids in membranes of mitochondria purified from WT 
and ups2Δ cells; these cells were cultured with or without LCA. I found that, in cells cultured in 
the presence or absence of LCA, the ups2Δ mutation 1) raises the PA/PS, PA/PC and PA/PI ratios 
for non-bilayer forming PA vs. bilayer forming PS, PC and PI; 2) lowers the PE/PS, PE/PC and 
PE/PI ratios for non-bilayer forming PE vs. PS, PC and PI; 3) lessens the CL/PS, CL/PC and CL/PI 
ratios for non-bilayer forming CL vs. PS, PC and PI; 4) does not alter the PS/PI, PS/PC and PI/PC 
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ratios for all these bilayer forming classes of phospholipids; 5) rises the PA/PE and PA/CL ratios 
for all these non-bilayer forming phospholipid classes; and 6) does not alter the PE/CL ratio for 
these two non-bilayer forming phospholipids (Figure 2.7). Thus, unlike the ups1Δ mutation, ups2Δ 
allows to maintain the equimolar concentrations of two non-bilayer forming phospholipids, PE 
and CL, by proportionally decreasing their concentrations.  
           
Figure 2.7. The ups2Δ mutation exhibits differential effects on the ratios between concentrations of different 
pairwise combinations of phospholipid classes in mitochondrial membranes of chronologically aging yeast. 
ups2Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or 
without it. Mitochondria were purified from cells recovered on day 2 (A), 4 (B) or 7 (C) of cell culturing. Extraction 
of mitochondrial membrane lipids, and mass spectrometric identification and quantitation of the extracted 
phospholipid classes were carried out as described in Materials and methods. Based on these data, the ratios between 
concentrations of all possible pairwise combinations of phospholipid classes were calculated. Data are presented as 
means ± SEM (n = 3; *p < 0.05; ns, not significant). These experiments were conducted by Anthony Arlia-Ciommo, 
Simon Bourque, Olivia Koupaki and Karamat Mohammad. 
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          My assessment of the effect of the ups2Δ mutation on the CLS of yeast cultured with or 
without LCA revealed that ups2Δ 1) extends yeast CLS in the absence of LCA (Figures 2.8A and 
2.8B); and 2) significantly amplifies the geroprotective efficiency of LCA by enhancing the ability 
of this bile acid to increase both the mean and the maximum CLS (Figures 2.8A-2.8D). 
           
Figure 2.8. The ups2Δ mutation extends yeast CLS in the absence of LCA and amplifies the geroprotective 
efficiency of LCA. WT and ups2Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% 
glucose with 50 µM LCA or without it. (A) Survival curves of chronologically aging WT and ups2Δ strains are shown. 
Data are presented as means ± SEM (n = 3). (B) p Values for different pairs of survival curves of WT and ups2Δ 
strains cultured with or without LCA. Survival curves shown in (A) were compared. Two survival curves were 
considered statistically different if the p value was less than 0.05. The p values for comparing pairs of survival curves 
using the logrank test were calculated as described in Materials and methods. (C and D) Survival curves shown in (A) 
were used to calculate the percentage of increase of the mean and maximum CLS by LCA for WT and ups2Δ strains. 
Data are presented as means ± SEM (n = 3; *p < 0.05). (E) The pattern of mitochondrial lipidome characteristic of the 
ups2Δ mutation is shown. Arrows next to the ratios between concentrations of different pairwise combinations of 
phospholipid classes indicate ratios that are increased (red arrows) or decreased (blue arrows) in ups2Δ cells (as 
compared to WT cells) cultured with or without LCA. Each colored line connects the names of two phospholipid 
classes whose concentration ratio is increased (red lines) or decreased (blue lines) by the ups2Δ mutation and cannot 
be restored by LCA. These experiments were conducted by Anthony Arlia-Ciommo, Simon Bourque, Olivia Koupaki 
and Karamat Mohammad. 
          Taken together, the above findings indicate that the ups2Δ mutation may slow down yeast 
chronological aging and increase the geroprotective efficiency of LCA because it establishes a 
distinctive aging-delaying pattern of mitochondrial lipidome. This ups2Δ-specific pattern may 
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consist of the following distinct changes in the relative concentrations of different phospholipid 
classes: 1) an increase of the PA/PS, PA/PC and PA/PI ratios for non-bilayer forming PA vs. 
bilayer forming PS, PC and PI; 2) a decrease of the PE/PS, PE/PC and PE/PI ratios for non-bilayer 
forming PE vs. bilayer forming PS, PC and PI; 3) a decline of the CL/PS, CL/PC and CL/PI ratios 
for non-bilayer forming CL vs. bilayer forming PS, PC and PI; and 4) a rise of the PA/PE and 
PA/CL ratios for these non-bilayer forming classes of phospholipids (Figure 2.8E). 
 
2.3.4  The psd1Δ mutation elicits changes in mitochondrial membrane lipidome and lessens 
the geroprotective efficiency of LCA 
          I compared lipidomes of purified mitochondria from WT cells cultured with or without LCA 
to those from psd1Δ cells. These cells were recovered for purification of mitochondria on day 2, 4 
or 7 of cell culturing. The psd1Δ mutation eliminates phosphatidylserine decarboxylase which 
catalyzes the conversion of PS to PE in the IMM and OMM [195, 196, 199, 208, 209]. I found 
that, similar to the effect of LCA on mitochondrial membrane lipidome in WT, LCA causes an 
age-related rise in the concentrations of PS, PI, PC and PA in mitochondria of psd1Δ; however, 
the concentration of PA in mitochondria of psd1Δ is higher than in mitochondria of WT cultured 
with or without LCA (compare Figures 2.2 and 2.9). I also observed that, akin to the effect of LCA 
on mitochondrial membrane lipidome in WT, LCA triggers an age-related decline in the 
concentrations of PE and CL in mitochondria of psd1Δ; however, the concentrations of both PE 
and CL in mitochondria of psd1Δ are lower than in mitochondria of WT cultured with or without 
LCA (compare Figures 2.2 and 2.9). 
           
Figure 2.9. LCA exhibits age-related differential effects on the concentrations of different classes of 
mitochondrial membrane phospholipids in chronologically aging psd1Δ yeast. Cells of the psd1Δ mutant strain 
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were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it. 
Mitochondria were purified from cells recovered on day 2, 4 or 7 of cell culturing. Extraction of mitochondrial 
membrane lipids, and mass spectrometric identification and quantitation of the extracted phospholipid classes were 
carried out as described in Materials and methods. The concentrations of phospholipids were calculated as nmoles 
phospholipid/mg protein. (A) PS, PI and PC are phospholipid classes that exhibit the bilayer forming shape of a 
cylinder; they decrease the extent of membrane curving for the IMM. (B) PA, PE and CL are phospholipid classes 
that have the non-bilayer forming shape of a cone; they increase the extent of membrane curving for the IMM. Data 
are presented as means ± SEM (n = 3; *p < 0.05; ns, not significant). Abbreviations: CL, cardiolipin; PA, phosphatidic 
acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PA, phosphatidic acid; PI, phosphatidylinositol; PS, 
phosphatidylserine. 
          I then used the above data to compare the ratios between concentrations of all possible 
pairwise combinations of phospholipid classes in mitochondrial membranes of WT and psd1Δ 
cells cultured in the presence or absence of LCA. I found that, in cells cultured with or without 
LCA, the psd1Δ mutation 1) augments the PA/PS, PA/PC and PA/PI ratios for non-bilayer forming 
PA vs. bilayer forming PS, PC and PI; 2) reduces the PE/PS, PE/PC and PE/PI ratios for non-
bilayer forming PE vs. PS, PC and PI; 3) lessens the CL/PS, CL/PC and CL/PI ratios for non-
bilayer forming CL vs. PS, PC and PI; 4) does not change the PS/PI, PS/PC and PI/PC ratios for 
all these bilayer forming classes of phospholipids; 5) rises the PA/PE and PA/CL ratios for all 
these non-bilayer forming phospholipid classes; and 6) decreases the PE/CL ratio for these two 
non-bilayer forming phospholipids (Figure 2.10). Thus, unlike ups2Δ and similar to ups1Δ, the 
psd1Δ mutation does not allow to maintain the equimolar concentrations of two non-bilayer 
forming phospholipids, PE and CL. 
           
Figure 2.10. The psd1Δ mutation differently affects the ratios between concentrations of pairwise combinations 
of different phospholipid classes in mitochondrial membranes of chronologically aging yeast. psd1Δ cells were 
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cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it. 
Mitochondria were purified from cells recovered on day 2 (A), 4 (B) or 7 (C) of cell culturing. Extraction of 
mitochondrial membrane lipids, and mass spectrometric identification and quantitation of the extracted phospholipid 
classes were carried out as described in Materials and methods. Based on these data, the ratios between concentrations 
of all possible pairwise combinations of phospholipid classes were calculated. Data are presented as means ± SEM (n 
= 3; *p < 0.05; ns, not significant). 
 
          My assessment of how the psd1Δ mutation influences the CLS of yeast cultured with or 
without LCA showed that psd1Δ 1) shortens yeast CLS in the absence of LCA (Figures 2.11A and 
2.11B); and 2) substantially decreases the aging-delaying efficiency of LCA by significantly 
lowering the ability of this bile acid to increase both the mean and the maximum CLS (Figures 
2.11A-2.11D). 
 
           
Figure 2.11. The psd1Δ mutation shortens yeast CLS in the absence of LCA and considerably decreases the 
geroprotective efficiency of LCA. WT and psd1Δ cells were cultured in the nutrient-rich YP medium initially 
containing 0.2% glucose with 50 µM LCA or without it. (A) Survival curves of chronologically aging WT and psd1Δ 
strains are shown. Data are presented as means ± SEM (n = 3). (B) p Values for different pairs of survival curves of 
WT and psd1Δ strains cultured with or without LCA. Survival curves shown in (A) were compared. Two survival 
curves were considered statistically different if the p value was less than 0.05. The p values for comparing pairs of 
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survival curves using the logrank test were calculated as described in Materials and methods. (C and D) Survival 
curves shown in (A) were used to calculate the percentage of increase of the mean and maximum CLS by LCA for 
WT and psd1Δ strains. Data are presented as means ± SEM (n = 3; *p < 0.05). (E) The pattern of mitochondrial 
lipidome characteristic of the psd1Δ mutation is shown. Arrows next to the ratios between concentrations of different 
pairwise combinations of phospholipid classes indicate ratios that are increased (red arrows) or decreased (blue 
arrows) in psd1Δ cells (as compared to WT cells) cultured with or without LCA. Each colored line connects the names 
of two phospholipid classes whose concentration ratio is increased (red lines) or decreased (blue lines) by the psd1Δ 
mutation and cannot be restored by LCA. 
 
          Collectively, these findings suggest that the psd1Δ mutation may accelerate yeast 
chronological aging and decrease the geroprotective efficiency of LCA because it establishes a 
distinct pro-aging pattern of mitochondrial lipidome. This characteristic for psd1Δ pattern may 
include the following specific changes in the relative concentrations of different classes of 
membrane phospholipids: 1) an increase of the PA/PS, PA/PC and PA/PI ratios for non-bilayer 
forming PA vs. bilayer forming PS, PC and PI; 2) a decrease of the PE/PS, PE/PC and PE/PI ratios 
for non-bilayer forming PE vs. bilayer forming PS, PC and PI; 3) a decline of the CL/PS, CL/PC 
and CL/PI ratios for non-bilayer forming CL vs. bilayer forming PS, PC and PI; 4) an increase of 
the PA/PE and PA/CL ratios for these non-bilayer forming phospholipid classes; and 5) a decrease 
in the PE/CL ratio for these two non-bilayer forming classes of phospholipids (Figure 2.11E). 
 
2.3.5  A distinct pro-longevity pattern of mitochondrial lipidome extends yeast CLS in the 
absence of LCA and amplifies the geroprotective efficiency of LCA  
          I noticed that the ups1Δ, ups2Δ and psd1Δ mutations cause some similar changes to the 
ratios between concentrations of various pairwise combinations of mitochondrial membrane 
phospholipids (compare Figures 2.5E, 2.8E and 2.11E). I therefore compared the datasets of such 
ratios that have been statistically significantly changed (SSC) by the ups1Δ, ups2Δ and psd1Δ 
mutations in yeast cultured with or without LCA. I found the following for the total of 12 SSC 
ratios: 1) 8 SSC ratios overlap between the ups1Δ, ups2Δ and psd1Δ datasets; 2) 3 SSC ratios are 
common to the datasets of the CLS-extending ups2Δ mutation that amplifies the geroprotective 
efficiency of LCA and the CLS-shortening psd1Δ mutation that lessens such efficiency; and 3) 1 
SSC ratio, namely PE/CL, is common to the datasets of the ups1Δ and psd1Δ mutations, both of 
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which are CLS-shortening mutations that lower the geroprotective efficiency of LCA (ups1Δ 
increases the PE/CL ratio, whereas psd1Δ decreases it) (Figure 2.12A).    
          I also noticed that some ratios between concentrations of various pairwise combinations of 
mitochondrial membrane phospholipids are not statistically changed by the ups1Δ, ups2Δ and 
psd1Δ mutations. My analysis of these statistically unchanged (SU) ratios revealed the following: 
1) 3 SU ratios overlap between the ups1Δ, ups2Δ and psd1Δ datasets; 2) 3 SU ratios are unique to 
the dataset of ups1Δ, a CLS-shortening mutation that lowers the geroprotective efficiency of LCA; 
and 3) 1 SU ratio, namely PE/CL, is unique to the dataset of ups2Δ, a CLS-extending mutation 
that amplifies the geroprotective efficiency of LCA (Figure 2.12B).    
           
Figure 2.12. Venn diagrams showing a comparison of the effects of the ups1Δ, ups2Δ and psd1Δ mutations on 
the ratios between concentrations of various pairwise combinations of mitochondrial membrane phospholipids. 
A comparison of the datasets for the ratios that have been statistically significantly changed (A) or statistically 
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unchanged (B) by the ups1Δ, ups2Δ and psd1Δ mutations in yeast cultured with or without LCA are shown. (C) The 
maintenance of equimolar concentrations of PE and CL is an essential feature of the pro-longevity pattern of 
mitochondrial lipidome. Arrows next to the ratios between concentrations of different pairwise combinations of 
phospholipid classes indicate ratios that are increased (red arrows) or decreased (blue arrows) in ups1Δ, ups2Δ or 
psd1Δ cells (as compared to WT cells) cultured with or without LCA. 
 
          In sum, these findings suggest that the maintenance of equimolar concentrations of two non-
bilayer forming and cone-shaped phospholipids, PE and CL, may be critical feature of the pro-
longevity pattern of mitochondrial lipidome (Figure 2.12C). This feature is a longevity assurance 
trait in the absence of LCA. This feature is also required for the delay of yeast chronological aging 
by exogenous LCA. 
          The maintenance of equimolar concentrations of PE and CL is a trait that is common to WT 
and ups2Δ, a mutant strain that not only lives longer than WT but also exhibits an amplified (as 
compared to WT) geroprotective efficiency of LCA (Figure 2.8). It is conceivable, therefore, that 
some traits distinguishing mitochondrial lipidome of ups2Δ from that of WT may represent 
additional features of the pro-longevity pattern of mitochondrial lipidome. These additional 
features are likely to be responsible for the ability of the ups2Δ mutation to extend longevity in the 
absence of LCA and also to increase the geroprotective efficiency of LCA. Among these additional 
features are the ones that differentiate mitochondrial lipidome of ups2Δ from that of WT; they 
include the following: 1) an increased concentration of PA, another non-bilayer forming and cone-
shaped phospholipid; 2) a decreased concentration of PE; and 3) a proportionally (as compared to 
PE) decreased concentration of CL (compare Figures 2.2 and 2.6). I therefore hypothesize that the 
proportional decrease in the concentrations of PE and CL in mitochondrial membranes of ups2Δ 
may be responsible for the increased concentration of PA in these membranes. 
           
2.3.6 The ups1Δ and ups2Δ mutations alter the concentrations of many mitochondrial 
proteins in yeast cultured with or without LCA 
          My hypothesis posits that the LCA-dependent establishment and maintenance of a distinct 
pro-longevity pattern of mitochondrial lipidome may have a causal role in the age-related 
remodeling of mitochondrial proteome. I therefore used quantitative mass spectrometry to 
compare the identities and relative concentrations of proteins that were recovered in mitochondria 
purified from WT, ups1Δ and ups2Δ cells cultured with or without LCA. The ups1Δ mutation 
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establishes and maintains a distinct pro-aging pattern of mitochondrial lipidome (Figures 2.4, 2.5 
and 2.12), shortens CLS (Figure 2.5), and lowers the geroprotective efficiency of LCA (Figure 
2.5). In contrast, the ups2Δ mutation institutes and preserves a specific pro-longevity pattern of 
mitochondrial lipidome (Figures 2.7, 2.8 and 2.12), extends CLS (Figure 2.8), and amplifies the 
geroprotective efficiency of LCA (Figure 2.8).  
          I found that both mutations, ups1Δ and ups2Δ, alter the age-related chronology of changes 
in concentrations of numerous mitochondrial proteins in yeast cultured in the presence of LCA or 
in its absence; these proteins have been implicated in many essential mitochondrial functions (see 
Figure 2.13 for ups1Δ and Figure 2.14 for ups2Δ).  
           
Figure 2.13. Scatter plots comparing the relative concentrations of proteins in mitochondria purified from WT 
or ups1Δ (short-lived) cells cultured with or without LCA. Mitochondria were purified from WT or ups1Δ cells 
recovered on day 2, 4 or 7 of cell culturing. Mass spectrometry-based identification and quantitation of proteins 
recovered in purified mitochondria were performed as described in Materials and methods. Scatter plots comparing 
the relative abundance of mitochondrial proteins between specified datasets were plotted on a log-log scale spanning 
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six orders of magnitude. Data on the relative abundance of mitochondrial proteins are presented as means of 2 
independent experiments. 
 
Figure 2.14. Scatter plots comparing the relative concentrations of proteins in mitochondria purified from WT 
or ups2Δ (long-lived) cells cultured with or without LCA. Mitochondria were purified from WT or ups2Δ cells 
recovered on day 2, 4 or 7 of cell culturing. Mass spectrometry-based identification and quantitation of proteins 
recovered in purified mitochondria were performed as described in Materials and methods. Scatter plots comparing 
the relative abundance of mitochondrial proteins between specified datasets were plotted on a log-log scale spanning 
six orders of magnitude. Data on the relative abundance of mitochondrial proteins are presented as means of 2 
independent experiments. 
 
          I then compared the datasets of relative concentrations of mitochondrial proteins that are 
statistically significantly downregulated or upregulated 1) by LCA in WT; 2) by the ups1Δ or 
ups2Δ mutation in the absence of LCA; and 3) by LCA in ups1Δ or ups2Δ cells.  
          My comparative analysis of these datasets for ups1Δ revealed the following: 1) many 
mitochondrial proteins that are downregulated or upregulated in ups1Δ cells cultured without LCA 
are unique to these datasets (i.e. these proteins are not present in the datasets of mitochondrial 
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proteins that are downregulated or upregulated by LCA in WT or by LCA in ups1Δ cells) (Figures 
2.15A – 2.15F); and 2) the total number and identities of mitochondrial proteins that are 
downregulated or upregulated in ups1Δ cells cultured with or without LCA fluctuate significantly 
in cells recovered on day 2, 4 or 7 of cell culturing (i.e. at different stages of chronological aging) 
(Figures 2.15H – 2.15L).  
          For ups2Δ, I found that: 1) a number of mitochondrial proteins that are downregulated or 
upregulated in ups2Δ cells cultured in the absence of LCA cannot be found in the datasets of 
mitochondrial proteins downregulated or upregulated by LCA in WT or by LCA in ups2Δ cells 
(Figures 2.16A – 2.16F); 2) the total number and identities of mitochondrial proteins that are 
downregulated or upregulated in ups2Δ cells cultured in the absence of LCA vary substantially 
with the chronological age of cells (Figures 2.16H and 2.16K); 3) numerous mitochondrial proteins 
that are downregulated or upregulated by LCA in ups2Δ cells are unique to these datasets as they 
cannot be found in the datasets of mitochondrial proteins downregulated or upregulated by LCA 
in WT or by the ups2Δ mutation in the absence of LCA (Figures 2.16A – 2.16F); and 4) the total 
number and identities of mitochondrial proteins that are downregulated or upregulated by LCA in 
ups2Δ cells fluctuate significantly with the chronological age of cells (Figures 2.16I and 2.16L).  
 
Figure 2.15. The ups1Δ mutation alters the concentrations of many mitochondrial proteins in yeast cultured 
with or without LCA. (A – F) Venn diagrams showing a comparison of the datasets of relative concentrations of 
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mitochondrial proteins that are statistically significantly downregulated or upregulated by LCA in WT, by the ups1Δ 
mutation in the absence of LCA, and by LCA in ups1Δ cells; WT cells were recovered on day 2, 4 or 7 of culturing. 
(G and J) Venn diagrams showing a comparison of the datasets of relative concentrations of mitochondrial proteins 
that are statistically significantly downregulated or upregulated by LCA in WT cells recovered on day 2, 4 or 7 of 
culturing. (H and K) Venn diagrams showing a comparison of the datasets of relative concentrations of mitochondrial 
proteins that are statistically significantly downregulated or upregulated by the ups1Δ mutation in the absence of LCA; 
ups1Δ cells were recovered on day 2, 4 or 7 of culturing. (I and L) Venn diagrams showing a comparison of the 
datasets of relative concentrations of mitochondrial proteins that are statistically significantly downregulated or 
upregulated by LCA in ups1Δ cells recovered on day 2, 4 or 7 of culturing. 
 
 
Figure 2.16. The ups2Δ mutation alters the concentrations of many mitochondrial proteins in yeast cultured 
with or without LCA. (A – F) Venn diagrams showing a comparison of the datasets of relative concentrations of 
mitochondrial proteins that are statistically significantly downregulated or upregulated by LCA in WT, by the ups2Δ 
mutation in the absence of LCA, and by LCA in ups2Δ cells; WT cells were recovered on day 2, 4 or 7 of culturing. 
(G and J) Venn diagrams showing a comparison of the datasets of relative concentrations of mitochondrial proteins 
that are statistically significantly downregulated or upregulated by LCA in WT cells recovered on day 2, 4 or 7 of 
culturing. (H and K) Venn diagrams showing a comparison of the datasets of relative concentrations of mitochondrial 
proteins that are statistically significantly downregulated or upregulated by the ups2Δ mutation in the absence of LCA; 
ups2Δ cells were recovered on day 2, 4 or 7 of culturing. (I and L) Venn diagrams showing a comparison of the 
datasets of relative concentrations of mitochondrial proteins that are statistically significantly downregulated or 
upregulated by LCA in ups2Δ cells recovered on day 2, 4 or 7 of culturing. 
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          Taken together, these findings indicate that in yeast cultured with or without LCA 1) the 
establishment and maintenance of a distinct pro-aging pattern of mitochondrial lipidome in short-
lived ups1Δ cells (Figures 2.4, 2.5 and 2.12) correlate with the establishment and maintenance of 
a specific aging-accelerating pattern of mitochondrial proteome in these mutant cells; and 2) the 
institution and preservation of a specific pro-longevity pattern of mitochondrial lipidome in long-
lived ups2Δ cells (Figures 2.7, 2.8 and 2.12) correlate with the institution and preservation of a 
distinctive aging-delaying pattern of mitochondrial proteome in these mutant cells. 
 
2.3.7  The mitochondrial proteomes of ups1Δ and ups2Δ differ substantially  
          Because my findings suggest that in yeast cultured with or without LCA the ups1Δ and 
ups2Δ mutations can establish and maintain either an aging-accelerating or an aging-delaying 
(respectively) pattern of mitochondrial proteome, I compared the datasets of relative 
concentrations of mitochondrial proteins that are statistically significantly downregulated or 
upregulated in ups1Δ or ups2Δ cells in the absence or presence of LCA.  
          For ups1Δ and ups2Δ cells cultured without LCA, I found the following: 1) many 
mitochondrial proteins that are downregulated or upregulated in long-lived ups2Δ cells are not 
present in the datasets of mitochondrial proteins that are downregulated or upregulated in short-
lived ups1Δ cells (Figures 2.17A – 2.17F); and 2) the total number and identities of mitochondrial 
proteins that are downregulated or upregulated only in long-lived ups2Δ cells fluctuate 
significantly in cells recovered at different stages of chronological aging (Figures 2.17A – 2.17F). 
Functions of some mitochondrial proteins that are downregulated or upregulated only in long-lived 
ups2Δ cells remain to be established (Figures 2.17G – 2.17L). Many mitochondrial proteins that 
are downregulated or upregulated only in long-lived ups2Δ cells have been implicated in essential 
mitochondrial functions, including the electron transport chain (ETC), respiration, the 
tricarboxylic acid (TCA) cycle, ribosome assembly, amino acid metabolism, carbohydrate 
metabolism, protein import, proteostasis, metabolite synthesis, protein synthesis, ATP synthesis, 
metabolite transport, lipid metabolism, contact sites and cristae maintenance, redox homeostasis, 
mitochondrial DNA (mtDNA) maintenance, stress response, mRNA synthesis and processing, the 
maintenance of contact sites between mitochondria and vacuoles, and mitochondrial fusion 
(Figures 2.17G – 2.17L). 
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Figure 2.17. In cells cultured without LCA, many mitochondrial proteins that are downregulated or 
upregulated in long-lived ups2Δ cells are not downregulated or upregulated in short-lived ups1Δ cells. (A – F) 
Venn diagrams showing a comparison of the datasets of relative concentrations of mitochondrial proteins that are 
statistically significantly downregulated or upregulated in ups1Δ or ups2Δ cells cultured in the absence of LCA; cells 
were recovered on day 2, 4 or 7 of culturing. (G – L) Mitochondrial proteins that are downregulated or upregulated 
only in long-lived ups2Δ cells belong to various functional categories. The names of functional categories whose 
protein representatives were downregulated or upregulated in ups2Δ cells recovered on every of the three days are 
underlined. Functions of some mitochondrial proteins that are downregulated or upregulated only in ups2Δ cells are 
currently unknown. Abbreviations: ETC, electron transport chain; mtDNA, mitochondrial DNA; TCA, the 
tricarboxylic acid cycle. 
 
          For ups1Δ and ups2Δ cells cultured with LCA, I found the following: 1) a number of 
mitochondrial proteins that are downregulated or upregulated by LCA in long-lived ups2Δ cells 
cannot be found in the datasets of mitochondrial proteins that are downregulated or upregulated 
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by LCA in WT or short-lived ups1Δ cells (Figures 2.18A – 2.18F); and 2) the total number and 
identities of mitochondrial proteins that are downregulated or upregulated by LCA only in long-
lived ups2Δ cells vary notably in cells recovered at different stages of chronological aging (Figures 
2.18A – 2.18F). Functions of some mitochondrial proteins that are downregulated or upregulated 
by LCA only in long-lived ups2Δ cells remain unknown (Figures 2.18G – 2.18L). Numerous 
mitochondrial proteins that are downregulated or upregulated by LCA only in long-lived ups2Δ 
cells are known for their essential roles in the same set of mitochondrial functions as the ones 
played by proteins that are downregulated or upregulated only in long-lived ups2Δ cells culture 
without LCA (compare Figures 2.17G – 2.17L to Figures 2.18G – 2.18L).   
 
          
Figure 2.18. In cells cultured with LCA, many mitochondrial proteins that are downregulated or upregulated 
by LCA in long-lived ups2Δ cells are not downregulated or upregulated by LCA in WT or short-lived ups1Δ 
cells. (A – F) Venn diagrams showing a comparison of the datasets of relative concentrations of mitochondrial proteins 
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that are statistically significantly downregulated or upregulated by LCA in WT, ups1Δ or ups2Δ; cells were recovered 
on day 2, 4 or 7 of culturing. (G – L) Mitochondrial proteins that are downregulated or upregulated by LCA only in 
long-lived ups2Δ cells belong to many different functional categories. The names of functional categories whose 
protein representatives were downregulated or upregulated by LCA in ups2Δ cells recovered on every of the three 
days are underlined. Functions of some mitochondrial proteins that are downregulated or upregulated by LCA only in 
ups2Δ cells are currently unknown. Abbreviations: ETC, electron transport chain; mtDNA, mitochondrial DNA; TCA, 
the tricarboxylic acid cycle. 
 
          In sum, these findings suggest that in yeast cultured with or without LCA the ups2Δ mutation 
may establish and maintain an aging-delaying pattern of mitochondrial proteome. 
 
2.3.8  Many mitochondrial proteins that are downregulated or upregulated by LCA only in 
long-lived ups2Δ cells play essential roles in aging delay by LCA  
          Because my findings suggest that in yeast cultured with LCA the ups2Δ mutation may 
establish and maintain a distinct pattern of mitochondrial proteome that is essential for the ability 
of LCA to delay aging, I investigated how single-gene-deletion mutations eliminating the key 
proteins constituting such pattern affect the geroprotective efficiency of LCA. 
          I thought that some of the proteins downregulated by LCA in ups2Δ may function in 
attenuating the geroprotective efficiency of LCA, and thus the elimination of these proteins by 
mutations may increase such efficiency. I also thought that some of the proteins upregulated by 
LCA in ups2Δ may act as facilitators of aging delay by LCA, and therefore the elimination of these 
proteins by mutations may decrease the geroprotective efficiency of LCA. 
          I found that mutants that lack 10 out of 12 proteins most highly downregulated by LCA in 
ups2Δ exhibit a statistically significantly increase of the aging-delaying efficiency of LCA; a slight 
increase of such efficiency seen in mutants that lack 2 other downregulated by LCA proteins was 
not statistically significant (Figures 2.19A – 2.19C). I also found that mutants that lack 11 out of 
12 proteins vastly upregulated by LCA in ups2Δ display a statistically significantly decrease of the 
geroprotective efficiency of LCA; a minor decrease of such efficiency observed in a mutant lacking 
one of the downregulated by LCA proteins was not statistically significant (Figures 2.19D – 
2.19F). Of note, none of these mutants exhibits such robust change of the aging-delaying efficiency 
of LCA as the changes seen in the ups1Δ, ups2Δ and psd1Δ mutants (compare Figures 2.5, 2.8, 
2.11 and 2.19). This finding suggests that Ups1, Ups2 and Psd1 may function as upstream 
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regulators of various mitochondrial processes whose synergistic action defines the efficiency of 
aging delay by LCA. 
 
           
Figure 2.19. Many mutations eliminating proteins downregulated by LCA in ups2Δ increase the aging-delaying 
efficiency of LCA, while many mutations eliminating proteins upregulated by LCA in ups2Δ decrease such 
efficiency. WT and mutant cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 
50 µM LCA. (A - C) Survival curves of chronologically aging WT and mutant strains that lack proteins most highly 
downregulated by LCA in ups2Δ are shown. Data are presented as means ± SEM (n = 3). Also shown are p values for 
different pairs of survival curves of WT and mutant strains cultured with LCA. Survival curves shown in (A - C) were 
compared. Two survival curves were considered statistically different if the p value was less than 0.05. The p values 
for comparing pairs of survival curves using the logrank test were calculated as described in Materials and methods. 
(D - F) Survival curves of chronologically aging WT and mutant strains that lack proteins most substantially 
upregulated by LCA in ups2Δ are shown. Data are presented as means ± SEM (n = 3). Also shown are p values for 
different pairs of survival curves of WT and mutant strains cultured with LCA. Survival curves shown in (D - F) were 
compared. Two survival curves were considered statistically different if the p value was less than 0.05. The p values 
for comparing pairs of survival curves using the logrank test were calculated as described in Materials and methods. 
Pavlo Kyryakov, Paméla Dakik, Mélissa McAuley, Younes Medkour and Tamara Di Maulo conducted experiments 
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          Taken together, these findings further support the notion that the ups2Δ mutation may allow 
to sustain a distinct aging-delaying pattern of mitochondrial proteome that is essential for the 
ability of LCA to delay aging. 
 
2.3.9 The ups1Δ and ups2Δ mutations have different effects on some key aspects of 
mitochondrial functionality in yeast cultured with LCA 
          My hypothesis posits that the LCA-dependent remodeling of mitochondrial lipidome and 
the resulting changes in mitochondrial proteome may create an aging-delaying pattern of 
mitochondrial functionality that is essential for the ability of LCA to delay aging. To test this 
hypothesis, I monitored the age-related chronology of changes in four vital cellular processes 
confined to and regulated by mitochondria. These processes include the following: 1) 
mitochondrial respiration; 2) the maintenance of electrochemical potential (ΔΨ) across the IMM; 
3) the maintenance of the homeostasis of cellular ROS known to be produced primarily as by-
products of mitochondrial respiration [210, 211]; and 4) the modulation of cellular concentrations 
of ATP, which in yeast cultured in media with low (0.2%) glucose concentration is generated 
mainly in mitochondria [210, 211]. These vital processes were monitored in chronologically aging 
WT, ups1Δ and ups2Δ cells cultured with LCA.      
          I found that in WT cells cultured with LCA the rate of mitochondrial respiration 1) is 
increased when cells enter diauxic (D) growth phase that begins on day 2 of culturing; 2) reaches 
a plateau in post-diauxic (PD) growth phase that occurs between days 3 and 7 of culturing; and 3) 
slightly declines during the subsequent stationary (ST) growth phase that follows PD phase and 
begins after day 7 of culturing (Figure 2.20A). In ups2Δ cells cultured with LCA the rate of 
mitochondrial respiration 1) is increased to a significantly higher extent during D phase than in 
WT cells; and 2) reaches a plateau in PD phase and then additionally rises in ST phase to a 
substantially higher level than that in WT cells (Figure 2.20A). In ups1Δ cells cultured with LCA 
the rate of mitochondrial respiration 1) is increased to a significantly lower degree during D phase 
than in WT cells; and 2) substantially declines in PD and ST phases to reach a markedly lower 
level than that in WT cells (Figure 2.20A).   
          In WT cells cultured with LCA the value of ΔΨ 1) is increased during D phase; 2) reaches 
a plateau during PD phase; and 3) slightly rises during ST phase (Figure 2.20B). In ups2Δ cells 
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cultured with LCA the value of ΔΨ 1) is increased to a similar extent during D phase as in WT 
cells; 2) further rises during PD phase to reach a level significantly exceeding that in WT cells; 
and 3) slightly declines but remains higher than that in WT cells during ST phase (Figure 2.20B). 
In ups1Δ cells cultured with LCA the value of ΔΨ 1) is increased to a significantly lower degree 
during D phase than in WT cells; and 2) slightly rises during PD phase and then declines in ST 
phase to reach a substantially lower level than that in WT cells (Figure 2.20B).    
          In WT cells cultured with LCA the concentration of ROS 1) is increased during D phase; 2) 
reaches a plateau during PD phase; and 3) remains mainly unchanged during ST phase (Figure 
2.20C). In ups2Δ cells cultured with LCA the concentration of ROS 1) is increased to a lower 
degree during D phase than in WT cells; and 2) undergoes minor changes during PD and ST phases 
to reach a level that is significantly lower than that in WT cells (Figure 2.20C). In ups1Δ cells 
cultured with LCA the concentration of ROS 1) is increased to a similar extent during D phase as 
in WT cells; and 2) further rises during PD and ST phases to reach a level significantly exceeding 
that in WT cells (Figure 2.20C).   
          In WT cells cultured with LCA the concentration of ATP 1) is increased during D phase; 2) 
reaches a plateau during PD phase; and 3) slightly declines during ST phase (Figure 2.20D). In 
ups2Δ cells cultured with LCA the concentration of ATP 1) is increased to a similar degree during 
D phase as in WT cells; 2) further rises during PD phase to reach a level significantly higher than 
that in WT cells; and 3) slightly declines but remains higher than that in WT cells during ST phase 
(Figure 2.20D). In ups1Δ cells cultured with LCA the concentration of ATP 1) is increased to a 
significantly lower extent during D phase than in WT cells; and 2) remains unchanged during PD 
phase and then declines in ST phase to reach a substantially lower level than that in WT cells 
(Figure 2.20D). 
          In sum, these findings support the notion that the LCA-dependent remodeling of 
mitochondrial lipidome and the resulting changes in mitochondrial proteome can create an aging-




Figure 2.20. In yeast cultured with LCA, the ups1Δ and ups2Δ mutations differently affect four key aspects of 
mitochondrial functionality. WT and mutant cells were cultured in the nutrient-rich YP medium initially containing 
0.2% glucose with 50 µM LCA. The dynamics of age-related changes in the rate of oxygen consumption my cells (A), 
electrochemical potential (ΔΨ) across the IMM (B), cellular concentration of ROS (C) and cellular concentration of 
ATP (D) during chronological aging of yeast. Data are presented as means ± SEM (n = 3; *p < 0.05; **p < 0.01; ***p 
< 0.001). Pavlo Kyryakov, Paméla Dakik, Mélissa McAuley, Younes Medkour and Tamara Di Maulo conducted 
experiments. 
 
2.4        Discussion 
             This study provides evidence that the mitochondrial lipidome defines not only the rate of 
yeast chronological aging but also the geroprotective efficiency of LCA in chronologically aging 
yeast. I demonstrate the existence of a distinct pro-longevity pattern of mitochondrial lipidome, 
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which extends yeast CLS in the absence of LCA and amplifies the geroprotective efficiency of 
LCA. This pattern consists in a proportional decrease of PE and CL concentrations, and in a 
concomitant increase of PA concentration. PE, CL and PA are non-bilayer forming, cone-shaped 
phospholipid classes that increase the extent of membrane curving for the IMM to rise the 
abundance of mitochondrial cristae (formed by the IMM) and mitochondrial contact cites (formed 
between the IMM and OMM) [81, 198, 199, 202-207]. I also show that these LCA-driven specific 
changes in the composition of mitochondrial membrane lipids cause a distinct remodeling of 
mitochondrial proteome by decreasing and increasing concentration of many mitochondrial 
proteins. These proteins have been implicated in such vital mitochondrial functions as the ETC 
and respiration, the TCA cycle, ribosome assembly, amino acid metabolism, carbohydrate 
metabolism, protein import, proteostasis, metabolite synthesis, protein synthesis, ATP synthesis, 
metabolite transport, lipid metabolism, contact sites and cristae maintenance, redox homeostasis, 
mtDNA maintenance, stress response, mRNA synthesis and processing, the maintenance of 
contact sites between mitochondria and vacuoles, and mitochondrial fusion. I provide evidence 
that the LCA-dependent remodeling of mitochondrial lipidome and the resulting changes in 
mitochondrial proteome allow to change the age-related chronology of changes in such vital 
mitochondrial processes as respiration, electrochemical potential maintenance, ROS homeostasis 
preservation and ATP synthesis. These changes facilitate the establishment and maintenance of an 
aging-delaying pattern of mitochondrial functionality that is essential for the ability of LCA to 
delay aging. 
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3 Caloric restriction extends yeast chronological lifespan via a mechanism linking 
cellular aging to cell cycle regulation, maintenance of a quiescent (Q) state, entry into 
a non-quiescent (NQ) state and survival in the NQ state 
 
3.1       Introduction 
            CR is a dietary intervention that delays aging in yeast and other evolutionarily distant 
eukaryotic organisms [84, 85, 185-189]. Mechanisms linking yeast chronological aging to a 
quiescence program under non-CR conditions are well established; these mechanisms are 
discussed in Chapter 1 of my thesis [88-92, 94, 126, 127, 180, 190]. It was unknown, however, if 
the aging-delaying effect of CR in chronologically aging yeast is due in part to the ability of this 
low-calorie diet to control the quiescence program. To test if the ability of CR to slow down yeast 
chronological aging, I investigated how the CR diet influences the differentiation of 
chronologically aging yeast cultures into Q and NQ cells, and how it affects their properties.     
 
3.2     Materials and methods 
3.2.1  Yeast strains, media and growth conditions 
          The wild-type strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 
ura30) from Open Biosystems/Dharmacon (a part of GE Healthcare) was grown in YP medium 
(1% yeast extract, 2% peptone; both from Fisher Scientific; #BP1422-2 and #BP1420-2, 
respectively) initially containing 0.2% or 2% glucose (#D16-10; Fisher Scientific) as carbon 
source. Cells were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer flasks at a 
″flask volume/medium volume″ ratio of 5:1. 
 
3.2.2  A plating assay for the analysis of chronological lifespan 
          Cells were grown in YEPD (0.2% glucose or 2% glucose, as specified in the text) medium 
at 30oC with rotational shaking at 200 rpm in Erlenmeyer flasks at a flask volume/medium volume 
ratio of 5:1. A sample of cells was removed from each culture at various time points. A fraction of 
the cell sample was diluted to determine the total number of cells per ml of culture using a 
hemacytometer. 10 l of serial dilutions (1:10 to 1:103) of cells were applied to the hemacytometer, 
where each large square is calibrated to hold 0.1 l. The number of cells in 4 large squares was 
then counted and an average was taken to ensure greater accuracy. The concentration of cells was 
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calculated as follows: number of cells per large square x dilution factor x 10 x 1,000 = total number 
of cells per ml of culture. A second fraction of the cell sample was diluted and serial dilutions 
(1:102 to 1:105) of cells were plated onto YEPD (2% glucose) plates in triplicate to count the 
number of viable cells per ml of each culture. 100 l of diluted culture was plated onto each plate. 
After a 48-h incubation at 30oC, the number of colonies per plate was counted. The number of 
colony forming units (CFU) equals to the number of viable cells in a sample. Therefore, the number 
of viable cells was calculated as follows: number of colonies x dilution factor x 10 = number of 
viable cells per ml. For each culture assayed, % viability of the cells was calculated as follows: 
number of viable cells per ml / total number of cells per ml x 100%. The % viability of cells in 
mid-logarithmic phase was set at 100% viability for that culture. The life span curves for wild-
type and some of the mutant strains were also validated using a LIVE/DEAD yeast viability kit 
(Invitrogen) following the manufacturer's instructions for stationary-phase cultures. 
 
3.2.3  Separation of Q and NQ cells by centrifugation in Percoll density gradient 
          1 ml of 1.5 M NaCl (#S7653; Sigma) was placed into a 50-ml conical polypropylene 
centrifuge tube (#055398; Fisher Scientific), and 8 ml of the Percoll solution (#P1644; Sigma) was 
added to this tube. The NaCl and Percoll solutions were then mixed by pipetting. To form two 
Percoll density gradients, 4 ml of the NaCl/Percoll mixture was put into each of the two 
polyallomer tubes for an MLS-50 rotor for an Optima MAX ultracentrifuge (all from Beckman 
Coulter, Inc.). The tubes were centrifuged at 25,000 × g (16,000 rpm) for 15 min at 4oC in an 
Optima MAX ultracentrifuge. A sample of yeast cells was taken from a culture at a certain time-
point. A fraction of the sample was diluted to determine the total number of cells per ml of culture 
using a hemacytometer (#0267110; Fisher Scientific). For each Percoll density gradient, 1 × 109 
yeast cells were placed into a 15-ml conical polypropylene centrifuge tube (#0553912; Fisher 
Scientific) and then pelleted by centrifugation at 5,000 rpm for 7 min at room temperature in an 
IEC Centra CL2 clinical centrifuge (Thermo Electron Corporation). Pelleted cells were 
resuspended in 500 μl of 50 mM Tris/HCl buffer (pH 7.5), overlaid onto the preformed Percoll 
gradient and centrifuged at 2,300 × g (5,000 rpm) for 30 min at 25oC in an Optima MAX 
ultracentrifuge. The upper and lower fractions of cells were collected with a pipette, Percoll was 
removed by washing cells twice with 50 mM Tris/HCl buffer (pH 7.5) and cells were resuspended 
in 50 mM Tris/HCl buffer (pH 7.5) for subsequent assays. 
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3.2.4  Reproductive (colony forming) capability assay for Q and NQ cells separated by 
centrifugation in Percoll density gradient 
          An aliquot of the upper or lower fraction of cells recovered from the Percoll gradient and 
washed twice with 50 mM Tris/HCl buffer (pH 7.5) was diluted to determine the total number of 
cells per fraction using a hemacytometer (#0267110; Fisher Scientific). Serial dilutions (1:102 to 
1:105) of cells were also plated onto YEPD (1% yeast extract, 2% peptone, 2% glucose) plates in 
duplicate to count the number of viable cells per ml of each cell fraction. 100 µl of diluted culture 
was plated onto each plate. After 48-h incubation at 30oC, the number of colonies per plate was 
counted. The number of colony forming units (CFU) equals to the number of reproductively 
capable cells in a sample. Therefore, the number of reproductively capable cells was calculated as 
follows: number of CFU × dilution factor × 10 = number of reproductively capable cells per ml. 
For each cell fraction assayed, % reproductive capability of the cells was calculated as follows: 
number of CFU per ml/total number of cells per ml × 100%.  
 
3.2.5   Synchronous reentry into mitosis assay for Q and NQ cells separated by centrifugation 
in Percoll density gradient 
          5 × 106 cells recovered in the upper or lower fraction of the Percoll gradient and washed 
twice with 50 mM Tris/HCl buffer (pH 7.5) were harvested by centrifugation for 1 min at 21,000 
× g at room temperature. Pelleted cells were washed twice with water and then inoculated into 50 
ml of YP medium (1% yeast extract, 2% peptone; both from Fisher Scientific; #BP1422-2 and 
#BP1420-2, respectively) initially containing 0.2% or 2% glucose (#D16-10; Fisher Scientific) as 
carbon source. Cells were cultured for 4 h at 30oC with rotational shaking at 200 rpm in Erlenmeyer 
flasks at a “flask volume/medium volume” ratio of 5:1. A sample of cells was taken from a culture 
at a certain time-point and examined microscopically for the percentage of cells with new buds. 
At least 500 cells were examined per time point, and the budding percentage was calculated as 
follows: (number of cells with new buds per ml/total number of cells per ml) × 100%.  
 
3.2.6  Measurement of trehalose and glycogen concentrations 
          2 × 109 cells were harvested by centrifugation for 1 min at 16,000 × g at 4oC. The cell pellet 
was washed three times in ice-cold PBS (20 mM KH2PO4/KOH (pH 7.5) and 150 mM NaCl) and 
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then resuspended in 200 μl of ice-cold SHE solution (50 mM NaOH and 1 mM EDTA). 800 μl of 
ice-cold SHE solution were added to the cell suspension. The resulting alkali extract was incubated 
at 60oC for 30 min to destroy endogenous enzyme activities and pyridine nucleotides. The extract 
was neutralized by adding 500 μl of THA solution (100 mM Tris/HCl (pH 8.1) and 50 mM HCl). 
The extract was then divided into 150 μl aliquots, quickly frozen in liquid nitrogen and stored at - 
80oC prior to use.  
          To measure trehalose concentration, 50 μl of alkali extract were added to 150 μl of trehalose 
reagent (25 mM KH2PO4/KOH (pH 7.5) and 0.02% BSA) with or without 15 mU trehalase. The 
mixture was incubated for 60 min at 37oC. 800 μl of glucose reagent (100 mM Tris/HCl (pH 8.1), 
2 mM MgCl2, 1 mM DTT, 1 mM ATP, 0.2 mM NADP+, and mixture of hexokinase (7 U) and 
glucose-6-phosphate dehydrogenase (8 U)) were added, and the mixture was incubated for 30 min 
at 25oC. The NADPH generated from NADP+ was measured fluorimetrically (excitation at 365 
nm, emission monitored at 460 nm). 
          To measure glycogen concentration, 50 μl of alkali extract were added to 500 μl of glycogen 
reagent (50 mM sodium acetate (pH 4.6) and 0.02% BSA; with and without 5 μg/ml 
amyloglucosidase 14 U/mg). The mixture was incubated for 30 min at 25oC. 500 μl of glucose 
reagent (100 mM Tris/HCl (pH 8.1), 2 mM MgCl2, 1 mM DTT, 1 mM ATP, 0.2 mM NADP+, and 
mixture of hexokinase (7 U) and glucose-6-phosphate dehydrogenase (8 U)) were added, and the 
mixture was incubated for 30 min at 25oC. The NADPH generated from NADP+ was measured 
fluorimetrically (excitation at 365 nm, emission monitored at 460 nm). 
 
3.2.7  Lipid extraction from yeast cells [191] 
          Yeast cells were harvested by centrifugation in a Centra CL2 clinical centrifuge at 3,000 × 
g for 5 min at room temperature. The cell pellet was resuspended in ice-cold 155 mM ammonium 
bicarbonate (pH 8.0), and the cells were subjected to centrifugation at 16,000 × g for 1 min at 4oC. 
The cell pellet was stored at -80ᴼC until lipid extraction. For lipid extraction, the pelleted cells kept 
at -80ᴼC were thawed on ice before being resuspended in 1 ml of ice-cold nanopure water. The 
volume that contained 5 × 107 cells was transferred to a 15-ml high-strength glass screw top 
centrifuge tube with a Teflon lined cap (#0556912; Fisher Scientific). The volume of each sample 
was topped off to 1 ml with ice-cold nanopure water. To each tube the following was added: 20 µl 
of the internal standard mix prepared in Chromasolv HPLC (>99.9%) chloroform (Sigma-Aldrich) 
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(Table 3.1), 800 µl of 425-600 µM acid-washed glass beads to break open the cells (#G8772; 
Sigma-Aldrich) and 3 ml of a Chromasolv HPLC (>99.9%) chloroform-methanol mixture (both 
from Sigma-Aldrich) at a 17:1 ratio. The samples were then vortexed vigorously for 2 h at 4ᴼC 
and subjected to centrifugation in a Centra CL2 clinical centrifuge at 3,000 × g for 5 min at room 
temperature; this centrifugation allowed to separate the upper aqueous phase from the lower 
organic phase, which contained nonpolar lipids TAG, PC, PE and PG. The lower organic phase 
was then transferred to another 15-ml high-strength glass screw top centrifuge tube using a glass 
Pasteur pipette with careful attention not to disrupt the glass beads or upper aqueous phase. 1.5 ml 
of chloroform-methanol (2:1) solution was added to the remaining upper aqueous phase to allow 
the separation of polar lipids PA, PS, PI and CL. The samples were again vortexed vigorously at 
4oC for 1 h. The initial separated organic band was kept at 4oC for the duration of the second 
vortexing. At the end of 1 h, the samples were again centrifuged for 5 min at 3,000 × rpm at room 
temperature; the lower organic phase was then separated and added to the corresponding initial 
organic phase with a glass Pasteur pipette. With both lower organic phases combined, the solvent 
was evaporated off by nitrogen gas flow. Once all solvent was evaporated, the remaining lipid film 
was dissolved in 100 µl of chloroform-methanol (1:2) and immediately transferred into 2-ml glass 
vials with Teflon screw tops to avoid evaporation until samples were analyzed by mass 
spectrometry. Samples were then stored at -80oC and ran on the LTQ Orbitrap Mass Spectrometer 
within one week of the extraction. 







Lipid chain composition 
(number carbons: number 
double bonds on fatty acid 
chain) 








mix                    
(mg/µL) 
Negative 
CL 14:0 / 14:0 / 14:0 /14:0 1274.9000 619.4157 0.10 
FFA 19:0 298.2872 297.2711 0.02 
PA 14:0 / 14:0 614.3920 591.4026 0.10 
PE 14:0 / 14:0 635.4526 634.4448 0.10 
PG 14:0 / 14:0 688.4290 665.4394 0.10 
PS 14:0 / 14:0 701.4240 678.4271 0.02 
Positive 
TAG 13:0 / 13:0 / 13:0 680.5955 698.6299 0.10 
PC 13:0 / 13:0 649.4683 650.4761 0.10 
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Internal standards CL, PA, PE, PG, PS and PC were all from Avanti Polar Lipid, Alabaster, AL, 
USA. TAG internal standard originates from Larodan, Malmo, Sweden. 
 
3.2.8  Lipid identification and quantitation using mass spectrometry 
          Samples were diluted (1:1) with 1:2 chloroform-methanol supplemented with 0.1% 
ammonium hydroxide for improved ionization efficiency. Samples were injected one at a time 
using a Thermo Orbitrap Velos Mass Spectrometer equipped with HESI-II ion source (Thermo 
Scientific) at a flow rate of 5 µl/ min. The instrument settings for the Orbitrap used the optimized 
settings, as described in reference 191 (Table 3.2). 
Table 3.2. Thermo Orbitrap Velos mass spectrometer’s tune file instrument settings (from [191]) 
Instrument polarity  Positive Negative 
Source voltage (kV) 3.9 4 
Capillary temperature (ᴼC) 275 275 
Sheath gas flow 5 5 
Aux gas flow 1 1 
FT-MS injection time (ms) 100 500 
FT-MS microscans 3 1 
 
Data were acquired according to the Instrument Method for data-dependent acquisition for 5 min 
in both positive and negative modes by the FT-MS analyzer at a resolution of 100,000 for both 
MS and MS/MS data (Table 3.3). 
 
Table 3.3. Instrument method for data-dependent acquisition (from [191]) 
Acquisition time                                  5 min (with a 0.25-min delay) 
Instrument polarity Positive Negative 





















































Between each sample, the line was flushed with chloroform-methanol (1:2) mixture until the ion 
detection steadied and returned into the baseline level. Diluted internal standard mix was injected 
multiple times throughout the acquisition to ensure no sensitivity loss throughout the run. 
          Once all data was acquired, raw files were converted to open format mzXML using 
ProteoWizard MSConvert software (http://proteowizard.sourceforge.net/), the file format used by 
the Lipid Identification Software LipidXplorer (https://wiki.mpi-cbg.de/lipidx/Main_Page). Data 
files were then imported into this software using settings described in Table 3.4; all lipids in the 
PA, PC, PE, PI, PS, CL and TAG lipid classes were identified with the help of Molecular 
Fragmentation Query Language (MFQL) files. MFQL files were obtained from the LipidXplorer 
page listed above and aided in the identification of lipids by their m/z ratio as well as their 
fragmentation patterns.  
LipidXplorer’s output data was then opened under a Microsoft Excel file and all detected 
lipids were quantified by comparison with the intensity of the corresponding lipid class’ internal 
standard’s known concentration in the sample. Each quantified lipid had a corresponding internal 
standard from the same lipid class, allowing the calculation of molar percentage of each identified 
lipid species and, therefore, of each lipid class.  
 
Table 3.4. Lipid identification by LipidXplorer import settings for data acquired under positive and negative 
mode (from [191])  
 Positive mode  Negative mode 
Selection Window (Da) 
Time range (sec.) 
Calibration masses 
             MS 
             MS/MS 
m/z range (m/z-m/z) 
             MS 
             MS/MS 
Resolution (FMHW) 
             MS 
             MS/MS 
Tolerance (ppm) 
             MS 
             MS/MS 
Resolution Gradient (res/(m/z)) 
            MS 
            MS/MS 
Minimum Occupation (0<1) 
             MS 
             MS/MS 













































3.2.9  Oxygen consumption assay (cellular respiration measurement) 
          A sample of cells was taken from a culture at a certain time-point. Cells were pelleted by 
centrifugation and resuspended in 1 ml of fresh YP medium containing 0.05% glucose. Oxygen 
uptake by cells was measured continuously in a 2-ml stirred chamber using a custom-designed 
biological oxygen monitor (Science Technical Center of Concordia University) equipped with a 
Clark-type oxygen electrode. 
 
3.2.10  Mitochondrial membrane potential measurement  
            The mitochondrial membrane potential () was measured in live yeast by fluorescence 
microscopy of Rhodamine 123 (R123) staining. For R123 staining, 5 × 106 cells were harvested 
by centrifugation for 1 min at 21,000 × g at room temperature and then resuspended in 100 μl of 
50 mM sodium citrate buffer (pH 5.0) containing 2% glucose. R123 (Invitrogen) was added to a 
final concentration of 10 μM. Following incubation in the dark for 30 min at room temperature, 
the cells were washed twice in 50 mM sodium citrate buffer (pH 5.0) containing 2% glucose and 
then analyzed by fluorescence microscopy. Images were collected with a Zeiss Axioplan 
fluorescence microscope (Zeiss) mounted with a SPOT Insight 2-megapixel color mosaic digital 
camera (Spot Diagnostic Instruments). For evaluating the percentage R123-positive cells, the 
UTHSCSA Image Tool (Version 3.0) software was used to calculate both the total number of cells 
and the number of stained cells. Fluorescence of individual R123-positive cells in arbitrary units 
was determined by using the UTHSCSA Image Tool software (Version 3.0). In each of 3 
independent experiments, the value of median fluorescence was calculated by analyzing at least 
800-1000 cells that were collected at each time-point. The median fluorescence values were plotted 
as a function of the number of days cells were cultured. 
 
3.2.11  Monitoring the formation of ROS  
            ROS production in wild-type and mutant cells grown in YEPD (0.2% glucose) with LCA 
was tested microscopically by incubation with Dihydrorhodamine 123 (DHR). In the cell, this non-
fluorescent compound can be oxidized to the fluorescent chromophore rhodamine 123 by ROS. 
Cells were also probed with a fluorescent counterstain Calcofluor White M2R (CW), which stains 
the yeast cell walls fluorescent blue. CW was added to each sample to label all cells for their proper 
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visualization. DHR was stored in the dark at –20oC as 50 l aliquots of a 1 mg/ml solution in 
ethanol. CW was stored in the dark at –20oC as the 5-mM stock solution in anhydrous DMSO 
(dimethyl sulfoxide). The concurrent staining of cells with DHR and CW was carried out as 
follows. The required amounts of the 50 l DHR aliquots (1 mg/ml) and of the 5-mM stock 
solution of CW were taken out of the freezer and warmed to room temperature. The solutions of 
DHR and CW were then centrifuged at 21,000 × g for 5 min to clear them of any aggregates of 
fluorophores. For cell cultures with a titer of ~ 107 cells/ml, 100 l was taken out of the culture to 
be treated. If the cell titer was lower, proportionally larger volumes were used. 6 l of the 1 mg/ml 
DHR and 1 l of the 5-mM CW solutions were added to each 100 l aliquot of culture. After a 2-
h incubation in the dark at room temperature, the samples were centrifuged at 21,000 × g for 5 
min. Pellets were resuspended in 10 l of PBS buffer (20 mM KH2PO4/KOH, pH 7.5, and 150 
mM NaCl). Each sample was then supplemented with 5 l of mounting medium, added to a 
microscope slide, covered with a coverslip, and sealed using nail polish. Once the slides were 
prepared, they were visualized under the Zeiss Axioplan fluorescence microscope mounted with a 
SPOT Insight 2-megapixel color mosaic digital camera. Several pictures of the cells on each slide 
were taken, with two pictures taken of each frame. One of the two pictures was of the cells seen 
through a rhodamine filter to detect cells dyed with DHR. The second picture was of the cells seen 
through a DAPI filter to visualize CW, and therefore all the cells present in the frame. For 
evaluating the percentage of DHR-positive cells, the UTHSCSA Image Tool (Version 3.0) 
software was used to calculate both the total number of cells and the number of stained cells. 
Fluorescence of individual DHR-positive cells in arbitrary units was determined by using the 
UTHSCSA Image Tool software (Version 3.0). In each of 3-5 independent experiments, the value 
of median fluorescence was calculated by analyzing at least 800-1000 cells that were collected at 
each time point. The median fluorescence values were plotted as a function of the number of days 
cells were cultured. 
 
3.2.12  Measurement of oxidative damage to cellular proteins 
            107 yeast cells were harvested by centrifugation for 1 min at 21,000  g at room 
temperature. The cell pellet was resuspended in 1 ml of ice-cold 50 mM KH2PO4/KOH buffer (pH 
7.5) + 1 mM EDTA. The cells were sonicated on ice, harvested by centrifugation for 5 min at 
21,000  g at 4oC and then resuspended in 200 µl of ice-cold 50 mM KH2PO4/KOH buffer (pH 
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7.5) + 1 mM EDTA. The Protein Carbonyl Assay Kit assay kit (#10005020; Cayman Chemical) 
was used to measure protein carbonylation (i.e. protein oxidative damage) as the amount of 
protein-hydrozone produced in the DNPH (2,4-dinitrophenylhydrazine) reaction at an absorbance 
of 360 nm.      
 
3.2.13  Measurement of oxidative damage to cellular membrane lipids 
            107 yeast cells were harvested by centrifugation for 3 min at 16,000  g at room 
temperature. The cell pellet was washed with ice-cold ABC buffer (155 mM ammonium 
bicarbonate, pH 8.0) by centrifugation for 3 min at 16,000 × g at 4oC, and then resuspended in 1 
ml of ice-cold ABC buffer. 200 µl of glass beads were added, and the sample was vortexed for 5 
min. 1 ml of ice-cold nanopore water was added, and the sample was transferred to a 15-ml glass 
centrifuge tube. 3 ml of chloroform/methanol (17:1) mixture was added, and the sample was 
vortexed at 4°C for 2 h. The sample was subjected to centrifugation at 3000 × g for 5 min at room 
temperature to form two phases. The lower organic phase was transferred to a new 15-ml glass 
tube. The solvent was evaporated off under nitrogen flow or in a vacuum evaporator. The lipid 
film was dissolved in 100 µl of methanol/chloroform (2:1) mixture. The PeroXOquant 
Quantitative Peroxide Assay Kit (#23285; Thermo Scientific Pierce) was used to measure lipid 
hydroperoxides as the Fe3+ complexes with the xylenol orange dye at an absorbance of 595 nm.     
 
3.2.14  Measurement of the frequency of nuclear mutations  
            The frequency of spontaneous point mutations in the CAN1 gene of nuclear DNA was 
evaluated by measuring the frequency of mutations that caused resistance to the antibiotic 
canavanine. A sample of cells was removed from each culture at various time-points. Cells were 
plated in triplicate onto YNB (0.67% Yeast Nitrogen Base without amino acids [#DF0919153; 
Fisher Scientific]) plates containing 2% glucose and supplemented with L-canavanine (50 mg/l), 
histidine, leucine, lysine and uracil (#C1625, #H8125, #L8912, #L5751 and #U0750, respectively; 
all from Sigma). In addition, serial dilutions of each sample were plated in triplicate onto YP plates 
containing 2% glucose for measuring the number of viable cells. The number of CFU was counted 
after 4 d of incubation at 30oC. For each culture, the frequency of mutations that caused resistance 
to canavanine was calculated as follows: number of CFU per ml on YNB plates containing 2% 
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glucose, L-canavanine (50 mg/l), histidine, leucine, lysine and uracil/number of CFU per ml on 
YP plates containing 2% glucose. 
 
3.2.15  Measurement of the frequency of mitochondrial mutations affecting mitochondrial 
components 
            The frequency of spontaneous single-gene (mit- and syn-) and deletion (rho- and rhoo) 
mutations in mtDNA affecting essential mitochondrial components was evaluated by measuring 
the fraction of respiratory-competent (rho+) yeast cells remaining in their aging population. rho+ 
cells maintained intact their mtDNA and their nuclear genes encoding essential mitochondrial 
components. Therefore, rho+ cells could grow on glycerol, a non-fermentable carbon source. In 
contrast, mutant cells deficient in mitochondrial respiration were unable to grow on glycerol. These 
mutant cells carried mutations in mtDNA (including single-gene mit- and syn- mutations or large 
deletions rho-) or completely lacked this DNA (rhoo mutants). Serial dilutions of cell samples 
removed from different phases of growth were plated in triplicate onto YP plates containing either 
2% glucose or 3% glycerol (#BP229-4; Fisher Scientific) as carbon source. Plates were incubated 
at 30oC. The number of CFU on YP plates containing 2% glucose was counted after 2 d of 
incubation, whereas the number of CFU on YP plates containing 3% glycerol was counted after 6 
d of incubation. For each culture, the percentage of respiratory-deficient (mit-, syn-, rho-, rhoo and 
pet-) cells was calculated as follows: 100 - [(number of CFU per ml on YP plates containing 3% 
glycerol/number of CFU per ml on YP plates containing 2% glucose) × 100].  
          The frequency of spontaneous point mutations in the rib2 and rib3 loci of mtDNA was 
evaluated by measuring the frequency of mtDNA mutations that caused resistance to the antibiotic 
erythromycin. These mutations impair only mtDNA. A sample of cells was removed from each 
culture at various time-points. Cells were plated in triplicate onto YP plates containing 3% glycerol 
and erythromycin (1 mg/ml) [#227330050; Acros Organics]. In addition, serial dilutions of each 
sample were plated in triplicate onto YP plates containing 3% glycerol as carbon source for 
measuring the number of respiratory-competent (rho+) cells. The number of CFU was counted 
after 6 d of incubation at 30oC. For each culture, the frequency of mutations that caused resistance 
to erythromycin was calculated as follows: number of CFU per ml on YP plates containing 3% 
glycerol and erythromycin/number of CFU per ml on YP plates containing 3% glycerol. 
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3.2.16  Plating assays for the analysis of resistance to oxidative and thermal stresses 
            For the analysis of hydrogen peroxide (oxidative stress) resistance, serial dilutions (1:100 
to 1:105) of cells removed from each culture at various time-points were spotted onto two sets of 
plates. One set of plates contained YP medium with 2% glucose alone, whereas the other set 
contained YP medium with 2% glucose supplemented with 5 mM hydrogen peroxide. Pictures 
were taken after a 3-day incubation at 30oC. 
          For the analysis of thermal stress resistance, serial dilutions (1:100 to 1:105) of wild-type and 
mutant cells removed from each culture at various time-points were spotted onto two sets of plates 
containing YP medium with 2% glucose. One set of plates was incubated at 30oC. The other set of 
plates was initially incubated at 55oC for 30 min, and was then transferred to 30oC. Pictures were 
taken after a 3-day incubation at 30oC. 
           
3.2.17  Cell viability assay for monitoring the susceptibility of yeast to a mode of cell death 
induced by hydrogen peroxide  
            A sample of cells was taken from a culture on a certain day of culturing. A fraction of the 
sample was diluted to determine the total number of cells using a hemocytometer. 8 × 107 cells 
were harvested by centrifugation for 1 min at 21,000 × g at room temperature and resuspended in 
8 ml of YP medium containing 0.2% glucose as carbon source. Each cell suspension was divided 
into 8 equal aliquots. Three pairs of aliquots were supplemented with hydrogen peroxide (#H325-
500; Fisher Scientific) to the final concentration of 0.5 mM, 1.5 mM or 2.5 mM for each pair. One 
pair of aliquots remained untreated. All aliquots were then incubated for 2 h at 30oC on a Labquake 
rotator (#400110; Thermolyne/Barnstead International) set for 360o rotation. Serial dilutions of 
cells were plated in duplicate onto plates containing YP medium with 2% glucose as carbon source. 
After 2 d of incubation at 30oC, the number of CFU per plate was counted. The number of CFU 
was defined as the number of viable cells in a sample. For each aliquot of cells exposed to hydrogen 
peroxide, the % of viable cells was calculated as follows: (number of viable cells per ml in the 
aliquot exposed to hydrogen peroxide/number of viable cells per ml in the control aliquot that was 




3.2.18  Cell viability assay for monitoring the susceptibility of yeast to a mode of cell death 
induced by palmitoleic acid (POA)  
            A sample of cells was taken from a culture on a certain day of culturing. A fraction of the 
sample was diluted to determine the total number of cells using a hemocytometer. 8 × 107 cells 
were harvested by centrifugation for 1 min at 21,000 × g at room temperature and resuspended in 
8 ml of YP medium containing 0.2% glucose as carbon source. Each cell suspension was divided 
into 8 equal aliquots. Three pairs of aliquots were supplemented with POA (#P9417; Sigma) from 
a 50-mM stock solution (in 10% chloroform, 45% hexane and 45% ethanol; #650498, #248878 
and #34852, respectively; all from Sigma). The final concentration of POA was 0.05 mM, 0.1 mM 
or 0.15 mM for each pair of aliquots; in all these aliquots, the final concentrations of chloroform, 
hexane and ethanol were 0.03%, 0.135% and 0.135%, respectively. One pair of aliquots was 
supplemented only with chloroform, hexane and ethanol added to the final concentrations of 
0.03%, 0.135% and 0.135%, respectively. All aliquots were then incubated for 2 h at 30oC on a 
Labquake rotator (#400110; Thermolyne/Barnstead International) set for 360o rotation. Serial 
dilutions of cells were plated in duplicate onto plates containing YP medium with 2% glucose as 
carbon source. After 2 d of incubation at 30oC, the number of colony forming units (CFU) per 
plate was counted. The number of CFU was defined as the number of viable cells in a sample. For 
each aliquot of cells exposed to POA, the % of viable cells was calculated as follows: (number of 
viable cells per ml in the aliquot exposed to POA/number of viable cells per ml in the control 
aliquot that was not exposed to POA) × 100. 
 
3.2.19  Statistical analysis 
            Statistical analysis was performed using Microsoft Excel's (2010) Analysis ToolPak - 
VBA. All data on cell survival are presented as mean ± SEM. The p values for comparing the 
means of two groups using an unpaired two-tailed t test were calculated with the help of the 
GraphPad Prism 7 statistics software. The logrank test for comparing each pair of survival curves 
was performed with GraphPad Prism 7. Two survival curves were considered statistically different 





3.3      Results  
 
3.3.1 CR accelerates an age-related accumulation of low-density cells in chronologically 
aging yeast cultures 
          Chronologically aging yeast cultured under CR conditions in the nutrient-rich YP medium 
initially containing 0.2% glucose lived significantly longer than yeast undergoing chronological 
aging under non-CR conditions in YP medium initially supplemented with 2% glucose (Figure 
3.1A). Even before glucose is depleted from the medium at the diauxic shift, a yeast culture 
undergoing chronological aging under non-CR conditions is known to differentiate into cell 
populations with different buoyant densities [212, 213]. Each of these cell populations can be 
purified to homogeneity by centrifugation in Percoll density gradient [214].  
          Using centrifugation in Percoll density gradient for separating cell populations exhibiting 
different densities, I investigated how CR influences the differentiation of a chronologically aging 
yeast culture into these distinct cell populations. Samples of cells cultured in YP medium initially 
containing 0.2% glucose (CR conditions) or 2% glucose (non-CR conditions) were recovered at 
different time-points following glucose exhaustion from the medium, which occurs 16 or 22 h after 
cell inoculation, respectively (Figure 3.1B). I found that chronologically aging cultures of CR and 
non-CR yeast 1) contain both low-density (LD) and high-density (HD) cell populations during 
logarithmic (L), diauxic (D), post-diauxic (PD) and stationary (ST) growth phases, i.e. through the 
entire chronological lifespan; and 2) exhibit an age-related increase in the percentage of LD cells 
(Figures 3.1C and 3.1D). I also noticed that the percentage of LD cells in CR yeast cultures 
significantly exceeds that in non-CR yeast cultures during any of the four growth phases, i.e. at 
any stage of the chronological aging process (Figures 3.1C and 3.1D). Moreover, I showed that 
the percentage of LD cells in CR yeast cultures reaches a plateau on day 5 of culturing (in PD 
growth phase), whereas the percentage of LD cells in non-CR yeast cultures attains a steady-state 
level only on day 10 of culturing (in ST growth phase) (Figures 3.1C and 3.1D). 
          Collectively, these findings indicate that CR accelerates an age-related accumulation of LD 
cell population in chronologically aging yeast cultures.   





Figure 3.1. Caloric restriction (CR) accelerates an age-related accumulation of low-density (LD) cells, decreases 
the size of high-density (HD) cells, and lowers the abundance of budded cells in LD and HD populations of 
chronologically aging yeast cultures. (A) Survival of chronologically aging wild-type (WT) yeast cultured in the 
nutrient-rich YP medium initially containing 0.2% glucose (CR conditions) or 2% glucose (non-CR conditions). The 
logrank test for comparing each pair of survival curves was performed as described in Materials and Methods. Two 
survival curves were considered statistically different if the P value was less than 0.05. (B) Kinetics of glucose 
consumption for WT yeast cultured in YP medium initially containing 0.2% glucose (CR conditions) or 2% glucose 
(non-CR conditions). (C to I) Samples of WT yeast cultured in YP medium initially containing 0.2% glucose (CR 
conditions) or 2% glucose (non-CR conditions) were recovered from logarithmic (L), diauxic (D), post-diauxic (PD) 
or stationary (ST) growth phase and subjected to centrifugation in Percoll density gradient as described in Materials 
and Methods. Percoll density gradients (C), the percentage of LD cells (D), differential interference contrast 
micrographs of LD and HD cells recovered from ST growth phase on day 7 (E), mean diameters of LD (F) or HD (G) 
cells, and the percentages of budded cells present in LD (H) or HD (I) populations are shown. Data in A, B, D, F - I 
are presented as means ± SEM (n = 3; *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant). 
 
3.3.2  CR alters cell size and the abundance of budded cells in LD and HD populations 
          I then assessed how CR influences the morphology of cells present in LD and HD 
populations. These cell populations were first recovered from yeast cultures of different 
chronological ages and then separated from each other by centrifugation in Percoll density 
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gradient. My differential interference contrast (DIC) microscopical examination and subsequent 
morphometric analysis of these LD and HD cell populations have revealed that through the entire 
chronological lifespan: 1) LD cells in CR cultures have sizes similar to those of LD cells in non-
CR cultures (Figures 3.1E, 3.1F and 3.2); 2) HD cells in CR cultures remain significantly smaller 
than HD cells in non-CR cultures (Figures 3.1E, 3.1G and 3.2); and 3) although LD cells in CR 
and non-CR cultures contain both budded and unbudded cells, the percentage of budded LD cells 
in CR cultures is significantly lower than that in non-CR cultures (Figures 3.1E, 3.1H and 3.2). I 
also found that, except for HD cells recovered from non-CR cultures in L growth phase, most of 
HD cells recovered from CR and non-CR cultures were unbudded (Figures 3.1E, 3.1 and 3.2). 
Moreover, I showed that the percentage of budded HD cells in CR cultures is significantly lower 
than that in non-CR cultures (Figures 3.1E, 3.1I and 3.2). 
          In sum, these findings indicate that CR decreases the size of HD cells and lowers the 
percentage of budded cells in both LD and HD populations through the entire process of 
chronological aging. 
 
Figure 3.2. Differential interference contrast micrographs of purified LD and HD cells. Samples of wild-type 
yeast cultured in YP medium initially containing 0.2% glucose (CR conditions) or 2% glucose (non-CR conditions) 
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were recovered from logarithmic (L), diauxic (D), post-diauxic (PD) or stationary (ST) growth phase and subjected to 
centrifugation in Percoll density gradient to purify LD and HD cell populations. 
 
3.3.3  CR delays an age-related decline in the reproductive proficiencies of LD and HD cell 
populations and in their abilities to synchronously re-enter mitosis   
          My observation that nearly all HD cells in CR and non-CR cultures were unbudded (except 
of HD cells purified from non-CR cultures in L growth phase, see Figure 3.1I) suggests a 
hypothesis that HD population contains predominantly Q cells. Q cells are known to be mainly 
unbudded [214]. Moreover, because LD population recovered from CR and non-CR cultures 
contained both budded and unbudded cells (Figure 3.1H), I hypothesized that LD population 
consists mainly of NQ cells. NQ cells are known to represent a mixture of budded and unbudded 
cells [214].  
          To test this hypothesis, I compared the following two features of LD and HD populations: 
1) the reproductive competence, i.e. the ability of a yeast cell to form a colony when plated on 
fresh solid medium; and 2) the ability of a yeast cell population to synchronously re-enter the 
mitotic cell cycle if returned to growth-promoting conditions. Both these abilities are known to be 
characteristic of Q cells; these fundamental characteristics of Q cells distinguish them from NQ 
cells [215]. I recovered LD and HD cell populations from CR or non-CR yeast cultures of different 
chronological ages and then separated them from each other by centrifugation in Percoll density 
gradient.  
          My comparative analyses of the reproductive (colony-forming) capacities of LD and HD 
cells purified from differently aged CR and non-CR yeast cultures have revealed the following: 1) 
LD cells in CR cultures maintain reproductive (colony-forming) capacity for a long period of time 
in the course of chronological aging, whereas LD cells in non-CR cultures exhibit a very rapid 
age-related deterioration in reproductive competence (Figure 3.3A), and 2) HD cells in CR cultures 
sustain reproductive (colony-forming) ability through the entire process of chronological aging, 
whereas HD cells in non-CR cultures display an age-related gradual decline in reproductive 
capability (Figure 3.3B).   
          My comparison of the abilities of LD and HD cells purified from differently aged CR and 
non-CR yeast cultures to synchronously re-enter the mitotic cell cycle after cell transfer into fresh 
medium and incubation for 1 to 4 h has revealed the following: 1) LD cells in CR cultures remain 
 70 
Q cells (i.e. maintain the ability to synchronously re-enter mitosis following cell transfer) for a 
long period of time in the course of chronological aging, whereas LD cells in non-CR cultures 
become NQ cells (i.e. senescent) soon after being formed in the process of differentiation (Figure 
3.3C); and 2) HD cells in CR cultures continue to be Q cells through most of the chronological 
aging process, whereas HD cells in non-CR cultures progressively become NQ cells (Figure 3.3D). 
          Taken together, these findings provide evidence that 1) HD population contains 
predominantly Q cells, whereas LD population consists mainly of NQ cells; and 2) CR slows an 
age-related deterioration in the reproductive competences of Q and NQ cells and in their 
capabilities to synchronously re-enter the mitotic cell cycle when nutrients become available. 
 
Figure 3.3. CR delays an age-related decline of the reproductive competences of LD and HD cells and of their 
capabilities to synchronously re-enter the mitotic cell cycle when nutrients become available. (A to D) Samples 
of WT yeast cultured in YP medium initially containing 0.2% glucose (CR conditions) or 2% glucose (non-CR 
conditions) were recovered from L, D, PD or ST growth phase and subjected to centrifugation in Percoll density 
gradient to purify LD and HD cell populations, as described in Materials and Methods. The reproductive (colony 
forming) efficiencies of LD (A) or HD (B) cells, and the efficiencies with which LD (C) or HD (D) cells can 
synchronously re-enter the mitotic cell cycle after cell transfer into fresh medium and incubation for 1 to 4 h are 
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shown. These efficiencies were measured as described in Materials and Methods. Data in A and B are presented as 
means ± SEM (n = 3; ***P < 0.001; ns, not significant). Data in C and D are presented as means (n = 3 - 4). 
 
3.3.4 CR increases the abundance of daughter cells in Q and NQ populations 
A culture of the budding yeast S. cerevisiae is known to contain first- and higher-generation 
daughter cells without bud scars and first- and higher-generation mother cells with one or more 
bud scars on the cell surface [216-218]. Each bud scar marks a division site on the surface of a 
mother cell and, thus, the number of bud scars accumulating on the mother cell surface is a measure 
of its replicative age [219-221]. 
          I assessed the relative abundance of first- and higher-generation daughters and replicatively 
aged mothers present in Q and NQ cell populations. These cell populations were first recovered 
from CR or non-CR yeast cultures of different chronological ages and then separated from each 
other by centrifugation in Percoll density gradient. Bud scars were microscopically visualized by 
staining with Calcofluor White M2R. My comparative analysis of Q and NQ cell populations 
purified from differently aged CR and non-CR cultures has revealed the following: 1) CR increases 
the abundance of first- and higher-generation daughters and decreases the percentage of first- and 
higher-generation mothers present in NQ cell populations through the entire chronological lifespan 
(Figures 3.4A and 3.5); 2) the abundance of daughter cells decreases and the abundance of mother 
cells increases in NQ cell populations from non-CR cultures recovered on days 10, 14 and 18 of 
culturing (Figures 3.4B and 3.5); 3) the percentages of daughter and mother cells remain 
unchanged through the entire chronological lifespan in NQ cell populations from CR cultures 
(Figures 3.4C and 3.5); 4) through the entire chronological lifespan, Q cell population in CR 
cultures is predominantly composed of daughter cells whereas Q cell population in non-CR 
cultures is a mixture of daughter and mother cells (Figures 3.4D and 3.5); 5) the abundance of 
daughter cells decreases and the abundance of mother cells increases in the Q cell population that 
was purified from non-CR cultures recovered very late in chronological lifespan, namely on day 
18 of culturing (Figures 3.4E and 3.5); and 6) the percentages of daughter and mother cells remain 
unaltered through the entire chronological lifespan in Q cell populations purified from CR cultures 
(Figures 3.4F and 3.5). 
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          Collectively, these findings indicate that 1) through the entire chronological lifespan, CR 
rises the fraction of daughter cells in Q and NQ populations; and 2) late in chronological lifespan, 
CR prevents budding of daughter cells in NQ population and, to a lesser extent, in Q population. 
 
 
Figure 3.4. CR increases the abundance of daughters in Q and NQ cell populations through the entire 
chronological lifespan and prevents budding of daughters in these cell populations late in life. (A to F) Samples 
of WT yeast cultured in YP medium initially containing 0.2% glucose (CR conditions) or 2% glucose (non-CR 
conditions) were recovered from L, D, PD or ST growth phase and subjected to centrifugation in Percoll density 
gradient to purify Q and NQ cell populations, as described in Materials and Methods. Bud scars were microscopically 
visualized by staining with Calcofluor White M2R, as described in Materials and Methods. The percentages of cells 
with 0, 1, 2 or 3 bud scars in NQ (A to C) or Q (D to F) populations of different chronological ages are shown. Data 
in B, C, E and F are presented as means ± SEM (n = 3; *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant; R, 





Figure 3.5. CR rises the fraction of daughter cells in Q and NQ populations and, late in chronological lifespan, 
prevents budding of daughter cells present in both populations. Samples of WT yeast cultured in YP medium 
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initially containing 0.2% glucose (CR conditions) or 2% glucose (non-CR conditions) were recovered from L, D, PD 
or ST growth phase and subjected to centrifugation in Percoll density gradient to purify Q and NQ cell populations, 
as described in Materials and Methods. Bud scars were microscopically visualized by staining with Calcofluor White 
M2R, as described in Materials and Methods. 
 
3.3.5  CR increases the concentrations of glycogen and trehalose in Q and NQ cell populations 
          One of the metabolic hallmarks of Q cells that distinguish them from NQ cells is an 
accumulation of glycogen and trehalose, the two major glucose stores in yeast [214, 222]. In 
addition to being reserve carbohydrate, trehalose has also been implicated in protecting yeast cells 
and cellular proteins from oxidative and other stresses [223-226], modulating cellular proteostasis 
[227-229], and allowing Q cells to re-enter the mitotic cell cycle when nutrients become available 
[222].  
          I investigated how CR influences the intracellular concentrations of glycogen and trehalose 
in Q and NQ cell populations. These cell populations were first recovered from CR or non-CR 
yeast cultures of different chronological ages and then separated from each other by centrifugation 
in Percoll density gradient. My comparative analysis of Q and NQ cell populations purified from 
differently aged CR and non-CR cultures has revealed the following: 1) through most of the 
chronological lifespan (i.e. since day 3 of culturing), the concentrations of glycogen in NQ and Q 
cells from CR cultures significantly exceed those in NQ and Q cells from age-matched non-CR 
cultures (Figures 3.6A and 3.6B, respectively); 2) through the entire chronological lifespan, the 
concentrations of glycogen in Q cells from CR cultures were higher than those in NQ cells from 
CR cultures of the same chronological age (compare Figures 3.6A and 3.6B); 3) for the most part 
(i.e. since day 5 of culturing), the concentrations of trehalose in NQ and Q cells from CR cultures 
considerably surpass those in NQ and Q cells from age-matched non-CR cultures (Figures 3.6C 
and 3.6D, respectively); and 4) through the entire chronological lifespan, the concentrations of 
trehalose in Q cells from CR cultures exceed those in NQ cells from CR cultures of the same 
chronological age (compare Figures 3.6C and 3.6D).       
          In sum, these findings indicate that through most of the chronological aging process CR 






Figure 3.6. CR alters the abundance of glycogen, trehalose, triacylglycerols (TAG) and cardiolipins (CL) in Q 
and NQ cell populations through most of the chronological lifespan. Samples of WT yeast cultured in YP medium 
initially containing 0.2% glucose (CR conditions) or 2% glucose (non-CR conditions) were recovered from L, D, PD 
or ST growth phase and subjected to centrifugation in Percoll density gradient to purify Q and NQ cell populations, 
as described in Materials and Methods. The concentrations of glycogen (A and B), trehalose (C and D), TAG (E and 
F) and CL (G and H) were measured as described in Materials and Methods. Data are presented as means ± SEM (n 
= 3; *P < 0.05; **P < 0.01; ***P < 0.001). 
 
3.3.6  CR alters the abundance of two lipid classes in Q and NQ cell populations 
          Recent studies have revealed that the longevity-extending effect of CR in chronologically 
aging yeast depends on the cellular homeostasis of two classes of lipids, namely triacylglycerols 
(TAG) and cardiolipins (CL) [85, 87, 230-243]. TAG are so-called neutral lipids that in yeast are 
synthesized in the endoplasmic reticulum and then deposited in lipid droplets to serve as the main 
storage molecules for maintaining energy homeostasis and supplying free fatty acids [244-247], 
whereas CL are signature lipids of the inner mitochondrial membrane implicated in oxidative 
phosphorylation and several other vital processes confined to mitochondria [248-251]. 
          I examined the effect of CR on the abundance of TAG and CL in Q and NQ cell populations 
that were first recovered from CR or non-CR yeast cultures of different chronological ages and 
then purified by centrifugation in Percoll density gradient. My comparison of these Q and NQ cell 
populations has revealed the following: 1) through the entire chronological lifespan, the 
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concentrations of TAG in NQ and Q cells from CR cultures are significantly lower than those in 
NQ and Q cells from age-matched non-CR cultures (Figures 3.6E and 3.6F, respectively); 2) for 
the most part (i.e. since day 3 of culturing), the concentrations of CL in NQ and Q cells from CR 
cultures significantly exceed those in NQ and Q cells from non-CR cultures of the same 
chronological age (Figures 3.6G and 3.6H, respectively); 3) through the entire chronological 
lifespan, the concentrations of TAG in Q and NQ cells from age-matched CR and non-CR cultures 
are similar (compare Figures 3.6E and 3.6F); and 4) for the most part (i.e. since day 3 of culturing), 
the concentrations of CL in Q and NQ cells from CR and non-CR cultures of the same 
chronological age are also similar (compare Figures 3.6G and 3.6H). 
          I therefore concluded that through the entire chronological aging process CR induces a 
significant decline in the concentrations of TAG in Q and NQ cell populations. In contrast, through 
most of the chronological lifespan CR elicits a substantial rise in the abundance of CL in both these 
cell populations. 
 
3.3.7   CR alters the dynamics of age-related changes in mitochondrial functionality in Q and 
NQ cells 
          Mitochondrial electron transport chain, electrochemical potential across the inner 
mitochondrial membrane (ΔΨm) and mitochondrial ROS play essential roles in defining longevity 
of chronologically aging yeast [84, 85, 87, 233, 243, 252-261]. Q cells purified from non-CR yeast 
cultures have been shown to exhibit high rates of mitochondrial respiration and low ROS, whereas 
NQ cells present in these cultures are known to have low rates of mitochondrial respiration and 
high ROS [88-90, 262]. 
          I therefore investigated the effect of CR on some longevity-defining traits of mitochondrial 
functionality in Q and NQ cell populations recovered from CR or non-CR yeast cultures of 
different chronological ages and purified by centrifugation in Percoll density gradient. These traits 
included the rate of mitochondrial respiration, ΔΨm and cellular ROS, which in yeast are known 
to be produced primarily as by-products of mitochondrial respiration [263, 264]. 
          My comparative analyses of these traits of mitochondrial functionality in Q and NQ cells 
purified from differently aged CR and non-CR yeast cultures have revealed the following: 1) 
through the entire chronological lifespan, the rate of mitochondrial respiration in NQ cells from 
CR cultures is significantly higher than that in NQ cells from age-matched non-CR cultures (Figure 
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3.7A); 2) for the most part (i.e. since day 3 of culturing), the rate of mitochondrial respiration in Q 
cells from CR cultures substantially exceeds that in Q cells from age-matched non-CR cultures 
(Figure 3.7B); 3) through most of the chronological lifespan (i.e. since day 3 of culturing), the 
rates of mitochondrial respiration in NQ and Q cells from CR cultures are considerably higher than 
those in NQ and Q cells from non-CR cultures of the same chronological age (Figures 3.7C and 
3.7D, respectively); 4) early in chronological lifespan (i.e. until day 7 for NQ cells or day 5 for Q 
cells) the concentrations of ROS in NQ and Q cells from CR cultures are notably lower than those 
in NQ and Q cells from age-matched non-CR cultures (Figures 3.7E and 3.7F, respectively); and 
5) late in chronological lifespan (i.e. after day 10 for NQ cells or day 7 for Q cells) the 
concentrations of ROS in NQ and Q cells from CR cultures considerably exceed those in NQ and 
Q cells from non-CR cultures of the same chronological age (Figures 3.7E and 3.7F, respectively). 
          Taken together, these findings show that CR creates distinct patterns of mitochondrial 
functionality in Q and NQ cells by altering the chronology of age-related changes in mitochondrial 
respiration, ΔΨm and ROS. 
 
Figure 3.7. CR alters the patterns of age-related changes in certain traits of mitochondrial functionality in Q 
and NQ cells. Samples of WT yeast cultured in YP medium initially containing 0.2% glucose (CR conditions) or 2% 
glucose (non-CR conditions) were recovered from L, D, PD or ST growth phase and subjected to centrifugation in 
Percoll density gradient to purify Q and NQ cell populations, as described in Materials and Methods. The rate of 
mitochondrial respiration (A and B), ΔΨm (C and D) and ROS (E and F) were measured as described in Materials and 
Methods. Data are presented as means ± SEM (n = 3; *P < 0.05; **P < 0.01; ***P < 0.001). Rachel Feldman, Amanda 
Piano, Anthony Arlia-Ciommo, Vicky Lutchman, Masoumeh Ahmadi, Sarah Elsaser, Hana Fakim, Mahdi Heshmati-
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Moghaddam, Asimah Hussain, Sandra Orfali, Harshvardhan Rajen, Negar Roofigari-Esfahani and Leana Rosanelli 
conducted the experiments. 
 
3.3.8  CR decreases the extent of age-related oxidative damage to proteins, lipids and DNA 
in Q and NQ cells 
          An age-related buildup of ROS-inflicted oxidative damage to various cellular 
macromolecules impairs their stability and is one of the major causes of aging in yeast and other 
eukaryotes [233, 265-272]. Q cells purified from non-CR yeast cultures are known to be 
genomically stable, whereas nuclear and mitochondrial DNA (nDNA and mtDNA, respectively) 
in NQ cells are likely instable because these cells exhibit an age-related excessive production of 
petite colonies [88, 90, 93]. Moreover, Q cells purified from non-CR yeast cultures do not 
accumulate SDS-insoluble protein aggregates, whereas NQ cells present in these cultures have 
been shown to amass such aggregates of irreversibly denatured/damaged proteins [189].       
          I therefore analyzed how CR influences the extent of age-related oxidative damage to 
cellular proteins, membrane lipids, nDNA and mtDNA in Q and NQ cell populations that were 
recovered from differently aged CR or non-CR yeast cultures and purified by centrifugation in 
Percoll density gradient. My analyses have revealed the following: 1) through most of the 
chronological lifespan (i.e. since day 3 of culturing), the extent of oxidative damage to proteins in 
NQ cells from CR cultures is considerably lower than that in NQ cells from age-matched non-CR 
cultures (Figure 3.8A); 2) late in chronological lifespan (i.e. since day 10) proteins in Q cells from 
CR cultures are oxidatively damaged to a lesser degree than proteins in Q cells from non-CR 
cultures of the same chronological age (Figure 3.8B); 3) late in chronological lifespan (i.e. after 
day 7 for NQ cells or after day 10 for Q cells), the extent of oxidative damage to membrane lipids 
in Q and NQ cells from CR cultures is significantly decreased as compared to that in NQ cells 
from age-matched non-CR cultures (Figures 3.8C and 3.8D, respectfully); 4) late in chronological 
lifespan (i.e. after day 10 for NQ cells or on day 18 for Q cells), the frequencies of spontaneous 
point mutations in the CAN1 gene of nDNA in Q and NQ cells from CR cultures are substantially 
lower than those in Q and NQ cells from age-matched non-CR cultures – probably due to a 
decreased degree of oxidative damage to nDNA in Q and NQ cells from CR cultures (Figures 3.8E 
and 3.8F); and 5) late in chronological lifespan (i.e. after day 10 for NQ cells or on day 18 for Q 
cells), the frequencies of spontaneous point mutations in the RIB2 and RIB3 genes of mtDNA in 
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Q and NQ cells from CR cultures are markedly decreased as compared to those in Q and NQ cells 
from age-matched non-CR cultures – perhaps due to a decline in the extent of oxidative damage 
to mtDNA in Q and NQ cells from CR cultures (Figures 3.8G and 3.8H). 
          In sum, these data imply that CR lessens the degree of age-related oxidative damage to 
proteins, lipids, nDNA and mtDNA in Q and NQ cells. 
 
Figure 3.8. CR lessens the extent of age-related oxidative damage to proteins, lipids, nDNA and mtDNA in Q 
and NQ cells. Samples of WT yeast cultured in YP medium initially containing 0.2% glucose (CR conditions) or 2% 
glucose (non-CR conditions) were recovered from L, D, PD or ST growth phase and subjected to centrifugation in 
Percoll density gradient to purify Q and NQ cell populations, as described in Materials and Methods. Carbonylated 
cellular proteins (A and B), oxidatively damaged membrane lipids (C and D), the frequencies of spontaneous point 
mutations in the CAN1 gene of nDNA (E and F), and the frequencies of spontaneous point mutations in the RIB2 and 
RIB3 genes of mtDNA (G and H) were measured as described in Materials and Methods. Data are presented as means 
± SEM (n = 3; *P < 0.05; **P < 0.01; ***P < 0.001). Rachel Feldman, Amanda Piano, Anthony Arlia-Ciommo, Vicky 
Lutchman, Masoumeh Ahmadi, Sarah Elsaser, Hana Fakim, Mahdi Heshmati-Moghaddam, Asimah Hussain, Sandra 
Orfali, Harshvardhan Rajen, Negar Roofigari-Esfahani and Leana Rosanelli conducted experiments. 
 
3.3.9  CR increases the resistance of Q and NQ cells to long-term thermal and oxidative 
stresses 
          Thermotolerance is one of the characteristic features of Q cells that distinguish them from 
NQ cells [88, 90]. Moreover, a development of the enhanced resistance to chronic (long-term) 
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thermal and/or oxidative stresses is known to delay aging in yeast and other eukaryotes [84, 85, 
87, 186, 263, 267-279]. 
          I assessed the effects of CR on the abilities of Q and NQ cell populations to resist chronic 
oxidative and thermal stresses. Q and NQ cell populations were recovered from differently aged 
CR or non-CR yeast cultures and purified by centrifugation in Percoll density gradient. Chronic 
thermal stress was administered by spotting pure Q and NQ cells on plates with solid YEPD 
medium containing 2% glucose, incubating these plates at 55oC for 60 min, and then transferring 
them to 30oC and incubating for 3 days. Chronic oxidative stress was applied by spotting pure Q 
and NQ cells on plates with solid YEPD medium containing 2% glucose and 5 mM hydroxide 
peroxide, and incubating them at 30oC for 3 days. My analyses have revealed the following: 1) 
early in chronological lifespan (i.e. on day 5 for thermal stress or on day 3 for oxidative stress), 
NQ cells from CR cultures become more resistant to both these kinds of chronic stresses as 
compared to NQ cells from age-matched non-CR cultures (Figure 3.9A); and 2) late in 
chronological lifespan (i.e. since day 10), Q cells from CR cultures exhibit higher resistance to 
both oxidative and thermal stresses then Q cells from non-CR cultures of the same chronological 
age (Figure 3.9B).   
          Collectively, these findings indicate that CR elicits a significant rise in the resistance of Q 
and NQ cells to long-term thermal and oxidative stresses. Q cells display the stimulatory effect of 
CR on the tolerance to both kinds of stresses only late in chronological lifespan, whereas in NQ 
cells such effect can be seen already early in life. 
 
Figure 3.9. CR increases the resistance of Q and NQ cells to long-term thermal and oxidative stresses. Samples 
of WT yeast cultured in YP medium initially containing 0.2% glucose (CR conditions) or 2% glucose (non-CR 
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conditions) were recovered from L, D, PD or ST growth phase and subjected to centrifugation in Percoll density 
gradient to purify Q and NQ cell populations, as described in Materials and Methods. Spot assays for monitoring 
thermal or oxidative stress resistance were performed as described in Materials and Methods. For chronic thermal 
stress, serial 10-fold dilutions of pure NQ (A) and Q (B) cells were spotted on plates with solid YEPD medium 
containing 2% glucose; these plates were initially exposed to 55oC for 60 min, and then transferred to 30oC and 
incubated for 3 days. For chronic oxidative stress, serial 10-fold dilutions of pure NQ (A) and Q (B) cells were spotted 
on plates with solid YEPD medium containing 2% glucose and 5 mM hydroxide peroxide; these plates were then 
incubated at 30oC for 3 days. Rachel Feldman, Amanda Piano, Anthony Arlia-Ciommo, Vicky Lutchman, Masoumeh 
Ahmadi, Sarah Elsaser, Hana Fakim, Mahdi Heshmati-Moghaddam, Asimah Hussain, Sandra Orfali, Harshvardhan 
Rajen, Negar Roofigari-Esfahani and Leana Rosanelli conducted experiments. 
 
3.3.10  CR delays the onsets of the age-related apoptotic and necrotic modes of PCD in Q and 
NQ populations 
            In NQ cells from non-CR yeast cultures, the onsets of the age-related apoptotic and necrotic 
modes of PCD are known to occur much earlier in chronological lifespan than in Q cells from 
these cultures [88, 90]. Furthermore, chronologically aging yeast cells in non-CR cultures have 
been shown to die exhibiting characteristic markers of the apoptotic and/or necrotic subroutines of 
PCD [85, 280-291]. 
          I therefore investigated how CR influences the onsets of age-related the apoptotic and 
necrotic modes of PCD in Q and NQ cell populations. Q and NQ cell populations were recovered 
from differently aged CR or non-CR yeast cultures and purified by centrifugation in Percoll density 
gradient. Apoptotic PCD was microscopically visualized by Annexin V staining for monitoring 
phosphatidylserine (PS) translocation from the inner to the outer leaflet of the plasma membrane, 
a characteristic marker of this PCD subroutine. Propidium iodide (PI) staining for measuring the 
extent of plasma membrane permeability for small molecules, a hallmark of necrotic PCD, was 
used to microscopically visualize programmed necrosis. My analyses have revealed the following: 
1) through most of the chronological lifespan (i.e. since day 3 of culturing), the percentage of cells 
undergoing an apoptotic or necrotic mode of PCD in NQ cells from CR cultures is significantly 
lower than that in NQ cells from age-matched non-CR cultures (Figures 3.10A and 3.10C, 
respectively); and 2) late in chronological lifespan (i.e. since day 14 for apoptotic PCD or day 10 
for necrotic PCD), the percentage of cells committed to any of these two PCD modes in Q cells 
from CR cultures is considerably decreased as compared to that in Q cells from non-CR cultures 
of the same chronological age (Figures 3.10B and 3.10D, respectively).    
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          I therefore concluded that CR decelerates the onsets of age-related apoptotic and necrotic 
PCD in Q and NQ cell populations. In Q cells these effects of CR take place only late in 




Figure 3.10. CR causes a decline in the susceptibilities of Q and NQ cells to the exogenously induced apoptotic 
and liponecrotic modes of PCD. Samples of WT yeast cultured in YP medium initially containing 0.2% glucose (CR 
conditions) or 2% glucose (non-CR conditions) were recovered from L, D, PD or ST growth phase and subjected to 
centrifugation in Percoll density gradient to purify Q and NQ cell populations, as described in Materials and Methods. 
Clonogenic assays for monitoring the susceptibilities of NQ (E and G) and Q (F and H) cells to the apoptotic (E and 
F) or liponecrotic (G and H) mode of PCD induced in response to a short-term (for 2 h) exposure to exogenous 2.5 
mM hydrogen peroxide (E and F) or 0.15 mM POA (G and H), respectively, were performed as described in Materials 
and Methods. Data are presented as means ± SEM (n = 3; *P < 0.05; **P < 0.01; ***P < 0.001). Rachel Feldman, 
Amanda Piano, Anthony Arlia-Ciommo, Vicky Lutchman, Masoumeh Ahmadi, Sarah Elsaser, Hana Fakim, Mahdi 
Heshmati-Moghaddam, Asimah Hussain, Sandra Orfali, Harshvardhan Rajen, Negar Roofigari-Esfahani and Leana 
Rosanelli conducted experiments.    
 
3.3.11 CR decreases the susceptibilities of Q and NQ cells to the exogenously induced 
apoptotic and liponecrotic modes of PCD  
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            Because CR delays the onsets of age-related the apoptotic and necrotic modes of PCD in 
Q and NQ populations of chronologically aging yeast, I examined how CR influences the 
susceptibilities of Q and NQ cells to each of these PCD subroutines that were elicited in response 
to certain exogenous stimuli. A brief exposure of yeast to exogenous hydrogen peroxide is known 
to decrease clonogenic survival of cells by causing mitochondria-controlled apoptotic PCD [281, 
284, 289, 292, 293], whereas a short-term treatment of yeast with exogenous palmitoleic acid 
(POA) has been shown to reduce clonogenic survival of cells by eliciting a liponecrotic mode of 
PCD [288-291]. 
          My comparative analyses have revealed the following: 1) through most of the chronological 
lifespan (i.e. since day 3 of culturing), clonogenic survival of NQ cells from CR cultures briefly 
exposed to exogenous hydrogen peroxide (to elicit apoptotic PCD) or POA (to trigger liponecrotic 
PCD) significantly exceeds that of NQ cells from age-matched non-CR cultures (Figures 3.10E 
and 3.10G, respectively); and 2) late in chronological lifespan (i.e. since day 10), clonogenic 
survival of Q cells from CR cultures subjected to a short-term treatment with exogenous hydrogen 
peroxide (to initiate apoptotic PCD) or POA (to induce liponecrotic PCD) is significantly higher 
than that of Q cells from non-CR cultures of the same chronological age (Figures 3.10F and 3.10H, 
respectively). 
          In sum, these data indicate that CR causes a decline in the susceptibilities of Q and NQ cell 
populations to the apoptotic and liponecrotic modes of PCD induced in response to a short-term 
exposure to exogenous hydrogen peroxide or POA, respectively. In Q cells, the abilities of CR to 
cause these effects can be seen only late in chronological lifespan, whereas NQ cells display both 
effects of CR already early in life. 
 
3.4     Discussion 
          This study revealed that CR extends yeast chronological lifespan via a mechanism that links 
cellular aging to cell cycle regulation, maintenance of the Q state, entry into the NQ state and 
survival in the NQ state. My comparative analyses of physical, morphological, reproductive, 
biochemical and physiological properties of Q and NQ cells from differently aged CR or non-CR 
yeast cultures suggest a hypothetical model for this mechanism. This model is depicted 
schematically in Figure 3.11. 
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          The model posits that Q and NQ cell populations exist as several subpopulations related to 
each other in a chronological age-dependent manner. One of these subpopulations is a 
subpopulation of non-differentiated Q cells that represents a ″stem″ cell niche (Figure 3.11). I call 
these stem cells GQHD because they are high-density cells that are arrested at the G1 phase of the 
cell cycle and exist in a specialized non-proliferative state called G0. GQHD cells constituting the 
stem cell niche are viable unbudded cells that 1) exhibit high reproductive (colony-forming) 
capacity; 2) are able to synchronously re-enter the mitotic cell cycle after cell transfer into fresh 
medium; 3) display high concentrations of glycogen and trehalose, the two major glucose stores; 
4) possess low concentrations of TAG and high concentrations of CL; 5) have fully functional 
mitochondria; 6) exhibit low concentrations of ROS; 7) display low degree of oxidative damage 
to proteins, lipids and DNA; 8) are resistant to long-term thermal and oxidative stresses; and 9) 
display low susceptibilities to the mitochondria-controlled apoptotic and fatty acid-induced 
liponecrotic forms of PCD.  
          In L (for CR yeast cultures) or SP (for non-CR yeast cultures) phase, GQHD cells become 
committed to entry into a program that we call the differentiation program (Figure 3.11). Such 
commitment of GQHD cells to differentiation is manifested in a significant decrease of their buoyant 
density, so that they are converted to a subpopulation of Q cells that we call GQLD cells because of 
their low density. The chronological age-related progression of GQLD cells through the 
differentiation program causes a gradual decline in the following features: viability, reproductive 
(colony-forming) capacity, the ability to synchronously re-enter the mitotic cell cycle after cell 
transfer into fresh medium, glycogen and trehalose concentrations, TAG concentration, 
mitochondrial functionality, the ability to maintain low concentration of ROS, the capacity to limit 
oxidative molecular damage, the tolerance to long-term thermal and oxidative stresses, and the 
resistance to the apoptotic and liponecrotic modes of PCD. The progression of GQLD cells through 
the differentiation program ultimately leads to their conversion into a subpopulation of NQ cells 
that we call GNQLD cells; these cells are committed to the programmed, age-related modes of 
apoptotic and/or liponecrotic cell death (Figure 3.11).             
          When a yeast culture enters ST phase, most (for CR yeast cultures) or many (for non-CR 
yeast cultures) of non-differentiated GQHD cells from the stem cell niche have been committed to 
entry into and progression through the differentiation program and, thus, exist in the GQLD and 
GNQLD forms. However, a portion of cells within this culture still remains in the GQHD form (Figure 
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3.11). Through the entire chronological lifespan, these non-differentiated stem cells progress 
through a program which we call the maintenance program. A progression of GQLD stem cells 
through this maintenance program is manifested in a much slower deterioration in the same 
features as the ones whose relatively fast decline occurs during the differentiation program (Figure 
3.11). The advancement of GQHD cells through the maintenance program eventually results in their 
conversion into a subpopulation of NQ cells that we call GNQHD cells; these cells are susceptible 
to the chronological age-related subroutines of apoptotic and/or liponecrotic PCD (Figure 3.11).   
           
 
 
Figure 3.11. A model for how CR extends yeast chronological lifespan via a mechanism that links cellular aging 
to cell cycle regulation, maintenance of quiescence, entry into the non-quiescent state and survival in the non-
quiescent state. CR delays yeast chronological aging by causing specific changes at the G1 checkpoint for cell cycle 
arrest and entry into the G0 state, timing of GQHD (high-density, quiescent) cells commitment to conversion into GQLD 
(low-density, quiescent) cells, pace of progression of GQLD (low-density, quiescent) cells through a differentiation 
program yielding GNQLD (low-density, non-quiescent) cells, and rate of advancement of GQHD (high-density, quiescent) 
cells via a maintenance program leading to their conversion into GNQHD (high-density, non-quiescent) cells. Please see 
text for additional details. 
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          My findings suggest that CR delays yeast chronological aging by causing specific changes 
in a G1 checkpoint for cell cycle arrest and entry into the G0 state, a growth phase in which GQHD 
cells undergo the commitment to become GQLD cells, the differentiation of GQLD cells into GNQLD 
cells, and the conversion of GQHD cells into GNQHD cells. These changes are described below. 
          Judging from the very small size of GQHD stem cells seen in CR cultures (Figure 3.1G), CR 
may arrest the cell cycle at a previously unknown checkpoint in early G1. This is unlike the large 
size of GQHD stem cells observed in non-CR cultures (Figure 3.1G), whose cell cycle is known to 
be arrested at the checkpoint START A in late G1 [97, 294]. 
          Furthermore, CR is likely to accelerate the onset of commitment of GQHD stem cells to entry 
into the differentiation program (Figure 3.11). Indeed, GQHD cells in CR cultures become 
committed to entry into this program already in L growth phase, whereas in CR cultures such 
commitment occurs only in SP phase (Figure 3.1D).    
          Moreover, my data indicate that CR can also decrease both the pace of progression of GQLD 
cells through the differentiation program and the rate of advancement of GQHD cells via the 
maintenance program (Figure 3.11). These effects of CR slow down yeast chronological aging 
because they delay the conversion of these two subpopulations of Q cells into GNQLD and GNQHD 
subpopulations of NQ cells (respectively), both of which are committed to the chronological age-
related modes of apoptotic and liponecrotic PCD (Figure 3.11). My findings suggest that the 
observed abilities of CR to decelerate the differentiation and maintenance programs are due to 
specific effects of this low-calorie diet on a distinct set of morphological, reproductive, 
biochemical and physiological processes in GQLD and GQHD cells (as outlined above, all these 
processes have been implicated in defining longevity of chronologically aging yeast). These 
specific effects of CR in GQLD and GQHD cells include the following: 1) CR slows a chronological 
age-related deterioration in the reproductive competences of these cells and in their capabilities to 
synchronously re-enter the mitotic cell cycle when nutrients become available; 2) CR increases 
glycogen and trehalose concentrations in these cells; 3) CR decreases the concentrations of TAG 
and raises CL concentrations in these cells; 4) CR improves mitochondrial functionality in these 
cells; 5) CR reduces ROS concentrations and lessens the degree of oxidative molecular damage in 
these cells; 6) CR increases the resistance of these cells to long-term thermal and oxidative stresses; 
and 7) CR decreases the susceptibilities of these cells to the apoptotic and liponecrotic forms of 
PCD (Figure 3.11). 
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4 A network of interorganellar communications underlies cellular aging 
 
4.1       Introduction 
            Aging of multicellular and unicellular eukaryotic organisms is due to dysregulation of 
many processes within cells; the extent of such dysregulation progresses with cellular and 
organismal age [301]. The spatiotemporal organization of these numerous cellular processes and 
their functional states define the replicative and chronological age of a eukaryotic cell [302, 303]. 
All these cellular processes are governed by an evolutionarily conserved signaling network. The 
network integrates the insulin/insulin-like growth factor 1 (IGF-1), AMP-activated protein 
kinase/target of rapamycin (AMPK/TOR) and cAMP/protein kinase A (cAMP/PKA) nutrient- and 
energy-sensing signaling pathways [301, 302]. By sensing the intracellular and organismal nutrient 
and energy status, this longevity signaling network coordinates information flow along its 
convergent, divergent and multiply branched pathways to regulate cellular aging, influence age-
related pathologies and define organismal lifespan [301, 303]. 
          A theoretical framework of network biology has been successfully applied to system 
biological and computational analyses of age-related changes in gene expression, protein-protein 
interactions and metabolomes; these analyses yielded several models of the so-called biomolecular 
networks of cellular aging [302, 304, 305]. Recent findings support the notion that such 
biomolecular networks may progress through a series of lifespan checkpoints, each being 
monitored by a checkpoint-specific nutrient- and energy-sensing signaling pathway or pathways 
[302, 304, 305]. 
          Numerous processes that define the replicative and chronological age of a eukaryotic cell 
are confined to various cellular organelles and take place in the cytosol [306, 307]. The organelles 
housing these processes communicate with each other by establishing zones of close apposition 
and being involved in the unidirectional or bidirectional flow of certain soluble metabolites, 
peptides, proteins, DNA fragments and lipids; the flow of metabolites and proteins also underlies 
the communication between some of these organelles and the cytosol [306-308]. Emergent 
evidence supports the view that such directed, coordinated and regulated organelle-organelle and 
organelle-cytosol communications are essential for the development of a pro- or anti-aging cellular 
pattern [306-308]. To reflect the essential role of crosstalk between different types of organelles 
in regulating cellular aging, we coined the term an endomembrane system that governs cellular 
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aging [306]. Here, I outline numerous interorganellar communications that institute this 
endomembrane system. I discuss recent progress in understanding how various interorganellar 
communications within the system - along with crosstalk between this endomembrane system and 
the cytosol - influence the development of a pro- or anti-aging cellular pattern. I summarize and 
integrate into a model the evidence that an intricate network of intercompartmental (i.e., organelle-
organelle and organelle-cytosol) communications underlies cellular aging in evolutionarily distant 
organisms. 
 
4.2    Organelles generate, distribute and process the flow of information that initiates the 
development of a pro- or anti-aging cellular pattern 
          The functional state of a cellular organelle depends on the rates and efficiencies of processes 
confined to it. Growing evidence supports the notion that in response to age-related intracellular 
stresses and environmental factors some organelles can alter their functional states to become 
platforms for generating, directing and processing the flow of information that set off a pro- or 
anti-aging cellular pattern [306-311]. This critical information is generated by an organelle as 
certain soluble metabolites, lipids, proteins, peptides or DNA fragments. These primary molecular 
signals are then distributed to other cellular compartments capable of processing them into the 
secondary molecular signals that ultimately define the long-term viability of the cell [306-311]. In 
this section, I outline how several cellular organelles respond to age-related alterations in their 
functional states by generating certain primary molecular signals, how these primary signals are 
distributed to other compartments within the cell, and how these other cellular compartments 
process them into some secondary molecular signals that are critical for cell viability. 
 
Mitochondria 
Mitochondria compartmentalize numerous processes that regulate cellular aging [303, 307, 308, 
312, 313]. Age-related and environment-dependent changes in the rates and efficiencies of these 
processes modulate the ability of mitochondria to generate and release various molecular signals. 
Outside mitochondria, these signals initiate cascades of events that alter the rates and efficiencies 
of pro- and/or anti-aging processes in other cellular locations [303, 307, 308, 312, 313]. Such 
dynamic communications of mitochondria with other compartments within the cell are essential 
for establishing the rate of cellular aging. 
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          A progressive decline in mitochondrial respiratory chain activity with the replicative age of 
a yeast cell causes an age-related gradual reduction of mitochondrial membrane potential (Δψm) 
[312]. Such progressive deterioration of Δψm in replicatively aging yeast is the primary signal 
responsible for the activation of the mitochondrial retrograde (RTG) signaling pathway of cellular 
aging regulation [307, 312] (Figure 4.1; path 1). The decline in Δψm activates the Rtg2 protein via 
a yet-to-be characterized mechanism. Rtg2 then stimulates nuclear import of the Rtg1-Rtg3 
heterodimeric transcription factor, which in the nucleus triggers an anti-aging transcriptional 
program [307, 312]. In addition, the nuclear pool of Rtg2 in replicatively aging yeast plays a vital 
anti-aging role by enhancing genome stability and suppressing the deleterious accumulation of 
extrachromosomal rDNA circles [307, 312] (Figure 4.1; path 1). A similar mitochondrial RTG 
pathway exists in mammalian cells, where functionally compromised mitochondria stimulate the 
NFκB protein attached to their surface [312] (Figure 4.1; path 8). The ensuing association of NFκB 
with several other proteins yields heterodimeric transcription factors that are imported into the 
nucleus to orchestrate a global stress response program affecting several age-related pathologies 
[312].  
          In addition to its stimulating effect on the anti-aging RTG pathway, the progressive decline 
in Δψm with the replicative age of yeast cells also causes (via a yet-to-be established mechanism) 
a reduction of the TOR complex 1 (TORC1) protein kinase activity, thereby attenuating this master 
regulator of the key pro-aging signaling pathway [307, 312] (Figure 4.1; path 2).  
          Lack of Afo1, a protein component of the large subunit of the mitochondrial ribosome, 
delays replicative aging of non-respiring yeast cells in an independent of mitochondrial translation 
manner [314]. Afo1 regulates replicative aging of yeast cells via the so-called back-signaling 
pathway; this pathway operates under conditions repressing the RTG pathway and is mediated by 
Sfp1, a transcription activator of genes encoding cytoplasmic ribosomal proteins [314] (Figure 4.1; 
path 3). In addition, Afo1 indirectly suppresses the TORC1-governed pro-aging signaling pathway 
via a mechanism that remains to be defined [314] (Figure 4.1; path 4). 
          The maintenance of protein homeostasis in mitochondria of mammalian cells and cells of 
the nematode Caenorhabditis elegans plays an important role in regulating cellular aging; 
mitochondrial proteostasis in these cells is sustained with the help of several anti-aging unfolded 
protein response (UPRmt) pathways of mitochondria-to-nucleus communications [3013, 315]. If 
unfolded or misfolded proteins accumulate within the intermembrane space (IMS) of mitochondria 
 90 
in mammalian cells, a yet-to-be identified molecular signal activates the UPRmt pathway [313]. 
This anti-aging pathway is mediated by the protein kinase AKT, which initiates a cascade of events 
stimulating transcription of nuclear genes coding for an IMS quality control protease and a 
transcription factor essential for mitochondrial biogenesis [313] (Figure 4.1; path 5). Accumulation 
of unfolded or misfolded proteins within the matrix of mitochondria in mammalian cells triggers 
the anti-aging UPRmt pathway mediated by the protein kinase JNK2 and the transcription factor 
CHOP; a similar UPRmt pathway in C. elegans cells operates via the transcription factor ATFS-1 
[313, 315, 316] (Figure 4.1; path 6). Another UPRmt pathway activated in C. elegans cells in 
response to a build-up of unfolded or misfolded proteins within the mitochondrial matrix involves 
the ubiquitin-like protein UBL-5 and the transcription factor DVE-1 [313, 315] (Figure 4.1; path 
7). The UPRmt pathways maintaining proteostasis within the matrix of mitochondria activate 
transcription of nuclear genes encoding several mitochondrial quality control proteases and 
chaperones [313, 315, 316]. Both anti-aging UPRmt pathways operating in C. elegans cells are 
triggered by an HAF-1-driven efflux of peptides formed due to a ClpP-dependent proteolysis of 
the unfolded and misfolded proteins excessively accumulated within the mitochondrial matrix 
[317].            
          An age-related mitochondrial dysfunction and the resulting decline in Δψm in mammalian 
cells reduce mitochondrial uptake of Ca2+, thereby elevating the concentration of free Ca2+ in the 
cytosol [318]. This rise in cytosolic free Ca2+ stimulates calcineurin (a protein phosphatase) and 
several Ca2+-dependent protein kinases that in response activate nuclear import of a distinct set of 
transcription factors, including ATF2, CHOP, CREB, Egr1, NFAT and NFκB [318] (Figure 4.1; 
path 8). In the nucleus, these transcription factors cause a remodeling of gene expression patterns 
to influence several age-related pathologies – such as aging of neuronal cells, age-related 
degeneration of neurons and brain aging [319]. 
          Certain dietary and pharmacological interventions that slow down cellular and organismal 
aging have been shown to elevate the cytosolic NAD+/NADH ratio by activating mitochondrial 
fatty acid oxidation and stimulating a malate-aspartate shuttle in the mitochondrial membrane 
[320]. The resulting increase in cytosolic NAD+ level activates the NAD+-dependent type III 
deacetylase SIRT1, which resides predominately in the nucleus [321] (Figure 4.1; path 9). Active 
SIRT1 then de-acetylates and thus activates such transcription factors as FOXO1, FOXO3a, NFκB, 
PGC-1α and PPAR-α; in response, these transcription factors stimulate expression of numerous 
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genes that are required for delaying cellular aging and slowing down the age-related progression 
of metabolic disorders [303, 320, 321]. 
          Intracellular reactive oxygen species (ROS) are generated mainly as by-products of 
mitochondrial respiration; in addition, the IMS protein p66shc is involved in mitochondrial ROS 
formation in mice cells by oxidizing cytochrome c [322]. A body of evidence supports the view 
that ROS play a dual role in regulating cellular aging. If mitochondrially produced ROS are 
maintained at sub-lethal levels, these potent signaling molecules initiate an anti-aging cellular 
program by activating protein kinases JNK (in C. elegans and fruit flies Drosophila melanogaster) 
and MST-1 (in C. elegans) [303, 323-325] (Figure 4.1; path 10). Both JNK and MST-1 then 
phosphorylate and thus activate the forkhead transcription factor FOXO, known to turn on 
expression of many genes required for slowing down cellular aging [303, 323-325] (Figure 4.1; 
path 10). If, as it has been first postulated by the mitochondrial free radical theory of aging [326], 
mitochondria are unable to maintain ROS concentration below a toxic threshold, ROS promote 
cellular aging by oxidatively damaging proteins, lipids and nucleic acids in various cellular 
locations [322, 327] (Figure 4.1; path 16).  
          After being synthesized within and exported from mitochondria, iron-sulfur clusters (ISC) 
in the cytosol of yeast and mammalian cells are actively transferred to various apoproteins as 
essential inorganic cofactors required for their activity [328, 329]. Some of these ISC-containing 
proteins are then imported into the nucleus, where they play vital roles in slowing down cellular 
aging by sustaining genome integrity through their involvement in DNA replication, DNA repair 
and telomere maintenance [329, 330] (Figure 4.1; path 12). In replicatively aging yeast, the 
cytosolic ISC also attenuate activity and/or nuclear import of Aft1, a transcription factor that 
activates expression of genes involved in iron uptake by and distribution within cells [328, 330] 
(Figure 4.1; path 11). The resulting drop in free intracellular iron significantly reduces the extent 
of oxidative damage to various cellular proteins, thereby mitigating a process that accelerates 
cellular aging [330]. An age-related mitochondrial dysfunction and the ensuing decline in Δψm in 
replicatively aging yeast hamper ISC synthesis in and/or export from mitochondria and, thus, 
reduce genome stability and elevate oxidative protein damage [330].  
          Both, the rate of mitochondrial DNA (mtDNA) fragments migration to the nucleus and the 
frequency of mtDNA fragments insertion into nuclear DNA, rise with the chronological age of a 
yeast cell [331, 332]. These progressive mitochondria-originated processes with age make 
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essential contributions to cellular aging regulation in chronologically aging yeast, likely by 
influencing nuclear DNA replication, recombination, repair and transcription and ultimately 
reducing nuclear genome stability in an age-related manner [331, 332] (Figure 4.1; path 13).       
          Protein components comprising the so-called mitochondrial translation control (MTC) 
module are known to be involved in the processing, stabilization and translational activation of 
mtDNA-encoded mRNAs [333]. Lack of any of the eight specific members of this protein module 
slows down replicative aging of yeast cells 1) independently of the effects of its absence on 
mitochondrial translation, respiration, ROS production and oxidative damage; and 2) 
autonomously from the anti-aging RTG and back-signaling pathways (see Figure 4.1; paths 1 and 
3, respectively) [334]. The absence of any of these MTC proteins beneficially influences the 
replicative lifespan of a yeast cell via two different pathways. One pathway delays cellular aging 
by suppressing the deleterious accumulation of extrachromosomal rDNA circles in the nucleus in 
a Pnc1- and Sir2-dependent manner [334] (Figure 4.1; path 14); Pnc1 has been shown to deplete 
the level of nicotinamide, a strong non-competitive inhibitor of the NAD+-dependent protein 
deacetylase Sir2 [301, 302]. Another pathway slows down cellular aging by reducing cAMP level 
and the protein kinase A (PKA) activity [334] (Figure 4.1, path 15), thereby attenuating a global 
pro-aging PKA signaling network that inhibits vacuole-dependent autophagy, activates protein 
synthesis in the cytosol and suppresses a stress-response transcriptional program in the nucleus 
[301, 302]. The identity of the primary mitochondria-generated molecular signal that triggers these 
two pathways in response to the absence of a critical protein component of the MTC module 
remains to be established. 
          An age-related mitochondrial dysfunction and the resulting decline in intracellular ATP 
levels and rise in intracellular AMP levels increase the AMP-activated protein kinase (AMPK) 
activity in organisms across phyla [303, 320] (Figure 4.1; path 17). In C. elegans and mammals, 
AMPK, a central regulator of cellular energy homeostasis, can be also activated in response to 
certain longevity-extending dietary and pharmacological interventions [303, 320]. Activated 
AMPK delays cellular aging by 1) inhibiting the TORC1 protein kinase activity, thereby 
attenuating this master regulator of the key pro-aging signaling pathway [303]; 2) turning on an 
anti-aging process of lysosome-dependent autophagy [335]; 3) promoting a SIRT1-dependent 
activating de-acetylation of FOXO and PGC-1α transcription factors known to stimulate 
expression of numerous genes required for slowing down cellular aging and age-related metabolic 
 93 
disorders [303, 320, 321]; 4) phosphorylating histone H2b to activate transcription of numerous 
stress-response genes essential for cell survival [336]; and 5) inhibiting lipolysis of the neutral 
lipids triacylglycerols deposited in lipid droplets (LD) [337].    
          The m-AAA protease Afg3 with chaperone-like activity in the inner membrane of 
mitochondria is involved in degradation of unfolded and misfolded membrane proteins, assembly 
of electron transport chain complexes, and proteolytic maturation of a mitochondrial ribosomal 
protein of the large subunit [338]. Lack of Afg3 delays replicative aging of yeast cells, reduces the 
rate of protein synthesis in the cytosol and enhances resistance to the tunicamycin-induced 
unfolded protein stress in the endoplasmic reticulum (ER) [339]. Thus, the Afg3-assisted protein 
degradation and/or multi-protein complex assembly in the inner membrane of mitochondria may 
accelerate replicative aging of yeast cells by generating some yet-to-be identified molecular signals 
that stimulate the pro-aging processes of protein synthesis in the cytosol and unfolded protein 
stress build-up in the ER [339] (Figure 4.1; paths 18 and 19, respectively).   
          Lack of the outer mitochondrial membrane protein Uth1 slows down replicative aging of 
yeast cells and eliminates the micromitophagic mode of mitophagy, a mechanism of mitochondrial 
quality and quantity control responsible for the autophagic degradation within vacuoles of aged, 
dysfunctional, damaged or excessive mitochondria [340]. In the absence of Uth1, another mode of 
mitophagy, called macromitophagy, remains functional [340]. It has been recently suggested that 
macromitophagy could be a highly selective process responsible for autophagic degradation of 
only dysfunctional mitochondria accumulating in replicatively aging yeast cells, whereas a less 
selective process of micromitophagy could eliminate mitochondria en masse, regardless of their 
functional state [307]. If such a hypothesis is correct, then lack of Uth1 (or perhaps a progressive 
decline in its level with the replicative age of a yeast cell) could delay cellular aging by reducing 
the extent of non-selective micromitophagic degradation of functional mitochondria, while 
preserving (or even increasing) the efficacy with which only dysfunctional mitochondria are 
eliminated in a selective process of macromitophagy (Figure 4.1; path 20).      
          Aup1p is a protein phosphatase within the IMS of yeast mitochondria [340]. In 
chronologically aging yeast cells, Aup1 functions as a longevity assurance protein which 1) 
stimulates the anti-aging process of selective macromitophagy [340] (Figure 4.1; path 21); and 2) 
promotes the dephosphorylation and nuclear import of Rtg3, a key transcriptional activator of the 




Figure 4.1. Communications of mitochondria with many other compartments within the cell are essential for 
establishing the rate of cellular aging. Age-related changes in the rates and efficiencies of numerous processes that 
regulate cellular aging and are confined to mitochondria modulate the ability of these organelles to generate and release 
diverse molecular signals. After being released from mitochondria, these signals trigger cascades of events that cause 
the development of a pro- or anti-aging cellular pattern. Activation arrows and inhibition bars denote pro-aging 
processes (displayed in blue color) or anti-aging processes (displayed in red color). Please see text for additional 
details. ER, endoplasmic reticulum; ETC, electron transport chain; ISC, iron-sulfur clusters; LD, lipid droplet; MTC, 
mitochondrial translation control; mtDNA, mitochondrial DNA; PM, plasma membrane; ROS, reactive oxygen 
species; RTG, retrograde; TAG, triacylglycerols; UPRmt, mitochondrial unfolded protein response pathway; Ψm, 
electrochemical potential across the inner mitochondrial membrane. 
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Lysosomes and vacuoles 
The surface of lysosomes in mammalian cells (vacuoles in yeast cells) provides a platform for the 
activation of TORC1, a master regulator of the key signaling pathway accelerating cellular aging 
[310, 311]. Dietary regimens that reduce the intake of amino acids, the most critical intracellular 
signals for TORC1 activation, are known to delay aging in evolutionarily distant organisms [342]. 
A rise in the level of amino acids in the cytosol of yeast cells causes an increase in protein kinase 
activity of TORC1 by stimulating the formation of a complex between permanently bound to the 
vacuolar surface inactive TORC1 and two Rag family GTPases [343]. In mammalian cells, 
elevated levels of amino acids in the cytosol trigger the Rag GTPase-dependent recruitment of an 
enzymatically inactive TORC1 from the cytosol to the surface of lysosomes; TORC1 is activated 
at the lysosomal surface only after it binds to the small GTPase Rheb in its GTP-bound state 
acquired in response to active growth factor signaling [310, 343].     
          Once activated at the surface of lysosomes or vacuoles, TORC1 sets off a pro-aging program 
in the cell by phosphorylating several target proteins that then activate pro-aging processes or 
inhibit anti-aging processes confined to various cellular compartments [310, 311, 343]. From the 
surface of lysosomes or vacuoles, active TORC1 phosphorylates the following proteins essential 
for cellular aging regulation: 1) the key translational regulators 4E-BP1 and S6K1 in mammalian 
cells, thereby stimulating the pro-aging process of protein synthesis in the cytosol (Figure 4.2; path 
23); 2) the autophagy-initiating proteins ATG13 and ULK1 in mammalian cells (Atg13 in yeast 
cells), thus inhibiting autophagosome formation in the cytosol to suppress the anti-aging process 
of autophagy (Figure 4.2; path 24); 3) the nutrient-sensory protein kinase Sch9 in yeast cells, 
therefore attenuating the anti-aging processes of protein synthesis in mitochondria (Figure 4.2; 
path 25) and transcription of numerous stress-response genes in the nucleus (Figure 4.2; path 26); 
4) the phosphatidic acid phosphatase Lipin-1 in mammalian cells, consequently stimulating the 
pro-aging process of transcription of many genes involved in de novo lipid synthesis and 
adipogenesis (Figure 4.2; path 27); and 5) the transcription factor TFEB in mammalian cells, 
thereby suppressing the anti-aging process of transcription of several genes essential for lysosome 
biogenesis and autophagy (Figure 4.2; path 28) [310, 311, 344]. 
          It needs to be emphasized that in replicatively aging yeast cells cytosolic concentration of 
neutral amino acids (including glutamine, a potent TORC1 activator), is under the stringent control 
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of age-related changes in vacuolar pH [345, 346]. In replicatively “young” cells, the high activity 
of the vacuolar H+-ATPase maintains high vacuole acidity by efficiently coupling ATP hydrolysis 
to proton import into the vacuole [345]. The high concentration of protons in the vacuole of 
replicatively “young” cells drives the proton-dependent import of neutral amino acids from the 
cytosol into this organelle – thereby sustaining the concentration of neutral amino acids (including 
glutamine) in the cytosol at a low level [345]. A progressive decline in vacuole acidity with the 
replicative age of a yeast cell attenuates the proton-dependent import of neutral amino acids into 
the vacuole and, thus, increases their concentrations in the cytosol [345]. The gradual rise in the 
levels of neutral amino acids (including the potent TORC1 activator glutamine) in the cytosol of 
replicatively aging cells may initiate the development of a pro-aging cellular pattern by: 1) 
intensifying the proton-dependent uptake of amassed in the cytosol neutral amino acids by 
mitochondria, thereby significantly reducing Δψm to ultimately cause mitochondrial fragmentation 
[345] (Figure 4.2; path 29); and/or 2) activating TORC1 at the vacuolar surface in a glutamine-
dependent fashion [346] (Figure 4.2; path 30), thus promoting TORC1-dependent phosphorylation 
of several target proteins that in respond activate pro-aging processes or inhibit anti-aging 
processes confined to various cellular compartments (Figure 4.2; paths 23-28).  
 
Peroxisomes 
We recently discussed findings supporting the notion that dynamic communications of 
peroxisomes with other compartments within the cell influence the development of a pro- or anti-
aging cellular pattern [306, 309]. Efficient peroxisomal import of the hydrogen peroxide-
decomposing enzyme catalase (Cta1) in replicatively and chronologically “young” cells not only 
minimizes the oxidative macromolecular damage within peroxisomes but also enables these 
organelles to sustain the extraperoxisomal concentration of hydrogen peroxide at a certain non-
toxic and pro-hormetic level [306, 309]. At such a level, this ROS can stimulate a redox signaling 
network known to elicit “stress-response hormesis” by activating transcription of numerous 
nuclear stress-response genes essential for cell survival, thereby slowing down cellular aging [303, 
306, 309, 322, 325] (Figure 4.3A; path 31). A progressive decline in the efficacy of peroxisomal 
import of hydrogen peroxide-metabolizing catalase with the replicative and chronological age of 
a eukaryotic cell not only gradually elevates the oxidative macromolecular damage within 
peroxisomes but also impairs the ability of these organelles to maintain the extraperoxisomal  
 97 
 
Figure 4.2. Following its activation at the surface of mammalian lysosomes or yeast vacuoles, the target of 
rapamycin complex 1 (TORC1) initiates a pro-aging program by phosphorylating several target proteins in the 
cytosol. Once phosphorylated, these proteins activate pro-aging processes or inhibit anti-aging processes in several 
other cellular compartments. In replicatively aging yeast cells, a progressive reduction of vacuole acidity with cellular 
age mitigates the proton-dependent transport of neutral amino acids (AA) from the cytosol to the vacuole. The 
resulting increase in the cytosolic concentration of neutral amino acids (including the potent TORC1 activator 
glutamine) triggers the development of a pro-aging cellular pattern by impairing mitochondrial function and activating 
TORC1 at the vacuolar surface. Activation arrows and inhibition bars denote pro-aging processes (displayed in blue 
color) or anti-aging processes (displayed in red color). Please see text for additional details. Ψm, electrochemical 
potential across the inner mitochondrial membrane. 
 
concentration of hydrogen peroxide below a non-toxic threshold [306, 309]. Following a release 
of hydrogen peroxide in toxic concentrations from peroxisomes to the cytosol in replicatively and 
chronologically “old” cells, this ROS accelerates cellular aging by oxidatively damaging proteins, 
lipids and nucleic acids in various cellular locations [303, 306, 309, 322] (Figure 4.3B; path 32). 
          Replicatively and chronologically “young” cells are proficient in peroxisomal import of 
Fox1, Fox2, and Fox3, the core enzymes of fatty acid β-oxidation [306, 309]. Therefore, 
peroxisomes of these cells efficiently oxidize fatty acids to acetyl-CoA. The subsequent conversion 
of acetyl-CoA to citrate and acetyl-carnitine in anaplerotic reactions taking place within 
peroxisomes of “young” cells promotes the replenishment of tricarboxylic acid (TCA) cycle 
intermediates destined for mitochondria [309] (Figure 4.3A; path 33). The resulting stimulation of 
the TCA cycle and electron transport chain (ETC) in mitochondria of these cells allows these 
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organelles to maintain ROS at sub-lethal levels that turn on expression of many nuclear genes 
required for decelerating cellular aging (Figure 4.1; path 10). A progressive decrease in the efficacy 
of peroxisomal import of Fox1, Fox2, and Fox3 with the replicative and chronological age of a 
eukaryotic cell slows down fatty acid oxidation and anaplerotic reactions in peroxisomes, thereby 
diminishing the TCA cycle and ETC in mitochondria of “old” cells [309] (Figure 4.3B; path 34). 
This, in turn, leads to an age-related decline in Δψm and causes a fragmentation of mitochondria 
by promoting fission of a mitochondrial network [304]. The resulting release of cytochrome c (and, 
perhaps, of other pro-apoptotic proteins) from fragmented mitochondria in “old” cells triggers an 
age-related form of apoptotic cell death [304] (Figure 4.3B).           
          The age-related deterioration of peroxisomal import of Fox1, Fox2, and Fox3 seen in “old” 
cells ultimately suppresses peroxisomal oxidation of fatty acids that originate from triacylglycerols 
(TAG) synthesized in the ER and then deposited within lipid droplets (LD) [304, 347] (Figure 
4.3B). This initiates several negative feedback loops that reduce lipolysis of TAG in LD and their 
biosynthesis in the ER, thus causing the excessive accumulation of fatty acids and diacylglycerol 
both in the ER and LD [304, 347] (Figure 4.3B; path 35). Such remodeling of lipid dynamics 
promotes cellular aging and accelerates the onset an age-related form of necrotic cell death [304, 
344] (Figure 4.3B).  
          Peroxisomal polyamine oxidase in “young” cells is involved in the synthesis of spermidine, 
a polyamine whose intracellular level substantially declines with the replicative and chronological 
age of a eukaryotic cell [348, 349] (Figure 4.3A). Spermidine has been shown to delay cellular 
aging in evolutionarily distant organisms by stimulating an anti-aging process of 
lysosome/vacuole-dependent autophagy [348] (Figure 4.3A; path 36). 
          In addition to its essential roles in yeast peroxisomal protein import, ER-derived pre-
peroxisomal vesicle fusion, and cell differentiation [306], the predominantly peroxisomal protein 
Pex6 is also involved in sequestering dysfunctional mitochondria in replicatively “old” mother 
cells and/or segregating only functional mitochondria to their replicatively “young” budding 
progeny [350]. The ability of Pex6 to regulate replicative aging of yeast cells by ensuring the age-
related asymmetrical segregation of functional mitochondria between mother and daughter cells is 
likely due to its involvement in mitochondrial import of Atp2, a β-subunit of the F1 sector of 
mitochondrial F0, F1-ATP synthase [350]. It has been suggested that a mechanism underlying the 
essential contribution of peroxisome-associated pool of Pex6 to mitochondrial import of Atp2p 
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and to the maintenance of age asymmetry between the mother and daughter cells with respect to 
segregation of functional mitochondria may involve a recently discovered mitochondria-to-
peroxisome vesicular traffic [306] (Figure 4.3A; path 37). 
 
Figure 4.3. Age-related changes in the rates and efficiencies of several processes taking place in peroxisomes 
modulate the rates and efficiencies with which these organelles generate and/or release certain molecular 
signals. (A) In replicatively and chronologically “young” cells, these signals activate anti-aging processes in several 
other cellular compartments. (B) In replicatively and chronologically “old” cells, such signals activate pro-aging 
processes in other cellular locations. Activation arrows and inhibition bars denote pro-aging processes (displayed in 
blue color) or anti-aging processes (displayed in red color). Please see text for additional details. Ac-Carnitine, acetyl-
carnitine; DAG, diacylglycerol; ER, endoplasmic reticulum; ETC, electron transport chain; FA, fatty acids; LD, lipid 
droplet; ROS, reactive oxygen species; TAG, triacylglycerols; TCA, tricarboxylic acid cycle; ΔΨm, electrochemical 
potential across the inner mitochondrial membrane. 
 
4.3    A model of an intricate network of intercompartmental communications underlying 
cellular aging  
          A body of evidence summarized here and elsewhere [306, 309] suggests a depicted 
schematically in Figure 4.4 model for an intricate network of intercompartmental (i.e., organelle-
organelle and organelle-cytosol) communications that underlies cellular aging in evolutionarily 
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distant organisms. The presented in Figure 4.4 model summarizes Figures 4.1 to 4.3, and each path 
in Figure 4.4 is numbered as in Figures 4.1, 4.2 or 4.3. In my model, the network integrates 
unidirectional communications between 1) mitochondria and the nucleus (Figure 4.4; paths 1, 3, 
5-14 and 22); 2) peroxisomes and the nucleus (Figure 4.4; path 31); 3) lysosomes/vacuoles and the 
nucleus (Figure 4.4; paths 27 and 28); 4) mitochondria and lysosomes/vacuoles (Figure 4.4; paths 
2, 4, 20 and 21); 5) peroxisomes and mitochondria (Figure 4.4; paths 33, 34 and 37); 6) 
mitochondria and the ER (Figure 4.4; path 19); 7) mitochondria and the plasma membrane (Figure 
4.4; path 15); 8) the cytosol and the nucleus (Figure 4.4; path 26); and 9) peroxisomes and the 
cytosol (Figure 4.4; path 32). Mitochondria and the cytosol (Figure 4.4; paths 16-18, 25 and 29) 
as well as lysosomes/vacuoles and the cytosol (Figure 4.4; paths 23, 24, 27, 28, 30 and 36) are also 
involved in bidirectional communications within the network underlying cellular aging. As 
outlined in the previous section, these unidirectional and bidirectional communications between 
different cellular compartments integrated into the network operate as a flow of certain soluble 
metabolites, peptides, proteins and DNA fragments. Moreover, the ER, LD and peroxisomes 
establish zones of close apposition. Within the network underlying cellular aging, these three 
organelles communicate via unidirectional flow of several lipid species; this lipid flow is under 
the stringent control of several negative feedback loops [304, 344, 347] (Figure 4.4; path 35). 
          The central tenet of the depicted in Figure 4.4 model is that the numerous directed, 
coordinated and regulated organelle-organelle and organelle-cytosol communications integrated 
into the network are essential for the development of a pro- or anti-aging cellular pattern. Thus, 
this network of intercompartmental communications plays a critical role in regulating cellular 
aging by programming the long-term viability of a eukaryotic cell.        
 
4.4     Conclusions and future perspectives  
          Emergent evidence supports the view that numerous directed, coordinated and regulated 
organelle-organelle and organelle-cytosol communications within a eukaryotic cell are integrated 
into an intricate network critical for regulating cellular aging. The challenge remains to define 
molecular mechanisms underlying the various pathways of intercompartmental communications 
constituting this network. Future work will aim at understanding how age-related intracellular 
stresses and environmental factors influence the spatiotemporal dynamics of the entire network 
and how the network defines the long-term viability of a eukaryotic cell. This knowledge may 
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reveal novel targets for anti-aging dietary and pharmacological interventions that can slow down 
cellular and organismal aging by modulating information flow along the pathways of 
multidirectional intercompartmental communications within the network. 
 
 
Figure 4.4. A model of an intricate network of organelle-organelle and organelle-cytosol communications 
underlying cellular aging. The model summarizes Figures 4.1 to 4.3, and each path is numbered as in Figures 4.1, 
4.2 or 4.3. By defining the long-term viability of a eukaryotic cell, this network of intercompartmental communications 
plays an essential role in regulating cellular aging. Activation arrows and inhibition bars denote pro-aging processes 
(displayed in blue color) or anti-aging processes (displayed in red color). Please see text for additional details. ER, 
endoplasmic reticulum; LD, lipid droplet; PM, plasma membrane. 
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5        Future Directions 
 
          One challenge for the future is to define molecular mechanisms underlying the LCA-driven 
remodeling of mitochondrial lipidome and proteome. Our previous findings suggested a 
hypothesis in which LCA may cause such remodeling of mitochondrial lipidome by 1) slowing 
down the Psd1-dependent reaction of the synthesis of PE from PS in the IMM and/or OMM; 2) 
decelerating the Crd1-dependent reaction of CL synthesis from PG in the IMM; and 3) attenuating 
a negative feedback loop that involves a CL-dependent inhibition of PA transport from the OMM 
across the IMS to the IMM, which is catalyzed by the Ups1/Mdm35 protein complex (Figure 2.1) 
[81]. Studies aimed at testing this hypothesis are currently in progress in the Titorenko laboratory.      
          Furthermore, we previously demonstrated that LCA causes major changes not only in 
mitochondrial membrane lipidome but also in the size, number and morphology of mitochondria 
[81]. One could envision that these LCA-driven changes in mitochondrial abundance and 
morphology may affect mitochondrial protein import, folding, assembly and other aspects of 
mitochondrial proteostasis, thereby altering mitochondrial proteome. The ongoing studies in the 
Titorenko laboratory address the validity of this assumption. 
          Moreover, it will be important to test my hypothesis that CR decelerates the differentiation 
and maintenance programs of GQLD and GQHD cells (respectively) because this low-calorie diet 
modulates the above-mentioned set of longevity-defining processes. To test this hypothesis, it will 
be essential to assess how genetic interventions impairing each of these processes may influence 
the chronological age-related relative abundance of GQHD, GQLD, GNQHD and GNQLD subpopulations 
in CR and non-CR yeast cultures. It will be also interesting to examine how these genetic 
interventions may affect longevity of chronologically aging yeast under CR and non-CR 
conditions. 
          Another challenge for the future is to explore how genetic and pharmacological 
interventions known to delay yeast chronological aging by modulating a network of certain 
signaling pathways and protein kinases may impinge on the described here mechanism that links 
cellular aging to cell cycle regulation, maintenance of the Q state, entry into the NQ state and 
survival in the NQ state. This network integrates the TORC1, PKA, Snf1 and Pho85 core hubs of 
the signaling network of quiescence, as well as their downstream effector proteins Sch9, Rim15 
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